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Ci vuole un gran fisico per correre dietro ai sogni. Sono velocissimi, scappano, si nascondono, si 
mimetizzano e a volte sembrano sparire del tutto. Ma in fondo cos’è un sogno?  
Un sogno è un momento di silenzio, ma anche un urlo fortissimo, un sogno è un’occasione, un treno 
che percorre un binario che in certi momenti sembra non finire mai, un binario dove a volte le 
fermate sembrano durare ore, un binario che a volte si interrompe per prendere strade secondarie, 
un binario percorso da un treno dove in certi momenti diventa tutto buio, e dove la paura è la tua 
unica compagna.  
La passione è il motore dei nostri sogni. 
 
Stefano Benni 
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INTRODUZIONE 
I derivati degli Oligo(fenilenetinileni)  (OPEs; sigla in inglese), costituiscono un gruppo di coloranti 
luminescenti con una struttura coniugata molto stabile, con la forma caratteristica di bastoncino.1 Questi 
composti posseggono proprietà di enorme interesse applicativo in numerosi ambiti, fondamentalmente 
dovute al fatto che il loro scheletro possiede una estesa coniugazione. Le loro proprietà possono essere 
modulate con l’inserimento di differenti sostituenti agli anelli aromatici dello scheletro coniugato con 
conseguente modifica del sistema elettronico del sistema.2 La suddetta facilità nel variare le loro proprietà 
elettroniche ha determinato l’applicazione di questi derivati in vari campi, dalla sensoristica3 all’elettronica, 
4 ma anche in campo biologico.5 
L’uso di sonde fluorescenti, d’altra parte, ha ormai facilitato enormemente l’interpretazione di alcuni 
processi biologici a livello molecolare e cellulare.6  Perchè vi siano applicazioni biomediche, ai composti che 
possono essere utilizzati come sonde fluorescenti si richiedono caratteristiche strutturali ben definite, visto 
che devono subire eccitazione per irraggiamento ad una determinata lunghezza d’onda che sia compatibile 
con i substrati biologici, così come avere un’emissione in un determinato intervallo di . In più, perchè siano 
applicabili in campo biologico, queste molecole devono essere bio- e fotostabili, oltre a possedere la capacità 
di mantenere la propria farmacocinetica senza alterazioni nel tempo. Questa ultima caratteristica viene 
spesso ritrovata in strutture coniugate che posseggono frammenti di amminoacidi e carboidrati. 
Visti questi presupposti, si è pensato che l’introduzione di carboidrati semplici nella struttura degli 
OPEs avrebbe potuto aggiungere alle loro note caratteristiche strutturali un frammento naturale che ne 
avrebbe facilitato l’utilizzo come sonde fluorescenti in processi biologici. L’ntroduzione di residui zuccherini 
avrebbe potuto inoltre aumentare la solubilità in acqua di questi composti, oltre ad incrementarne la 
biocompatibilità. D’altra parte, la proporzione relativa tra frammenti aromatici (idrofobici) e carboidrati 
                                                          
1 Bunz, U. H. F. Chem. Rev. 2000, 100, 1605−1644. 
2 (a) Yamaguchi, Y.; Shimoi, Y.; Ochi, T.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-I. J. Phys. Chem. A 2008, 
112, 5074−5084. (b) Zhi, Y.-G.; Lai, S.-W.; Chan, Q. K.-W.; Law, Y.-C.; Tong, G.S.-M.; Che, C.-M. Eur. J. Org. 
Chem. 2006, 3125−3139. (c) Yamaguchi, Y.; Tanaka, T.; Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, 
Z.-i. J. Am. Chem. Soc. 2005, 127, 9332−9333. 
3 (a) Kim, U.-I.; Suk, J.-m.; Naidu, V. R.; Jeong, K.-S. Chem. Eur. J. 2008, 14, 11406−11414. (b) Thomas, S. W., 
III; Joly, G. D.; Swager, T. M. Chem. Rev. 2007, 107, 1339−1386. (c) Kim, I.-K.; Erdogan, B.; Wilson, J. N.; Bunz, 
U. H. F. Chem. Eur. J. 2004, 10, 6247−6254. 
4 (a) Kaliginedi, V.; Moreno-García, P.; Valkenier, H.; Hong, W.; García Suarez, V. M.; Buiter, P.; Otten, J. L. H.; 
Hummelen, J. C.; Lambert, C. J.; Wandlowski, T. J. Am. Chem. Soc. 2012, 134, 5262−5275. (b) Yamaguchi, Y.; 
Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. Angew. Chem., Int. Ed. Engl. 2005, 44, 7040−7044. 
5 (a) Hill, E. H.; Evans, D. G.; Whitten, D. G. Langmuir 2013, 29, 9712−9720. (b) Dascier, D.; Ji, E.; Parthasarathy, 
A.; Schanze, K. S.; Whitten, D. G. Langmuir 2012, 28, 11286−11290. (c) McRae, R. L.; Phillips, R. L.; Kim, I.-B.; 
Bunz, U. H. F.; Fahrni, C. J. J. Am. Chem. Soc. 2008, 130, 7851−7853.  
6 (a) He, X.; Wang, K.; Cheng, Z. Nanomed. Nanobiotechnol. 2010, 2, 349−366. (b) Kobayashi, H.; Ogawa, M.; 
Alford, R.; Choyke, P. L.; Urano, Y. Chem. Rev. 2010, 110, 2620−2640. (c) Rao, J.; Dragulescu-Andrasi, A.; Yao, 
H. Curr. Opin. Biotechnol. 2007, 18, 17−25. 
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(idrofilici) negli OPEs glicosilati, che è possibile modulare attraverso l’uso di un’adeguata metodologia 
sintetica, avrebbe potuto essere essenziale per successive applicazioni biologiche. Come conseguenza di 
queste premesse sono stati pianificati, per questa tesi di dottorato, gli obiettivi qui di seguito elencati. 
OBIETTIVI 
SINTESI 
 Il primo obiettivo di questa tesi di dottorato è stato incentrato sulla Síntesi di derivati di Oligo 
(fenilen etinileni), OPEs, di differente grandezza molecolare (fino a tre unità fenilenetinileniche), e 
contenenti due frammenti glicosidici derivati dal glucosio, oltre che sostituenti differenti (OMe, NMe2, 
+NMe3) agli anelli aromatici. Si è inoltre pianificata la sintesi di altri derivati analoghi con unità di BODIPY e 
azobenzene. Alcune delle strutture sintetizzate sono incluse in Figura 1. 
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Figura 1.- OPEs Glucosil Derivati sintetizzati 
11 
 
E’ stata inoltre realizzata la sintesi di analoghi galattosidici, col fine ultimo di studiare l’influenza della 
natura dello zucchero sulle proprietà degli OPEs risultanti (Figura 2). Alla stessa maniera, sono stati 
sintetizzati OPEs contenenti due residui di Isobornil solfossido. 
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Figura 2.- Galattoside e Solfossido derivati degli OPEs sintetizzati 
 
STUDIO DI PROPRIETA’ 
 Studio di propietà fotofísiche dei composti ottenuti e valutazione, in alcuni casi, della loro capacità 
di generare Ossigeno singoletto. 
 Studio delle propietà biologiche. Inizialmente questo studio è stato incentrato sulla valutazione della 
capacità di questi composti di attraversare la membrana cellulare del tessuto epidermoide del carcinoma 
della laringe (HEp-2), con il fine ultimo di determinare la loro possibile applicazione come sonde biologiche 
fluorescenti. Questa parte del lavoro è stata effettuata in collaborazione col gruppo di ricerca della Prof. 
Maria Teresa Sciortino dell’Università di Messina. Il distinto rapporto esistente negli OPEs sintetizzati  tra 
resti idrofilici (carboidrati) e resti idrofobici (areni sostituiti) permetterà di riconoscere la loro relativa 
influenza sulla bioaffinità. 
 Studio della capacità di alcuni degli OPEs ottenuti di agire come fotosensibilizzatori per 
un’applicazione in Terapia Fotodinamica (PDT).   Con questo fine, sono state utilizzate varie linee cellulari: 
Cellule di cheratinociti umani (HaCaT), cellule di cancro della cervice umana (HeLa) e cellule  del tessuto 
epidermoide del carcinoma della laringe (HEp-2). Questa parte di lavoro è stata portata avanti in 
collaborazione con il gruppo di ricerca della Prof. Ángeles Juarranz, del Departamento de Biología dell’ 
Universidad Autónoma de Madrid 
Sintesi di OPEs funzionalizzati con carboidrati. 
La metodologia applicata per la costruzione degli scheletri carboniosi dei suddetti oligo 
fenilenetinileni (OPEs) è stata basata sull’uso iterativo di una reazione di tipo Sonogashira catalizzata da 
Pd(0), in assenza di rame. Si è così riusciti ad occoppiare differenti frammenti con resti acetilenici con anelli 
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aromatico iodo e bromo sostituiti che, inoltre, contenessero i diversi gruppi funzionali presenti nelle strutture 
finali. La unità di acetilene iniziale reca il glicoside corrispondente. 
Come esempio rappresentativo, si riporta la sintesi dell’OPE 18 nello schema 1. A partire dall’1,5-
dimetossi-1,4-diiodo benzene è stato introdotto sull’anello aromatico, in maniera controllata, un equivalente 
di glucoside propargilico peracetilato 1. Il prodotto 4 derivato da questo monoaccoppiamento possiede 
ancora un resto di iodoarene che può essere sottoposto ad una nuova funzionalizzazione. Per disegnare una 
sintesi il più possibile convergente, è stata effettuata la doppia funzionalizzazione della 2,5-dibromo dimetil 
anilina 15,  con un eccesso di trimetilsililacetilene, in presenza di Pd(PPh3)4 e NEt3 in DMF, ottenendo il 
derivato 16. L’unione dei due frammenti 4 (2 equivalenti) e 16, è stata effettuata senza la necessità di 
eliminare i gruppi TMS da quest’ultimo, utilizzando nella reazione di Sonogashira Ag2O, oltre che il 
cataizzatore di Pd (0). Il ruolo dell’ossido di argento è fondamentale in quanto facilita la desililazione 
simultaneamente all’accoppiamento. Una volta ottenuto l’OPE adeguadamente funzionalizzato, è stata 
necessaria solo la deprotezione dei gruppi acetato del glucoside, ottenuta con resa quantitativa per 
trattamento del prodotto  17 con una soluzione di idrossido ammonico, utilizzando una miscela di THF e 
Metanolo per solubilizzare il substrato peracetilato. La metodologia si è dimostrata molto generale ed è stata 
applicata alla sintesi di una larga varietà di OPEs, solo sintetizzando previamente gli acetinil areni 
adeguadamente sostituiti. A partire dal propargil galattoside analogo a 1, si è potuta ottenere la sintesi della 
serie corrispondente mediante una metodologia simile. 
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(Schema 1) 
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La ricerca sviluppata ha anche permesso di accedere al substrato 43 indicato nello Schema 2, che contiene 
un frammento centrale di BODIPY, sintetizzato a partire dal 2,4-dimetilpirrolo, applicando una metodologia 
sintetica già descritta. L’introduzione di due residui acetilenici nel BOPIPY ha permesso di accedere al 
substrato 42, il cui accoppiamento con lo iodoarene glicosilato 4, ha portato alla molecola obiettivo 43. 
(Schema 2) 
 
 
Schema 2 
Il metodo ha portato anche alla sintesi del solfossido 50 (Schema 3), e al suo diastereomero (epimero 
ai due atomi di zolfo), grazie al doppio accoppiamento tra acetinilsolfinil derivato  48R e il 2,5-dimetossi-1,4-
iodobenzene 2. 
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Schema 3 
 
Nel caso caso dell’azoderivado 51, la sintesi è stata compiuta in maniera analoga, come indicato nello 
Schema 4, mediante il doppio accoppiamento tra il diiodoazobenzene 49 e il bisacetilene 5, che recava l’unità 
di carboidrato. 
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Schema 4 
 
STUDIO DI PROPRIETA’ 
La seconda parte di questa tesi di dottorato si è incentrata sullo studio di proprietà fotofisiche dei composti 
sintetizzati.  
PROPRIETA’ FOTOFISICHE 
Sono stati registrati gli spettri di assorbimento (UV/vis) degli OPES sintetizzati in soluzione acquosa 
tamponata (fosfato) così come dei precursori acetilati in diclorometano: è stata in ogni caso osservata 
un’intensa banda di assorbimento nella regione 340-390 nm, dovuta alla transizione -
sistemi aromatici coniugati. In tutti i casi si è osservato un comportamento spettroscopico le cui differenze 
vengono qui di seguito riassunte.  L’aumento della coniugazione causa uno spostamento batocromico della 
banda menzionata, com’era atteso. D’altra parte, anche il coefficiente di estinzione molare aumenta con la 
coniugazione. L’eccitazione di questi composti, nell’intervallo 280-420 nm, produce una emissione nella 
regione del blu e  blu-verde. La presenza del gruppo NMe2, fortemente elettrondonatore, all’anello centrale 
dell’oligomero  17 sposta la luminescenza verso il rosso e diminuisce leggermente la resa quantica, che 
comunque si mantiene elevata (0,57). Il profilo d’emissione di questo composto suggerisce l’esistenza di uno 
stato eccitato con un trasferimento di carica parziale attribuibile alla transizione n → π*.  
 
PROPRIETA’ BIOLOGICHE 
L’internalizzazione degli OPEs sintetizzati in cellule di tipo HEp-2 (tessuto epidermoide del carcinoma 
della laringe) è stata studiata con l’utilizzo della microscopia a fluorescenza. Gli esperimenti effettuati hanno 
messo in evidenza un comportamento di questi composti direttamente relazionato alle caratteristiche 
strutturali e spettroscopiche appena commentate. Nonostante l’oligomero 18, che possiede un anello 
centrale con un sostituente di tipo dimetilamminico e i due residui di glucosio con i gruppi OH liberi, sia 
risultato essere il composto più biocompatibile e promettente per essere utilizzato come sonda fluorescente 
nelle cellule, l’elevata emissione e le alte rese quantiche osservate per tutti gli OPEs studiati, così come la 
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loro alta stabilità fanno di questi glucosidi adeguati candidati per l’utilizzo come coloranti in microscopia a 
fluorescenza.  
 
Un altro studio di interesse effettuato in questa tesi corrisponde alla valutazione della capacità del substrato  
17 e dell’analogo con due anelli contenenti ognuno un gruppo NMe2,  di agire come fotosensibilizzatore in 
Terapia Fotodinamica (PDT). La PDT è un procedimento minimamente invasivo che può produrre 
l'eradicazione di malattie neoplastiche combinando l’effetto di un fotosensibilizzatore, di irraggiamento con 
luce di una determinata lunghezza d’onda e di ossigeno. Lo studio biologico dei nuovi ammino oligo(fenilen-
etinileni) sintetizzati in questo lavoro, e tra loro dell’OPE 18, ha messo in evidenza la loro capacità di agire 
come fotosensibilizzatori in combinazione con la luce UVA. I saggi sono stati effettuati su due linee cellulari 
tumorali (HEp-2 y HeLa) provenienti dal carcinoma della laringe e della cervice, rispettivamente. Una volta 
irradiati, questi composti causano un blocco mitotico che conduce alla finale morte cellulare. In più, sono 
risultati efficaci a concentrazioni fino a 3 µm.  
  
Conclusioni: 
 Il lavoro realizzato per questa tesi di dottorato ha permesso di mettere a punto una metodologia 
sintetica iterativa e convergente che conduce alla costruzione efficiente dello scheletro degli OPEs 
obiettivo. La versatilità del processo ha condotto a glicosidi contenenti anelli aromatici centrali 
diversamente sostituiti, attraverso un accoppiamento di tipo Sonogashira catalizzato da Pd(0), in 
assenza di catalizzatore di Cu, tra acetileni adeguatamente funzionalizzati e bromo o iodo areni. 
 Le proprietà fisiche, come l’alta resa quantica e la produzione di Ossigeno singoletto, sono state 
valutate, avendo potuto stabilire in origine la loro capacità di produrre luminescenza con emissione 
nella regione blu, blu-verde. 
 La loro stabilità, biocompatibilità, efficace internalizzazione nelle cellule e la loro buona risposta, 
anche a basse concentrazioni, fanno dei derivati amminici sostituiti fotosensibilizzatori promettenti 
in Terapia fotodinamica.  
 Gli ammino derivati sono capaci di produrre un efficace effetto foto dinamico quando irradiati con 
luce UVA provocando la morte cellulare, anche con bassa produzione di ossigeno singoletto. 
 Lo studio effettuato in questo lavoro ha messo in evidenza, per la prima volta, la possibilità di 
utilizzare gli OPEs come fotosensibilizzatori e può essere un punto di partenza per estendere le 
applicazioni di questi composti luminescenti nel campo della Terapia Fotodinamica (PDT). 
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INTRODUCCIÓN 
Los derivados de Oligo(fenilenetinileno)  (OPEs; siglas en inglés) constituyen un grupo de colorantes 
luminiscentes con una estructura conjugada muy estable, en forma de barra.7 Estos compuestos poseen 
propiedades de enorme interés aplicado en distintos campos que se deben fundamentalmente  a que su 
esqueleto presenta una conjugación extendida. Las propiedades se pueden modular a voluntad mediante la 
introducción de distintos sustituyentes en los anillos aromáticos del esqueleto conjugado que modifican las 
características electrónicas de los sistemas.8 Esta facilidad para variar sus propiedades electrónicas ha 
determinado que se hayan encontrado numerosas aplicaciones para estos derivados entre las que cabe 
destacar su uso como sensores,9  en electrónica,10 y en el campo de las aplicaciones biológicas.11 
Por otra parte, el uso de sondas fluorescentes ha facilitado enormemente la interpretación de 
algunos procesos biológicos a nivel molecular y celular.12  Las aplicaciones biomédicas de los compuestos que 
pueden utilizarse como sondas fluorescentes requieren unas características estructurales concretas ya que 
las moléculas fluorescentes han de sufrir la excitación por irradiación a una determinada longitud que sea 
compatible con los sustratos biológicos, así como presentar  una emisión en un determinado rango de . Para 
poder ser aplicadas en el campo biológico, estas moléculas han de ser bio y foto estables además de poseer 
la capacidad de mantener su farmacocinética sin alteraciones a lo largo del tiempo. Esta última característica 
se encuentra con mucha frecuencia en estructuras conjugadas que poseen fragmentos de amino ácidos o 
carbohidratos. 
La introducción de carbohidratos sencillos en las estructuras de los OPEs, añadiría a las características 
estructurales de los mismos un fragmento natural que facilitaría  su utilización como sondas fluorescentes 
en procesos biológicos. La introducción de restos de azúcar podría también aumentar la  solubilidad en agua 
de estos compuestos así como incrementar su biocompatibilidad. Por otra parte, la proporción relativa entre 
fragmentos aromáticos (hidrofóbicos) y carbohidratos (hidrofílicos) en los OPEs glicosilados, que puede 
modularse mediante metodología sintética, podría ser esencial para futuras aplicaciones biológicas. De 
                                                          
7 Bunz, U. H. F. Chem. Rev. 2000, 100, 1605−1644. 
8 (a) Yamaguchi, Y.; Shimoi, Y.; Ochi, T.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-I. J. Phys. Chem. A 2008, 112, 
5074−5084. (b) Zhi, Y.-G.; Lai, S.-W.; Chan, Q. K.-W.; Law, Y.-C.; Tong, G.S.-M.; Che, C.-M. Eur. J. Org. Chem. 
2006, 3125−3139. (c) Yamaguchi, Y.; Tanaka, T.; Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. J. Am. 
Chem. Soc. 2005, 127, 9332−9333. 
9 (a) Kim, U.-I.; Suk, J.-m.; Naidu, V. R.; Jeong, K.-S. Chem. Eur. J. 2008, 14, 11406−11414. (b) Thomas, S. W., III; 
Joly, G. D.; Swager, T. M. Chem. Rev. 2007, 107, 1339−1386. (c) Kim, I.-K.; Erdogan, B.; Wilson, J. N.; Bunz, U. H. F. 
Chem. Eur. J. 2004, 10, 6247−6254. 
10 (a) Kaliginedi, V.; Moreno-García, P.; Valkenier, H.; Hong, W.; García Suarez, V. M.; Buiter, P.; Otten, J. L. H.; 
Hummelen, J. C.; Lambert, C. J.; Wandlowski, T. J. Am. Chem. Soc. 2012, 134, 5262−5275. (b) Yamaguchi, Y.; 
Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. Angew. Chem., Int. Ed. Engl. 2005, 44, 7040−7044. 
11 (a) Hill, E. H.; Evans, D. G.; Whitten, D. G. Langmuir 2013, 29, 9712−9720. (b) Dascier, D.; Ji, E.; Parthasarathy, A.; 
Schanze, K. S.; Whitten, D. G. Langmuir 2012, 28, 11286−11290. (c) McRae, R. L.; Phillips, R. L.; Kim, I.-B.; Bunz, U. 
H. F.; Fahrni, C. J. J. Am. Chem. Soc. 2008, 130, 7851−7853.  
12 (a) He, X.; Wang, K.; Cheng, Z. Nanomed. Nanobiotechnol. 2010, 2, 349−366. (b) Kobayashi, H.; Ogawa, M.; Alford, 
R.; Choyke, P. L.; Urano, Y. Chem. Rev. 2010, 110, 2620−2640. (c) Rao, J.; Dragulescu-Andrasi, A.; Yao, H. Curr. Opin. 
Biotechnol. 2007, 18, 17−25. 
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acuerdo con estas premisas se plantearon, para esta tesis doctoral, los objetivos que se indican a 
continuación. 
OBJETIVOS 
SÍNTESIS 
 El primer objetivo de esta tesis doctoral se centró en la Síntesis de derivados de Oligo (fenilen 
etinilenos), OPEs, de diferente magnitud molecular (hasta tres unidades de fenilenetinileno), conteniendo 
dos fragmentos glicosídicos derivados de glucosa además de distintos sustituyentes (OMe, NMe2, +NMe3)  en 
los anillos aromáticos. También se planteó la síntesis de otros derivados análogos con unidades de BODIPY y 
azobenceno. Algunas de las estructuras sintetizadas se incluyen en la Figura 1. 
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Figura 1.- Glucósidos derivados de OPEs sintetizados 
 
La síntesis de galactósidos análogos también se llevó a cabo con el fin de estudiar la influencia de la 
naturaleza del azúcar en las propiedades de los OPEs resultantes (Figura 2). Asimismo, se sintetizaron OPEs 
conteniendo dos restos de isobornil sulfóxido. 
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Figura 2.- Glalactósido y sulfóxido derivados de OPEs sintetizados 
 
ESTUDIO DE PROPIEDADES 
 Estudio de las propiedades fotofísicas de los compuestos obtenidos y evaluación, en algunos casos, 
de su capacidad para generar Oxígeno singlete. 
 Estudio de propiedades biológicas. Inicialmente este estudio se centró en evaluar la capacidad de 
estos compuestos para atravesar las membranas celulares del tejido epidermoide del carcinoma de laringe 
(HEp-2), con el fin de determinar su posible aplicación como sondas biológicas fluorescentes. Esta parte del 
trabajo se llevó a cabo en colaboración con el grupo de investigación de la Prof. Maria Teresa Sciortino, de la 
Universidad de Messina. La distinta relación existente en los OPEs sintetizados de restos hidrofóbicos (arenos 
sustituidos) e hidrofílicos (carbohidratos) permitirá conocer su influencia relativa sobre la bioafinidad. 
 Estudio de la capacidad de algunos de los OPEs obtenidos de actuar como fotosensibilizadores para 
su aplicación en Terapia Fotodinámica (PDT).   Con este fin se utilizaron distintas líneas celulares:   Células de 
keratinocitos humanos (HaCaT), células humanas de cáncer cervical (HeLa) y  células del tejido epidermoide 
del carcinoma de laringe (HEp-2). Esta parte del trabajo se llevó a cabo en colaboración con el grupo de 
investigación de la Prof. Ángeles Juarranz, del Departamento de Biología de la Universidad Autónoma de 
Madrid. 
 
Síntesis de OPEs funcionalizados con carbohidratos. 
La metodología aplicada para la construcción de los esqueletos carbonados de  estos oligo 
fenilenetinilenos (OPEs) se basó en el uso iterativo de una reacción de tipo Sonogashira catalizada por Pd(0), 
en ausencia de cobre. Se lograron así acoplar distintos fragmentos con restos acetilénicos con anillos 
aromáticos Iodo o bromo sustituidos que, además, contenían los distintos grupos funcionales presentes en 
las estructuras finales. La unidad inicial de acetileno aportaba el glicósido correspondiente. 
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Como ejemplo representativo, se recoge la síntesis del OPE 18 en el Esquema 1. Así, a partir de 2,5-
dimetoxi-1,4-diiodo benceno se introdujo un equivalente del glucósido propargílico peracetilado 1 de forma 
controlada en el anillo aromático. El producto 4 resultante de este monoacoplamiento, todavía contenía un 
resto de iodo areno susceptible de ser funcionalizado nuevamente. Para diseñar una síntesis lo más 
convergente posible, se llevó a cabo la doble funcionalización de la 2,5-dibromo dimetil anilina 15,  con 
exceso de trimetilsililacetileno, en presencia de Pd(PPh3)4 y NEt3 en DMF, lográndose obtener el derivado 16. 
La unión entre los fragmentos 4 (2 equivalentes) y 16, se pudo llevar a cabo sin necesidad de eliminar los 
grupos TMS de este último, utilizando en la reacción de Sonogashira Ag2O, además del catalizador de Pd (0). 
El papel de la plata es fundamental ya que debe facilitar la desililacón de forma simultánea al acoplamiento. 
Una vez obtenido el OPE adecuadamente funcionalizado, sólo se requería la desprotección de los acetatos 
del glucósido, lo que se logró con rendimiento cuantitativo por tratamiento del producto  17 con una 
disolución de hidróxido amónico utilizando una mezcla de THF y Metanol para solubilizar el sustrato 
peracetilado.  
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(Esquema 1) 
La metodología se mostró muy general y pudo se aplicada a la síntesis de una variedad de OPEs sin más que 
sintetizar previamente los acetinil arenos adecuadamente sustituidos. A partir del propargil galactósido 
análogo a 1, se pudo llevar a cabo la síntesis de las series correspondientes mediante una metodología 
similar. 
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La investigación desarrollada permitió también acceder al sustrato 43 indicado en el Esquema 2, que contiene 
un fragmento central de BODIPY, sintetizado a partir de 2,4-dimetil pirrol, aplicando metodología descrita. 
La introducción de sendos acetilenos en el BOPIPY permitió acceder al sustrato 42, cuyo acoplamiento con el 
iodo areno glicosilado 4, condujo a la molécula objetivo 43. (Esquema 2) 
 
 
Esquema 2 
El método condujo también a la síntesis del sulfóxido 50 (Esquema 3)  y a su diastereomero (epimero 
a los dos azufre), gracias al doble acoplamiento entre el acetinil sulfinil derivado  48R y el 2,5-dimetoxi-1,4-
iodobenceno 2. 
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Esquema 3 
En el caso del azoderivado 51, la síntesis se completó de forma análoga, según se indica en el 
Esquema 4 medianrte el doble acoplamiento entre el diiodoazobenceno 49 y el bisacetileno 5, que aportaba 
la unidad de carbohidrato. 
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Esquema 4 
ESTUDIO DE PROPIEDADES 
La segunda parte de esta tesis doctoral se centró en el estudio de las propiedades fotofísicas de los 
compuestos sintetizados.  
PROPIEDADES FOTOFÍSICAS 
Se registraron los espectros de absorción (UV/vis) de los OPES sintetizados en disolución acuosa tamponada 
(fosfato) así como de los precursores acetilados en diclorometano, observándose una intensa banda de 
absorción en todos ellos en la región de 340-390 nm debida a la transición * de los sitemas aromáticos 
conjugados, permitida. Se observó en todos los casos, un comportamiento espectroscópico cuyas diferencias  
se resumen a continuación.  El aumento de la conjugación determina un desplazamiento batocrómico de la 
banda mencionada, como cabía esperar. Por otra parte, el coeficiente de extinción molar también aumenta 
con la conjugación. La excitación de estos compuestos en el rango de 280-420 nm, produce una emisión en 
la región azul y azul verde. La presencia del grupo NMe2, fuertemente electrón donador, en el anillo central 
del oligómero  17 desplaza la luminiscencia hacia el rojo y disminuye ligeramente el rendimiento cuántico, 
que en cualquier caso continúa siendo elevado (0,57). El perfile de la emisión de este compuesto sugiere la 
existencia de un estado excitado con una transferencia de carga parcial que se pudo atribuir a la transición n 
→ π*.  
 
PROPIEDADES BIOLÓGICAS 
La internalización de los OPEs sintetizados  en células de tipo HEp-2 (tejido epidermoide del 
carcinoma de laringe) se ha estudiado por microscopía de fluorescencia. Los experimentos llevados a cabo 
han puesto de manifiesto un comportamiento directamente relacionado con las características estructurales 
y espectroscópicas antes comentadas para estos compuestos.  Aunque el oligómero 18 que posee  un anillo 
central con un sustituyente de tipo dimetilamino y los dos restos de glucosa con los grupos OH libres, ha 
resultado ser el compuesto más biocompatible y prometedor para ser utilizado como sonda fluorescente en 
las células, la elevada emisión  y altos rendimientos cuánticos, observados en todos los OPEs estudiados, así 
como su estabilidad hacen de estos glucósidos candidatos  adecuados para ser utilizados como colorantes en 
microscopía de fluorescencia.  
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Otro estudio de interés llevado a cabo en este trabajo corresponde a la evaluación de la capacidad de los 
sustratos  17 y el análogo con dos anillos que contienen sendos grupos NMe2,  de actuar como 
fotosensibilizadores en Terapia Fotodinámica (PDT). La PDT es un procedimiento mínimamente invasivo que 
puede producir la erradicación de enfermedades neoplásicas combinando el efecto de un fotosensibilizador, 
irradiación con una luz de longitud de onda determinada y oxígeno. El estudio biológico de los nuevos amino 
oligo(fenilen-etinilenos) sintetizados en este trabajo, entre ellos, el OPE 18, ha puesto de manifiesto su 
capacidad para actuar como fotosensibilizadores en combinación con luz UVA. Los ensayos se realizaron 
sobre dos líneas tumorales celulares (HEp-2 y HeLa) derivadas del carcinoma de laringe y cervical, 
respectivamente. Una vez irradiados, estos compuestos disparan un bloqueo mitótico que conduce 
finalmente a la muerte celular. Además, resultaron efectivos en concentraciones de hasta 3 µm.  
  
Conclusiones: 
 El trabajo realizado en esta tesis doctoral ha permitido poner a punto una metodología sintética 
iterativa y convergente que conduce a la construcción de los esqueletos presentes en los OPEs 
objetivo. La versatilidad del proceso ha conducido a los glicósidos conteniendo distintos anillos 
aromáticos sustituidos centrales a través de acoplamientos de tipo Sonogashira catalizado por Pd(0), 
en ausencia de catalizador de Cu, entre acetilenos adecuadamente funcionalizados y bromo o iodo 
derivados aromáticos. 
 Las propiedades fotofísicas tales como alto rendimiento cuántico y producción de Oxígeno singlete, 
han sido evaluadas habiéndose podido establecer su capacidad para producir luminiscencia con 
emisión en la región de azul y azul-verde. 
 Su estabilidad, biocompatibilidad, eficaz inernalización en las células y su buena respuesta, incluso a 
baja concentración, hacen de los derivados amino sustituidos fotosensibilzadores prometedores 
aplicables en el campo de la Terapia fotodinámica.  
 Estos amino derivados son capaces de  producir un eficaz efecto fotodinámico al ser irradiados con 
luz UVA provocando la muerte celular incluso con baja producción de Oxígeno singlete. 
  El estudio llevado a cabo en este trabajo ha puesto de manifiesto, por primera vez, la posibilidad de 
utilizar los OPEs como fotosensibilizadores y pude ser el punto de partida para extender las 
aplicaciones d eestos compuestos luminiscentes en el campo de la Terapia Fotodinámica (PDT). 
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List of Abbreviations 
 
In this Ph. D. memory, the abbreviations used are listed in “Guidelines for Authors” (J. Org. Chem. 
2013) 
BODIPY: BoronDiPyrromethene  
cat: Catalyst 
DCE: 1,2-Dicloroethane 
DMF: Dimethylformamide 
DMSO: Dimethyl sulfoxide 
equiv: Equivalente(s)  
Et3N: Triethylamine 
HaCaT: Cultured Human Keratinocyte cells 
HeLa: Human Cervical Carcinoma cells 
HEp-2: Human epithelial type 2 cells 
NMR: Nuclear Magnetic Resonance 
OPEs: Oligo(Phenylene)ethynylenes 
PPEs: Poly(Phenylene)ethynylenes 
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PS:  Photosensitizer  
PDT: Photodinamic Therapy 
rt: room temperature 
TBAF: tetrabuthyl ammonium fluoride 
Tf: Trifluoromethansulfonate 
THF: Tetrahydrofurane 
TMS: Trimethylsylil 
Tripan Blu: (3Z,3'Z)-3,3'-[(3,3'-dimethylbiphenyl-4,4'-diyl)di(1Z)hydrazin-2-yl-1-ylidene]bis(5-
amino-4-oxo-3,4-dihydronaphthalene-2,7-disulfonic acid) 
UV/Vis: Ultraviolet/Visible 
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Chapter 1 
 
1.1.General features of Oligo(Phenylene)Ethynylenes (OPEs) 
Oligo(phenylene-ethynylenes) (OPEs) and the corresponding polymers, Poly(phenylene-
ethynylenes) (PPEs),represent a peculiar class of luminescent dyes with stable π-conjugated 
rigid rod-like skeletons.1 In particular, their structure is a succession of aromatic rings linked 
by carbon-carbon triple bonds (figure 1). This feature guarantees a high electronic conjugation 
and, consequently, their photochemical properties evidence high quantum yields and 
characteristic luminescence. The synthetic approaches leading to the construction of these 
molecules allow easy functional group manipulation and make their functional properties 
tunable. 
 
 
Figure 1 
 
Thanks to the possibility of tuning their properties, OPEs and PPEs have attracted significant 
attention in the scientific community. In the last two decades, OPEs and PPEs have found a 
                                                          
1Bunz, U. H. F. Chem. Rev. 2000, 100, 1605–1644. 
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great variety of applications in several fields, from sensing2 and electronics3 to the biological 
one.4 
1.2.Photophysical properties of OPEs 
The photophysical properties of OPEs are directly connected to their extensive conjugation. 
Modulation of these properties depends on their structure and on substitution on the aromatic 
conjugated skeleton.  
In 2005Yamaguchi,5 reported a study about the photophysical properties of OPEs (quantum 
yield Φf, emission wavelength λem, lifetime τ, absorption wavelength λabs) and their behavior 
when the π-conjugated molecular rods consisting of p-(phenylene)ethynylene units were 
modified by donor (OMe) and/or acceptor (CN) groups situated at the aromatic rings. They 
reported three different cases: (1) side-donor modification systems (SD systems), (2) side-
acceptor modification systems (SA systems), and (3) systems consisting of donor blocks and 
acceptor blocks (BL systems, figure 2). 
                                                          
2 a) Kim, U.-I.; Suk, J.-m.; Naidu, V. R.; Jeong, K.-S. Chem. Eur. J. 2008, 14, 11406−11414; b) Thomas 
III, S. W.; Joly, G. D.; Swager, T. M. Chem. Rev. 2007, 107, 1339-1386; c) Kim, I.-K.; Erdogan, B.; 
Wilson, J. N.; Bunz, U. H. F. Chem. Eur. J. 2004, 10, 6247-6254. 
3Kaliginedi, V.; Moreno-García, P.; Valkenier, H.; Hong, W.; García Suarez, V. M.; Buiter, P.; Otten, 
J. L. H.; Hummelen. J. C.; Lambert, C. J.; Wandlowski, T. J. Am. Chem. Soc. 2012, 134, 5262-5275. 
4a) Mc Rae, R. L.; Phillips, R. L.; Kim, I.-B.; Bunz, U. H.; Fahrni, C. J. J. Am. Chem. Soc. 2008, 130, 
7851-7853; b) Disney, M. D. ; Zheng, J.; Swager, T.M., Seeberger*, P.H. J. Am. Chem. Soc. 2004, 126, 
13343-13346. 
5Yamaguchi, Y.; Tanaka, T.; Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. J. Am. Chem. 
Soc. 2005, 127, 9332-9333. 
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Figure 2 
 
The best values in terms of Φf, were obtained for the block modification systems (BL,Φf>0.95). 
This result evidenced that the building a push-pull system by combination of electron donating 
and electron withdrawing groups in the same skeleton improved the photophysical properties 
of the OPEs. On the other side, the values of quntum yields obtained for the systems 
functionalized with –OMe  in the side donor moiety (SD) or with –CN in the side acceptor 
fragment, (SA) were higher(Φf>0.90).The study of the trend of bathochromic shift of emission 
(λem) compared to the elongation of aromatic chain gave very interesting results since the largest 
OPEs systems showed λem shifted toward higher wavelengths. 
Rodríguez et al. reported in 2003the new class of bended OPEs depicted in figure 3. These 
structures had an increased conjugation due to the link of new subunits with 1,3,5 substituted 
ethynyl benzenes shown a defined the conjugated geometry.6 
                                                          
6Gonzalo Rodrıguez,J.; Esquivias, J.; Lafuente, A.; Diaz, C.; J. Org. Chem. 2003, 68, 8120-8128. 
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Figure 3 
 
The study of their photophysical properties evidenced, that the maximum absorption 
wavelength in the UV-vis spectra (figure 4), had a bathochromic shift consistent with the 
increased conjugated phenylene ethynylene number n of repeated units. The corresponding 
molar extinction coefficients also increased with n. All the ethynylphenylene homologue 
compounds obtained showed a fluorescence emission radiation, with a bathochromic shift of 
20 nm for each additional ethynylphenyl unit increasing the conjugated chain. In general, the 
higher homologues showed high quantum yields (65-82%), which increased with conjugation. 
 
Figure 4: Normalized emission spectra in dicloromethane at RT. 
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Other appealing property of OPEs discovered corresponds to their ability to generate singlet 
oxygen  (1O2). The study by Monnereau and Andraud, reported recently, highlighted this 
characteristic of the OPEs systems.7 
 
 
Figure 5 
A series of compounds was obtained through a convergent  “building-blocks” synthesis based 
on successive Sonogashira–Hagihara reactions. It was demonstrated by the detection of the 
characteristic Δ1O2 → Σ3O2 phosphorescence at 1270 nm, that all brominated compounds 
shown in Figure 5 (2Br, 4Br and 6Br) generated singlet oxygen, with quantum yields of 0.10, 
0.50 and 0.35, respectively. Interestingly, fluorescence quantum yields and lifetimes evolved 
opposite to the 1O2 generation quantum yield (Figure 6).  
 
                                                          
7Lanoë, P. H.; Gallavardin,T.; Dupin,A.; Maury, O.; Baldeck, P. L.; Lindgren, M.; Monnereau C.; 
Andraud, C.; Org. Biomol. Chem., 2012, 10, 6275-6278. 
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Figure 6: Evolution of the photophysical parameters (fluorescence quantum yield f ;1O2 generation 
quantum yieldΔ, lifetime τf ) among the chromophores’ series (298 K, CHCl3). 
 
This was a very interesting result because it gave the possibility to use OPEs as photosensitizers, 
and showed that these are molecules possessing an accessible triplet excited state able to 
generate singlet oxygen (1O2) by an energy transfer to ground state oxygen, ultimately leading 
to cell death.8 
 
1.3. Aggregationof OPEs 
The fundamental properties of many OPEs and PPEs, such as light absorption and emission, 
depends not only on their molecular structure but also on the supramolecular interactions and 
on the nano/mesoscale organization of the chains in the solid state.  
Pescitelli et al. investigated the aggregates formed in solution of proper solvents or solvent 
mixtures of two related glucose-substituted OPEs and PPEs shown in Figure 7: the oligomer 
HO (n ≈ 10) and the alternate copolymer AP (n≈ 40, Figure 7).9 
 
                                                          
8DeRosa, M. C.; and Crutchley, R. J.; Coord. Chem. Rev., 2002, 233–234, 351–371 
9 Pescitelli, G., Omar,O. H., Operamolla,A., Farinola,G. M., Di Bari, L., Macromolecules 2012, 45, 
9626−9630 
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Figure 7 
 
Formation of aggregates was detected by absorption and luminescence spectroscopies for the 
alternate copolymer AP and for the homo oligomer OH in chloroform/methanol (used as 
solvent/non solvent) mixtures or in chloroform. They could also evidence that both HO and AP 
remained quite emissive upon aggregation. In particular, the copolymer AP retained43% of its 
emission, which demonstrated that Glucose units represent efficient substituents for reducing 
the quenching of aggregated PPE, in addition to the properties of bulkiness and chirality.10 It is 
noteworthy that in the 30:70 chloroform/methanol mixture only a small band of absorption was 
visible. In fact, in these conditions the few aggregates formed have a well defined structure 
which is preserved upon further aggregation. For the oligomer HO, the evolution of absorption 
spectra upon methanol addition is less evident than for the polymer AP (Figure 8). This was 
due to the presence of glucose groups that introduced some rigidity even in the oligomer, and 
prevented an effective aggregation. 
                                                          
10 Zahn, S.; Swager, T. M. Angew. Chem., Int. Ed.2002, 41, 4225−4230. 
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Figure 8. UV−vis absorption (top), and fluorescence (bottom) spectra of PPEs AP (left) and HO 
(right) in chloroform/methanol mixtures, normalized per monomer (9 × 10−5 M; 1 cm cell). 
 
 
Fernández et al.reported in 2013 the synthesis of the new oligophenylene ethynylene (OPE) 
Palladium derivative represented in figure 9,and investigated its self-assembly in solution, in 
the bulk state, and on surfaces.11The performed experiments to determine how the OPE 
compound aggregates were temperature and concentration dependent.  
 
 
 
Figure 9 
                                                          
11 Mayoral, M. J.;Rest,C.; Stepanenko,V., Schellheimer, J.; Albuquerque, R.;Fernández G., J. Am. 
Chem. Soc.2013, 135, 2148−2151 
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In fact, solutions of compound 2 in 6-mercapto-1-hexanol (MCH) at different concentrations 
were slowly cooled down from 343 to 278 K at a rate of 0.5 K min−1 to ensure that the process 
took place under thermodynamic control. Above 313 K, 2exhibited a sharp transition with a 
maximum at ∼350 nm that could be assigned to a molecularly dissolved state.12 On cooling 
the solution, a new red-shifted transition centered at =371 nm  was noticed that spreads into 
the visible region up to∼470 nm (Figure 10). This behavior could be attributed to the 
formation of self-assembled structures. 
 
Figure 10 
 
1.4.Applications of OPEs in biology 
There are very few examples of application of OPEs in the biological field.  Among them, 
interesting examples were illustrated by the work of  Whitten et al.,13which evidenced that the 
presence of a proper functionalization was essential to be used in the biological medium. Thus, 
                                                          
12a) Chen, Z.; Lohr, A.; Saha-Möller, C. R.; Würthner, F. Chem. Soc. Rev.2009, 38, 564; b) De Greef, 
T. F. A.; Smulders, M. M. J.; Wolffs, M.; Schenning, A. P. H. J.; Sijbesma, R. P.; Meijer, E. W. Chem. 
Rev.2009, 109, 5687-5754. 
13a) Hill, E. H.; Evans, D. G.; Whitten, D. G. Langmuir2013, 29, 9712−9720. b) Dascier, D.; Ji, E.; 
Parthasarathy, A.; Schanze, K. S.; Whitten, D. G. Langmuir 2012, 28, 11286−11290.  
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the structure depicted  in Figure 11, functionalized with two tetraalkylammonium side groups, 
was soluble in water and exhibited dark and light-activated biocidal activity. This water soluble 
family of conjugated oligomers had affinity for bacterial cell membranes and was shown to 
cause membrane disruption, agglomeration, and bacterial death. 
 
O
NNC6H13
O
N N C6H13
 
Figure 11 
 
Moreover, this compound had a remarkable bactericidal activity, and was demonstrated to be 
very effective against Escherichia coli (E. coli) biofilms when irradiated with UV light (Figure 
12). The damage was largely caused by the production of singlet oxygen by the OPEs when 
irradiated. A broad-spectrum damage to nucleic acids and proteins in the cell was produced. 
 
 
Figure 12 
 
The ultimate aim of this investigation was the use of cationic end-only functionalized 
oligo(arylene-ethynylene)s(EO-OPEs) for preventing and eliminating Escherichia coli (E.coli) 
infections in hospital and community acquired, to health care systems. 
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Functionalized oligo(phenylene-ethynylene)s (OPEs) with different conjugation lengths were 
used as luminescent labeling probes for proteins: their synthesis, reported by the group of Che,14 
utilized the Sonogashira coupling as key step. The photoluminescent properties for the OPE 
series with different chain lengths and their solvatochromic responses were examined.  
Introduction  of a N-hydroxysuccinimidyl (NHS) moiety into the oligo(arylene-ethynylene)s, 
as indicated in Figure 13, enabled covalent attachment of the fluorophore to the protein HSA 
(Human serum albumin) though the substitution of the N-hydroxysuccinimideby a lysine 
residue of the protein. This substitution was possible to the known ability of the primary NH2 
of lysine  to react with N-hydroxysuccinimide moiety . 
 
 
Figure 13 
 
In 2013, the synthesis of a new class of rigid ethynyl terminated OPE spacers of variable 
length15was described by Bernardi et al .The copper(I)-catalyzed alkyne-azide cycloaddition 
(CuAAC) “click” reaction of these spacers with glycosil azides (Figure 14) led to the formation  
of sugar terminated OPEs: the work  was projected  with the intent of testing the activity of the 
                                                          
14Zhi, Y.-G.; Lai, S.-W.; Chan, Q. K.-W.; Law, Y.-C.; Tong, G., S.-M.; Che, C.-M. Eur. J. Org. Chem. 
2006, 3125−3139. 
15Pertici, F., Varga, N.; van Duijn, A.; Rey-Carrizo, M.; Bernardi, A., Pieters, R. J.; Beilstein J. Org. 
Chem. 2013, 9, 215–222. 
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synthesized oligomers on bacterial adhesion inhibition. As the target, the bacterial lectin LecA, 
a virulence factor of the problematic pathogen Pseudomonas aeruginosa,  was chosen.  
Knowing that this lectin was able to bind galactosides and that the shortest distance between 
two binding sites is around 26 Å, the three-unit OPE spacer represented in Figure 14, measuring 
around 22 Å without the aglycon linking moiety, was chosen for this experiment. 
 
 
 
Figure 14 
 
In an ELISA (enzyme-linked immunosorbent) type assay, the behavior of deprotected 
carbohydrate derived compound 22 as inhibitor against the lectin LecA from Pseudomonas 
aeruginosa was demonstrated. 
In 2015, Bernardi et al.reported the design of other glycoside substituted OPEswith the aim of 
finding  inhibitors of HIV infection,16 particularly targeting against  DC-SIGN, a tetrameric C-
                                                          
16Ordanini,S.; Varga, N.; Porkolab, V.; The´paut, M.; Belvisi, L., Bertaglia, A.; Palmioli, A., Berzi, A.; 
Trabattoni, D.; Clerici, M.; Fieschi, F.; Bernardi, A. Chem. Commun.,2015, 51, 3816-3819. 
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type lectin receptor of dendritic cells involved in many pathogens infection cycle (HIV, Ebola 
and Dengue).The rod-like rigid OPE spacers were linked to multivalent glycosidic ligands by 
exploiting click-chemistry (Figure 15). A range of selected compounds were tested in a 
sensitive assay, using a cellular model of HIV-1 infection. The results of these transinfection 
studies showed a clear dose–response effect for all the tested inhibitors. 
 
 
 
Figure 15 
The only example of the use of an OPE as a cell dye, was described by Farinola in 2012.17 The 
amphiphilic aryleneethynylene O1 derivative represented in Figure 16 was used as a plasma 
membrane marker in fixed and living mammalian cells and liposome model systems,The 
structure included a central fluorene and two phenyleneethynylene branches to ensure good 
fluorescent properties (O1, figure16). Moreover, alkyl chains of 18 carbon atoms were 
                                                          
17 Cardone, A.; Lopez, F.; Affortunato, F.; Busco, G.; Hofer, A. M.; Mallamaci, R.; Martinelli, C.; 
Colella, M.; Farinola, G. M. Biochimica et Biophysica Acta20121818, 2808–2817. 
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introduced as alkoxy groups on the external phenyl rings, and polar sulfonate groups were 
attached to the central fluorene ring to guarantee the amphiphilic character of  O1. The synthesis 
of the compound O1 was based on a convergent palladium-catalyzed cross-coupling. O1 
exhibited fast staining, insensitivity to pH in the patho-physiological range, good photostability 
and effective multicolor labeling in inmunofluorescence experiments.  
 
 
 
 
Figure 16 
 
The reported results confirmed that these luminescent molecules, if opportunely functionalized, 
can be conveniently used as a novel class of membrane markers for a wide range of biological 
applications. 
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1.5. Objectives 
Considering the precedent work, and taking into account the expertise of the research 
group at the Universitá di Messina in the chemistry of carbohydrates,18 we decided to focus in 
the synthesis of differently substituted Oligo(Phenylene) Ethynylene (OPE) systems 
incorporating two glycosides at the external units. The presence of monosacharides in the OPE 
structure would add to the conjugated systems two natural fragments which could extend the 
applications of these synthetic molecules in the biological field by increasing their 
biocompatibility. This could facilitate for instance, the use of the resulting glycosilated OPEs 
as fluorescent probes in biological processes. Another important advantage of the presence of 
monosacharides in the OPEs would be the increase of their solubility in water expected in the 
sugar containing final targets.  Looking for useful applications, a versatile synthesis was 
required, since the possibility of making products with different relative ratios of -conjugated 
fragments (hydrophobic ) versus carbohydrates (hydrophilic) would also be essential.  
Taking into account all these considerations, we envisaged the following objectives for 
this Ph D work: 
 
1.5.1  Synthesis and properties of glucosyl derived OPEs 
Synthesis of 1,4-dimethoxyphenyl-2,5-ethynylene oligomers. A series of 1,4-dimethoxyphenyl-
2,5-ethynylenes derivatives with up to three units, incorporating two propargyl glucosides at 
                                                          
18 (a) Bonaccorsi, P.; Di Gioia, M. L.; Leggio, A.; Minuti, L.; Papalia, T.; Siciliano, C.; Temperini, A.; 
Barattucci, A. Beilstein J. Org.Chem. 2013, 9, 2410−2416. (b) Bonaccorsi, P.; Aversa, M. C.; Barattucci, 
A.; Papalia, T.; Puntoriero, F.; Campagna, S. Chem. Commun. 2012, 48, 10550−10552. (c) Bonaccorsi, 
P.; Marino-Merlo, F.; Barattucci, A.; Battaglia, G.; Papaianni, E.; Papalia, T.; Aversa, M. 
C.; Mastino, A. Bioorg. Med. Chem. 2012, 20, 3186−3195. (d) Aversa, M. C.; Barattucci, A.; 
Bonaccorsi, P. Synlett 2011, 254−258. (e) Aversa, M. C.; Barattucci, A.; Bonaccorsi, P.; Temperini, A. 
Eur. J. Org. Chem. 2011, 5668−5673. (f) Aversa, M. C.; Barattucci, A.; Bonaccorsi, P.; Marino-Merlo, 
F.; Mastino, A.; Sciortino, M. T. Bioorg. Med. Chem. 2009, 17, 1456−1463. (g) Aversa, M. C.; 
Barattucci, A.; Bonaccorsi, P. Eur. J. Org. Chem. 2009, 6335−6339. (h) Aversa, M. C.; Barattucci, A.; 
Bonaccorsi, P. Tetrahedron 2008, 64, 7659−7683. (i) Aversa, M. C.; Barattucci, A.; Bilardo, M. C.; 
Bonaccorsi, P.; Giannetto, P.; Rollin, P.; Tatibouet, A. J. Org. Chem. 2005, 70, 7389−7396. 
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the terminal moieties, was initially proposed. These target structurers A-C are indicated in 
Figure 17.  
 
Figure 17 
The retrosynthesis that would allow the rapid construction of these skeletons was based on the 
Pd catalyzed Sonogashira coupling of 2,5-dimethoxy-1,4-iodobenzene or adequately 
substituted analogues, with functionalized alkynes. This is illustrated for the monomer A in 
Scheme 1. The known propargyl glucoside, with all the OH groups protected, will be used for 
this coupling, to introduce the glucoside. After the Sonogashira type reaction, deprotection of 
the carbohydrate would produce the the desired substrate.  
 
Scheme 1 
 
Synthesis of OPE glucosides  with benzene and N,N-dimethyl aniline  cores.  
The structures represented in Figure 18 would also be synthesized using a similar strategy. 
These are characterized by the presence of different substituents in the central core of the OPEs, 
such a benzene (D), one or two N,N-dimethyl aniline rings (E and F) and the corresponding 
ammonium salts (G and H). 
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Figure 18 
Photo-physical measurements and singlet oxygen evaluation. 
With these structures in hands, a study of photophysical properties, using UV/vis and 
luminiscense measures, would be undertaken. 
Biological studies. 
The biological applications of these glucosides OPEs required a study of the behavior of these 
molecules faced to living cells. A primary aspect that was investigated was the possibility of 
the synthesized derivatives to go through the cell membranes. 
Cell internalization. 
The ability of the OPE glucosides to enter into the cells was studied to evaluate the possibility 
of further applications within the biological field. 
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Behavior of OPEs as photosensitizers in PDT. 
To investigate the possibility of using the synthesized OPEs as photosensitizers in 
Photodinamic Therapy other aspects of the behavior of these molecules face to the living cells 
must be initially studied. The efficiency of a photosensitizer for PDT is related to its ability to 
produce singlet oxygen under irradiation as well as to its subcellular localization.19 Both the 
ability to produce 1O2 under irradiation and the cell internalization and subcellular localization 
of OPEs 18 and 28 in HaCaT (human keratinocytecells),  HeLa (human cervical cancercells) 
and HEp-2 (human larynx cancer cells) cells wereanalyzed by fluorescence microscopy under 
UV excitation light. 
 
1.5.2. Synthesis of BODIPY-OPEs containing glucosides 
BoronDiPyrromethene (BODIPY) chromophores are highly fluorescent molecules20 which 
could considerably shift the wavelength of adsorption and emission of different molecules. 
Some glycoconjugated BODIPY derivatives21 have been synthesized in Messina to be applied 
in bio-imaging.22 In order to move further into the biological applications of our work, we 
thought of introducing astructural modifications on our OPEs, which could lead  to a shift of 
the absorption and emission to higher wavelengts, near the  biological ‘red-window’. The 
presence of a BODIPY moiety into our OPE glucosides, would probably improve their 
photophisycal properties for further applications. The interest of synthesizing a BODIPY 
containing structure such as I, indicated in Figure 19, stemmed on  the expected improvement 
of the luminescent properties due to the presence of the heterocyclic core. This could open the 
                                                          
19(a) Soares, A.R.M.; Neves M.G.P.M.S.; Tome, A.C.; Iglesias-de la Cruz M.C.; Zamarrón, A.; 
Carrasco, E.; González, S.; Cavaleiro, J.A.S.; Torres, T.; Guldi, D.M.; Juarranz, A., Chem. Res. Toxicol. 
2012, 25, 940-951. (b) Rello-Varona, S.;Gámez, A.;Moreno, V.;Stockert, J.C.; Cristóbal, J.;Pacheco, 
M.; Cañete, M.; Juarranz, A.; Villanueva, A. , Int. J. Biochem. Cell. Biol. 2006, 38, 2183–2195. 
20Ulrich, G.; Ziessel, R.; Harriman, A.;Ang. Chem. Int. Ed. 2008, 47, 1184-1201   
21Papalia, T.; Barattucci, A.; Aversa, M. C.;Campagna, S.; Puntoriero, F.; Bonaccorsi, P.; Chem. 
Commun.2012, 48, 10550–10552 
22Papalia, T.; Siracusano, G.; Colao, I.; Barattucci, A.; Aversa, M. C.;Serroni, S.; Zappala, G.; 
Campagna, S.; Sciortino M. T.; Puntoriero, F.; Bonaccorsi, P.; Dyes Pigments2014, 110, 67. 
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way to more efficient systems. Moreover, a good affinity of I for the cells could be  expected  
due to the presence of the glucose fragments. We thus proposed compound I as the next  target, 
since we envisaged that its synthesis could be completed, once again,using a similar strategy 
based on the use of Sonogashira reaction. 
 
Figure 19 
 
1.5.3. Synthesis of AZO-OPEs containing glucosides 
Other interesting core that was considered for introduction into the OPEs was the azobenzene. 
Azobenzenesare a group of compounds with the capacity to adsorb energy and use it for a 
molecular movement: the cis-trans isomerization. This process is a reversible transformation 
between two geometrical isomers leading to a notable change in the photophysical properties 
of the azobenzene, particularly in the dipolar moment and in the absorption spectrum.23 
 
Figure 20 
In previous work, the research group at the Universidad Autónoma de Madrid studied the 
photoisomerization and photochromic properties of different enantiopure sulfinyl azobenzenes 
                                                          
23a) Rau, H.; Photocromism, Molecules and Systems; 1990, 165. b) Suginome, H.; CRC Handbook of 
Organic Photochemistry and Photobiology; 1995, 824.   
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evidencing an efficient  transfer of chirality from the sulfoxide to the azo compound both in the 
cis and trans isomers which is controlled by the chirality at the sulfur atom.24The idea of 
synthesizing an OPE derivative with an azobenzene core was appealing in order to study how 
the photophysical properties of the resulting OPE were modulated by the azo group upon cis-
trans photoisomerization . The presence of the glucosides in compound J, would make it 
biocompatible thus, opening the way for new biological applications. 
Figure 21 
 
1.5.4. Synthesis of galactose derived OPEs 
Taking into account that a different monosaccharide could change the biological activity of the 
projected OPES, galactose containing OPEs would also be synthesized using a similar strategy.  
 
 
 
                                                          
24a) I.Núñez, E. Merino, M. Lecea, S.Pieraccini, G. P.Spada, C.Rosini, G.Mazzeo, M.Ribagorda,  M. 
C.Carreño, Chem.Eur. J.2013, 19, 3397-3406. b) M. C. Carreño, I. García, I. Núñez, E. Merino, M. 
Ribagorda, S. Pieraccini, G. P. SpadaJ. Am. Chem. Soc. 2007, 129, 7089-7100; c) M. C. Carreño, I. 
García, M. Ribagorda, E. Merino, S. Pieraccini, G. P. Spada, Org. Lett. 2005, 7, 2869-2872; d) M. C. 
Carreño, G. Fernández Mudarra, E. Merino, M. Ribagorda, J. Org. Chem. 2004, 69, 3413-3416. 
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Figure 22 
1.5.5. Synthesis of sulfoxide derived OPEs. 
The  research groups of Messina25 and Madrid26 have a great experience on stereoselective 
synthesis monitored by sulfoxides. The possibility of using phenylene ethylene units in the 
construction of C2-symmetric molecular architectures containing enantiomerically pure 
sulfinyl functions as potential chelating agents would be another interesting goal. In particular, 
the isoborneol sulfinyl moiety appears to be a significant chiral controller and an interesting 
_structurally privileged residue. For this purpose, the combining of the classical synthetic 
procedure of OPE preparation, the Sonogashira cross-coupling, with the well-known sulfenic 
acid/alkyne syn-addition to obtain sulfinyl derivatives in a stereocontrolled manner could 
represent an efficient strategy to buils sulfinyl OPEs as 50. 
 
                                                          
25 a) Barattucci, A.; Di Gioia, M.L.; Leggio, A.; Minuti, L.;  Papalia, T.; Siciliano, C.; Temperini, A.; Bonaccorsi, 
P. Eur. J. Org. Chem. 2014, 2099; b) Barattucci, A.; Plutino, M.R.; Faggi, C.; Bonaccorsi, P.; Monsu` 
Scolaro, L.; Aversa, M. C. Eur. J. Inorg. Chem. 2013, 3412;  c) Bonaccorsi, P.; Marino-Merlo, F.; Barattucci, 
A.; Battaglia, G.; Papaianni, E.; Papalia, T.; Aversa, M.C.; Mastino, A. Bioorg. Med. Chem. 2012, 20, 318: d) 
Aversa, M. C.; Barattucci, A.; Bonaccorsi, P.; Faggi, C.; Gacs-Baitz, E.; Marrocchi, A.; Minuti, 
L.;Taticchi, A. Tetrahedron 2005, 61, 7719. 
 
26 For a review, see: A. Urbano, M. C. Carreño, Or.g Biom. Chem. 2013, 11, 699-708A. For recent work see: a) 
A. M. del Hoyo, A. Latorre, R. Díaz, A. Urbano, M. C. Carreño; Adv. Synt. Cat.  2015,  357, 1154-1160. b) Latorre, 
A. Urbano, M. C. Carreño, Chem.Comm.  2011, 47, 8103–8105. c) A. Latorre, A. Urbano, M. C. Carreño, Chem. 
Commun., 2009, 6652-6655 
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Chapter 2 
 
The synthesis of the oligo phenylene ethynylenes that we had proposed as initial target structures 
for this PhD work, was achieved following the retrosynthetic scheme shown below. 
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The methodology applied for the building of our OPEs structures is based on the iterative use of 
Pd-mediated Sonogashira reaction. By this way, we can couple the glucosidic fragment to an 
bromo or iodo substituted aromatic ring and then link, the obtained monoderived compound, to a 
properly substituted central core.  
The methodoly is very generic, in fact, it was applied to the synthesis of a wide range of different 
OPEs, obtained only synthesized the appropriate aromatic central brick.  
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2.1 Synthesis of 1,4-dimethoxyphenyl-2,5-ethynylene oligomers 
 
After a careful research in the literature we could deduce that the most effective method to 
construct the skeleton of the conjugated oligomers object of this thesis is based on cross-
coupling Sonogashira reactions. 1 Thanks to the use of this versatile synthetic method, it was 
possible to build a new family of oligomers.  
In agreement with the retrosynthesis presented above, the first step was the choice and 
subsequent synthesis of the suitable building blocks to be  later treated under the key 
Sonogashira conditions. The chosen starting products were 2-propynyl-O-β-glucopyranoside-
2,3,4,6-tetraacetate 1 and 2,5-dimethoxy benzene 2 (schemes 1 and 2 respectively). Although 1 
was commercially available, it was synthesized in the laboratory following a known procedure.2 
Thus,reaction between 2-propynyl-O-β-glucopyranoside-2,3,4,6-tetraacetate and propargyl 
alcohol in the presence of trimethylsilyl trifluoromethanesulfonate (TMSOTf) (Scheme 1) 
followed by purification by column chromathography led to 1 with high purity grade and in good 
yields (78%). 
 
 
Scheme 1 
                                                          
1 Chinchilla, R.; Nájera, C.; Chem. Rev.2007, 107, 874–922 
2 Giovenzana, G. B.; Lay, L.; Monti, D.; Palmisano, G.; Panza, L. Tetrahedron 1999, 55, 14123-14136. 
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The control of the reaction was really essential for its full success: in fact, a longer period than 
1,5 hours caused considerable decrease in the yield percentage, because of the decomposition of 
the glucoderived alkyne  1 in the reaction conditions once formed.  
The second precursor, 1,4-diido-2,5-dimethoxy benzene (2), was synthesized from commercially 
available 2,5-dimethoxy benzene by treatment with H2IO5 and I2 in MeOH at 50°
3. After 4h 
under vigorous stirring, the quantitative and unique formation of di-substitution product 2 was 
observed by TLC. Compound 2 was pure enough to be used in next step without further 
purification, (Scheme 2). 
 
 
Scheme 2 
The subsequent step was the assembly of the first conjugated system, using the two building 
blocks 1 and 2 previously synthesized, with the exploitation of a Sonogashira reaction, in the 
copper-free variant. In this cross-coupling reaction, Pd(0) catalyzes the carbon-carbon bond 
formation between a terminal alkyne and aryl or vinyl halides, leading to the synthesis of aryl or 
vinyl substitued alkynes. The reaction can occur with or without co-catalyst. In the first case, a 
co-catalyst (generally CuI) is used to generate in situ Pd(0) from Pd(II) salts. In the second case, 
the direct use of a Pd(0) complex could produce low yields, probably by oxidation of the metal 
                                                          
33 Yi, C.; Blum, C.; Lehamann, M.; Keller, S.; Liu, S. X.; Frei, G.; Neels, A.; Hauser, J.; Schürch, S.; 
Decurtins, S. J. Org. Chem. 2010, 75, 3350-3357.  
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in the presence of atmospheric oxygen, if the conditions of reaction are not strictly degassed and 
dry. The use of a co-catalyst is in principle recommended, but there are some cases in which side 
reactions are produced in the presence of CuI. When we effected the reaction between 
compounds 1 and 2 in DMF using Pd(PPh3)4 as catalyst and CuI as a co-catalyst, we observed 
decomposition/auto-coupling of compound 1. These undesired processes had been already 
reported in the literature4. After an accurate bibliographic research, it was clear that only the 
direct use of Pd(0) would allow a successfull cross-coupling reactions with glucosydic 
substrates.5 
 
Scheme 3 
We thus carried out the reaction between  propargyl glucoside 1 and 1,4-diido-2,5-dimethoxy 
benzene 2 (in ratio 2:1) in a mixture 1:1 DMF/Et3N, in presence of Pd(PPh3)4, under Argon 
atmosphere. The amount of catalyst proved to be critical for the efficiency of the process. In fact, 
due to the difficult separation of the resulting product 3 from the reaction crude containing the 
catalyst, it was essential to look for the minimum amount that could guarantee high yields and, at 
                                                          
4André, S.; Liu, B.; Gabius, H. J.; Roy, R. Org. Biomol. Chem. 2003, 1, 3909-3916 
5 Roy, R.; Das, S. K.; Santoyo-González, F.; Hernándes-Mateo, F.; Dam, T. K.; Brewer, C. F. Chem. Eur. 
J. 2000, 6, 1757-1762 
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the same time, total purification in high yields. After several experiments, utilizing variable 
amounts of Pd(PPh3)4, the best conditions found for the coupling were the use of 10% mol of 
catalyst with respect to compound 1. Under these conditions, the bis glucoside 3 could be 
obtained and isolated with a 70% yield. 
The stepwise extension of the ethynyl-aromatic chain, was considered the most versatile 
synthetic approach to obtain increasingly longer molecular wires still decorated with glucosydic 
pendants. We thus focused on the synthesis of precursor 4 (scheme 4), retaining an aromatic iodo 
group. From a synthetic point of view 4 is a very interesting system since it maintains a ‘free 
arm’ available for a further cross-coupling reaction. It can be differently substituted, for 
example, with alkynes containing other monosaccharides (e.g. galactose or mannose) or with 
another kind of naturally occurring derivatives to give asymmetrically substituted systems with 
potential application in the biological field.  
Thus, starting from propargyl glucoside pentaacetate 1 and 1,4-diido-2,5-dimethoxy benzene  2 
in a 2:1= 2.1:1 ratio, under the same conditions as above [Pd(PPh3)4, Et3N, DMF, 60 ºC]  after 3 
h, a mixture of the mono-coupled derivative 4 and a small amount of the bis-coupled product 3 
was formed from which, the monoioido substituted system 4 could be isolated pure by 
chromatography in a 70% yield.6  
 
Scheme 4 
                                                          
6 Barattucci, A.; Deni, E.; Bonaccorsi, P.; Ceraolo, M. G.;  Papalia, T.; Santoro,A.; Sciortino, M. T.;  
Puntoriero, F., J. Org. Chem. 2014, 79, 5113−5120. 
59 
 
 
With the aim of building up an alternative counterpart exploitable in the Sonogashira reaction, 4 
was reacted with a large excess of commercial ethynyltrimethylsilane, giving 5. The use of a 
large excess of ethynyltrimethylsilane,  allowed an  almost quantitative cross-coupling reaction 
leading to compound 5. 
 
 
Scheme 5 
 
From a synthetic point of view, compound  could be very useful, because it bears a protected 
alkyne which could be able to react, once desilylated, as alkynyl donor in further Sonogashira 
reactions. Desilylation of 5 was treated n dry THF solution at -0°C,with a stoichiometric amount 
of tetra-n-butyl ammonium fluoride (TBAF), a typical desilylating agent.7 Under these 
conditions, the reaction failed and only the dimeric product 6 was formed. 6 The formation of 6 
could be a consequence of the immediate coupling of the reactive deprotected species, initially 
                                                          
7 Lin, H.-Y.; Huang, W.-C.;  Chen, Y.-C.;  Chou, H.-H.;  Hsu, C.-Y.; Lin, J. T.; Lin, H.-W. Chem. 
Commun. 2012, 48, 8913–8915 
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formed. The reaction was attempted by modulating temperature (-78°), time and dryness of 
solvents but in any case 6 was the predominant product. 
After a bibliographic research to find an alternative route, a modified cross-coupling reaction, 
adopting Ag2O as catalytic activator was attempted.
8 This reaction, reported  by Farinola et al9 to 
build up conjugated polymers, was very promising because it allowed the in situ formation of a 
reactive terminal triple bond which could immediately react with an aryl halide present in the 
reaction medium, under cross-coupling conditions. As suggested by the authors the role 
attributable to silver oxide could be explained only keeping in mind the simultaneous interaction 
between silver and iodine and between oxygen and silicon, as shown in figure 1, which would 
facilitate an almost concerted desilylation and coupling. Both interactions contributed to the 
proposed transition state from which the coupling product is finally formed in good yield. 
PdAryl
I
R
Ag
Si
O Ag
 
 
Figure 1 
With the aim to build up a new OPE bearing two ethynyl-aromatic unities, the new Ag2O-
modified Sonogashira reaction between an equimolar amount of monoioido derivative 4 and 
TMS ethynyl aromatic glucoside 5 was attempted (scheme 6), in a mixture DMF/THF (2:1) at 
70°C under the same conditions used above. The reaction was complete in 5 hours, but just only 
after 2 hours a first chromatic change from dark-grey to fluorescent yellow was appreciable The 
resulting crude reaction was a mixture the expected conjugated luminescent system 7 and a 
minor amount of compound 6. , formed by auto-coupling of 5. 
                                                          
8 Mori, A.; Kondo, T.; Kato, T.; Nishihara Y. Chem. Lett. 2001, 286-287. 
9 Babudri, F.; Colangiuli, D., Di Lorenzo, P. A.; Farinola, G. M.; Hassan Omar, O.; Naso, F. Chem. 
Commun. 2003, 130-131. 
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Scheme 6 
 
In order to further elongate the conjugate chain, we  thought of including a new 1,4-dimethoxy 
substituted aromatic core between two monosubstituted glucoderivates. To achieve this goel, 
2,5-diiodo-1,4-dimethoxybenzene 2, was reacted with two equivalents of the monoderivate 5 
following  the Ag2O-modified protocol (scheme 7). Under these conditions, compound 8 was 
obtained with high purity grade after column chromathography, as a glossy yellow crystal in a 
64% isolated yield. 
62 
 
 
Scheme 7 
Once the differently elongated derivatives 3, 6 and 8 obtained, an efficient method to trasform 
the acetates into free hydroxyl groups was developed. The aim of this synthetic step was the 
achievement of water-soluble compounds to facilitate the biocompatibility of our systems. 
Initially, the deprotection was attempted on derivative 3 following an already known 
procedure,10 in the presence of NH4OHaq. at room temperature and under stirring, in DMF/MeOH 
overnight. Deacetylated compound 1-OPE-9 was thus obtained with quantitative yield as a 
crystalline pale-yellow solid. Compounds 6 and 8 were in the same way easily deacetylated, 
giving quantitavely 2-OPE-10 and 3-OPE-11 respectively. 
All the deacetylated products were purified by simple washings of the obtained crude amorphous 
solids with a mixture of MeOH/Et2O, to remove the acetamide byproduct. 
                                                          
10 Hasegawa, T.; Numata, M.; Okumura, S.; Kimura, T.; Sakurai, K.; Shinkai, S. Org. Biomol. Chem. 
2007, 5, 2404-2412. 
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Scheme 8 
 
2.2 Synthesis of OPE glucosides  with benzene and N,N-dimethyl aniline cores 
With the aim to study which could be the influence of a different aromatic substitution on the 
photo-physical properties and on the biological behavior of our systems, the synthesis of new 
oligomers, with a modified central aromatic core was envisaged.  The convergent synthetic 
method alloweing the formation of compound  8 (scheme 7) could be applied to a great of 
variety of new oligomers that could result only by changing the central ‘brick’ and utilizing the 
same reaction conditions seen before, in terms of catalysts, solvents, molar ratios and 
temperature. 
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Scheme 9 
 
We firt tried to synthesize the system without substituents on the central aromaticring. With this 
aim, the monoderivate 4 and commercially available 1,4-diethynylbenzene, wer coupled in 2:1 
molar ratio, in the presence of catalytic Pd(0) in a copper-free Sonogashira reaction (scheme 9). 
The major product of this reaction was the desired compound 12,, but he crude reaction 
contained a mixture of  12 and 13 (12/13 4:1) whose structure corresponded to a double coupling 
of  4 with two queued central 1,4-diethynylbenzene moieties furnished The chromatographic 
separation of 12 and 13 was very hard due to  their similar Rf  in the majority of eluant systems. 
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The only mixture in which they could be separated was toluene/AcCN (95:5) and utilizing a very 
high weight ratio between crude and SiO2. Once isolated pure, oligomer 12 was deacetylated in 
the conditions shown in scheme 9 to give  free hydroxyl derivative 3-OPE-14 quantitatively as a 
pale-yellow powder, once the resulting  acetamide was eliminated by simple Et2O washings as 
mentioned before for 1-OPE-9, 2-OPE-10, 3-OPE-11. 
A new system having a central aromatic ‘brick’ 16, bearing an electron-donating NMe2 group, 
was also efficiently prepared, starting from commercially available 2,4-dibromoaniline (scheme 
10).  Basic NMe2 group appeared to be really promising for our purposes: it bears a lone pair on 
a heteroatom which could cause changes in the absorption and emission spectra of the OPE 
system and, from a chemical point of view, it has the possibility to be subjected to further and 
easy functionalization. 
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Scheme 10 
 
Thus, methylation11 of the aromatic nitrogen of 2,4-dibromoaniline  in DMF with a large excess 
of MeI and in presence of K2CO3 at 100° C, gave dimethyl amino derivative 15 in quantitative 
yield . Without further purification, compound 15 reacted under copper-free Pd(0) catalyzed 
Sonogashira coupling12 conditions, with an excess of ethynyltrimethylsilane (1:12) furnishing 16 
                                                          
11 Moroni, M.; Le Moigne, J.; Pham, T. A.; Bigot, J.-Y. Macromolecules 1997, 30, 1964-1972 
12 Shunichi, O.; Seok, R.C., Heinz, C.; Kung, H. F.J.Med. Chem. 2002, 45, 4716-4723. 
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in excellent quantities (Scheme 10).  Compound 16 could be separated by a very rapid column 
chromatography because of the low polarity of the formed compounds. 
With compound 16 in hands, the synthesis of OPE 17 was reached with good yields by using the 
Ag2O-modified Pd(PPh3)4 - mediated reaction between bis trimethyl silyl acetylene derivative 16 
and 4. After 7 hours the reaction was complete and resulted in the formation of a highly 
luminescent compound which could be isolated by chromatography and characterized as 17. 
 
 
Scheme 11 
 
The protected glucoside 17 was subjected to deacetylation, in the presence of aqueous ammonia. 
After one night stirring in THF/MeOH at rt, the free carbohydrate derivative 3-OPE-18 was 
obtained. Further washing of the crude mixture with Et2O gave 3-OPE-18 as a glossy yellow 
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crystalline powder in quantitative yield. Compounds 17 and 3-OPE-18 bearing the NMe2 
substituent were stable and easy to handle, in spite of what elsewhere reported13. 
 
The cross-coupling of 5 with 15 (Scheme 12). was also attempted as an alternative synthetic 
pathway but, in this case, 17 was obtained in poor yields (<20%), confirming the low reactivity 
of the dibromoaromatic system involved in cross-coupling reactions. 
 
OMe
MeO
O
O
OAcAcO
AcO
AcO
MeO
OMe
O
O
AcO OAc
OAc
OAc
NMe2
17
N
Br
Br
Me Me
15
1"
Pd(PPh3)4, Ag2O
THF/DMF
70°C, 7h
1 : 2
MeO
OMe
O
O
AcO OAc
OAc
OAc
5
TMS
 
Scheme 12 
 
The insertion of an electron withdrawing group such as NO2 in para position to the 
dimethylamino one in the central aromatic core of the OPE, following the same synthetic 
strategy used for the synthesis of 3-OPE-18 (scheme 13) was later tried.  To this aim, the 
synthetic sequence started with the obtention of such central core 23 achieved  starting from 
Compound 23was obtained through the five successive reactions shown in scheme 13. In the first 
                                                          
13 Yamaguchi, Y.; Tanaka, T.; Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. J. Am. Chem. 
Soc. 2005, 127, 9332-9333. 
68 
 
step commercial 2,5-dibromoaniline reacted with acetic anhydride in water, at reflux 
temperature. After 4 hours the new amide group was formed quantitatively. Without further 
purification 19 was treated in acid ambient (HNO3/H2SO4), in the typical condition for aromatic 
nitration, to give compound 20 with good yields (60%). Further deprotetion in acid ambien (HCl 
1M) led to the quantitative formation of compound 2114. 
 
NH2
Br
Br
NH
Br
Br
NH
Br
Br
O
O
NO2
NH2
Br
Br
NO2
N
Br
Br
NO2
19 20
2122
O
O O
H2O
100°, 4h
HNO3/H2SO4
0°C, 2 h
HCl 1M
100°, 24h
CH3I, K2CO3
DMF,
100°C, 48h
N
Me Me
TMS
TMS
TMS
Pd(PPh3)4
Et3N/DMF
70°C, 2hNO2
23  
 
Scheme 13 
 
Methylation at the aromatic primary amine of 21 followed by cross-coupling of the resulting 22 
with an excess of commercially available ethynyltrimethylsilane allowed the access to N,N-
dimethyl-4-nitro-2,5-bis[(trimethylsilyl)ethynyl]aniline 23 in good overall yield (70%) 
                                                          
14 Moroni et al.; Macromolecules, 1997, 30, 1964-1972.  
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Scheme 14 
 
The synthesis of the coupled product 24 was achieved by the Ag2O-modified Sonogashira 
reaction between 23 and 4 under the conditions shown in Scheme 14, in 24 hours. Once isolated, 
24 was a dark-green oil, highly unstable at room temperature. A test of deacetylation on 24 was 
attempted, but the reaction gave a very dirty crude mixture impossible to be purified because of 
its very rapid transformation into decomposition products, even in refrigerated and/or degassed 
conditions. 
 
Going on with the intention of luminescence modulation of our oligomers, we thought to insert 
an additional dimethylamino group in the OPE chain. For this scope it was projected to build a 
new monoderived building block (25 and its derivatives, scheme 14), analogous to 4 but 
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containing a dimethylamino substituent at the aromatic ring adjacent to the sugar moiety, able to 
react in the Sonogashira coupling with different substituted central cores.15 
 
 
Scheme 15 
 
Compound 25 was prepared using a Pd(0) cross-coupling reaction from propargyl glucoside 1 
and an excess of 2,5-dibromo aniline 15, as shown in Scheme 14. Under the conditions indicated, 
compound 25, with only one derivatized arm, was formed in a 75% isolated yield.  
 
Figure 2 
 
                                                          
15 Deni, E.; Zamarrón, A.; Bonaccorsi, P.; Carreño, M.C.; Juarranz, A.; Puntoriero, F.; Sciortino, 
M.T.; Ribagorda, M.; Barattucci,A., Eur. J. Med. Chem., 2016, (submitted). 
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The reaction was completely regioselective and proceeded with the formation of only one 
product, characterized as the mono susbstituted regioisomer 25, having the triple bond in meta 
position with respect to  to the bulky dimethylamino group, in a 75% yield.  
The regiochemistry of compound 25 could be unequivocally demonstrated by the NMR 
bidimensional experiment HMBC (Heteronuclear Multiple Bond Correlation). Significant detail 
of the obtained spectrum, reporting in ordinate the enlarged 13C region related to the quaternary 
acetylenic carbons, and in abscissa the aromatic and low-field aliphatic region of the 1H-NMR 
spectrum, is shown in figure 2.  The acetylenic carbon (red) near the aromatic ring shows an 
evident correlation with aromatic protons H-2 and H-6, allowing to exclude the other possible 
regioisomer. Moreover, the strong correlation between the other acetylenic carbon atom (green) 
and the CH2 groups gives confirmation to the exact structure of compound 25.  
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Scheme 16 
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The cross-coupling reaction of 25 with an excess of commercially available 
ethynyltrimethylsilane gave rise to the key intermediate 26 in high yield and very mild 
conditions [Pd(PPh3)4, Et3N, DMF, 60 ºC]. The final Ag2O-modified Pd(0) mediated coupling of 
1,4-diiodo-2,5-dimethoxy benzene 2 with 26 (2 equiv.) gave rise to the amino OPE glucoside 27. 
Quantitative deacetylation of 27 in the presence of an excess of aqueous ammonia gave the 
gluco-OPE 3-OPE-28 as a brilliant yellow solid, easily separated from residual acetamide by 
subsequent washings with MeOH, in almost quantitative yield. All the newly synthesized 
products are stable and easy to handle. 
All sugar free compounds 1-OPE-9, 2-OPE-10, 3-OPE-11, 3-OPE-14, 3-OPE-18 and 3-OPE-
28 show, by preliminary tests, low water solubility (up to 10-5 M), with the exception of 1-OPE-
9, where the hydrophilic part is predominant and 3-OPE-28, where it seems that the presence of 
two dimethylamino groups decreases the hydrophobicity of the conjugated OPEs.  
As already illustrated, compounds 17 and 27 possess one or two dimethylamino basic groups 
consisting in bearing a lone electron pair that, otherwise, can be shared with the conjugated 
system of the OPEs. With the aim to go on modulating the chemical, physical and biological 
behavior of our conjugated glucosides, it was thought to transform the –NMe2 groups into 
quaternary ammonium salts –NMe3+. In fact, the presence of a charged group could increase the 
solubility of the synthesized molecules in water and at the same time the absence of the lone pair 
on nitrogen could cause an alteration of the photo-physical properties. 
The first test of quaternization was performed using the typical methylating agent, iodomethane. 
Reaction of 17 with a large excess of iodomethane in refluxing acetone at didn’t lead to the 
formation of the expected quaternary product. By changing solvent, in order to increase the 
reflux temperature, 17 was tried to react with CH3I in acetonitrile, but even after 12 hours in 
these conditions no reaction occurred. 
The lack of reactivity of 17 is attributable to the low basicity of the aromatic nitrogen. For this 
reason it was necessary to use a stronger methylating agent like methyl 
73 
 
trifluoromethanesulfonate (TfOMe). TfOMe was slowly added to a solution of 17 in CH2Cl2 in 
1:1 molecular ratio, and the solution was heated up to the reflux temperature for 2 hours leading 
to the quantitative formation of the quaternized product 29. It was observed that a strict 
molecular ratio between 17 and triflate has to be maintained because a larger amount of TfOMe, 
which contains a small but critical amount of triflic acid, caused the  decomposition of 29. 
Purification was not necessary because, after evaporation under vacuo and following washings of 
the obtained solid with Et2O, the product 29 was obtained as an orange crystalline pure powder. 
 
 
Scheme 17 
A good success in terms of yield of the above described reaction is to utilize of properly stored 
methyl trifluoromethanesulfonate (freezed and under inert atmosphere) because it is extremely 
sensitive to air and heat.  
The same reaction was performed on the OPE 27, having two dimethyl amino groups, with the 
aim of  obtaining the doubly quaternarized salt. Thus, slow addition  of TfOMe to a solution 
CH2Cl2 of 27 in 27/TfOMe: a 1/2 molecular ratio, afforded the double quaternary ammonium 
salt 3-OPE-28 in quantitative yield as a brilliant orange powder. 
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Scheme 18 
 
Deacetylation of 29 and 30 was performed in the presence of large excess of NH3aq in MeOH and 
THF giving 31 and 32 respectively (scheme 19).  
 
 
Scheme 19 
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2.3 Photo-physical measurements and singlet oxygen evaluation 
 
In order to determine how the elongation of the conjugated system and the presence of different 
substituents on the aromatic rings could modulate the photo-physical properties of the 
synthesized OPEs, the photo-physical studies were performed on all the obtained compounds. 
This part of the PhD thesis was developed in collaboration with Prof. FaustoPuntoriero, from the 
University of Messina. 
To gain insightinto thelight-activatedactivity of the oligomers, we carried out systematic 
photophysical studies, both in organic solvents and in acqueous buffered solution. 
These studies have been performed not only for the strictly characterization of the excited state 
of OPEs but also to investigate their ability as photosensitizers for singlet oxygen generation. 
QUI devispiegarequaiproprietà si vanno a misurare (UV e amissione di luminescenza) e che 
informazioni ti daranno. Dovrestispiegare brevemente ildiagramma di Jablonski per giustificare 
la formazione di ossigenosingolettoìespiegare come si calcola la resaquantica. Questo è moltio 
importante. 
Reactions of singletoxygen1O2*(1g), are of much current interest because of their importance in 
many photo oxidations of chemical and biological systems including reactions used in photo-
chemotherapy. There is strong evidence for the involvement of singlet oxygen, a powerful 
oxidant, in many photosensitized oxidations, photodynamic inactivation of viruses and cells, in 
phototherapy for cancer, in photo carcinogenisis, in the photodegradation of dyes and polymers 
and in the dyes ensitization of the photodegradation of polymers. 
In solution, the singlet oxygen is often prepared by a process called photosensitization.  
Photosensitized generation is a simple and controllable method for the production of singlet 
oxygen, requiring only light of an appropriate wavelength, and a photosensitizer capable of 
absorbing and using that energy to excite oxygen to its singlet state. 
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A photosensitizer is irradiated to its singlet excited state, followed by intersystem crossing to its 
triplet excited state.  
Intersystem crossing generates the sensitizer triplet state,T1. The lifetime of the T1 state is 
longer (ms) than that of the S1 state (ns) allowing this excited state to react in one of two ways, 
defined as Types I (radical reactions) or Type II process (singlet oxygen production), see Figure 
3.16 
 
Figure 3. Generation of excited photosensitizer states and reactive dioxygen species. 
 
All the photophysical experiments were performed at room temperature using as solvents both 
CH2Cl2andphosphate buffer (100mM PBS, pH=7.0). 
All spectroscopic and photophysical data are reported in table 1: for the absorption, the maxima 
(or shoulders) of the lower energy bands are given. Some direct comparison of 
absorption/emission spectra in DCM are given in figures 4, 5 ad 6. 
 
 
                                                          
16 R. Bonnett, Chem. Soc. Rev. (1995) 19. 
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compound 
Absorption max, nm 
(/ M-1cm-1) 
Luminescence, 298 K 
max/ nm  /ns 
DCM PBS DCM PBS DCM PBS DCM PBS 
3/1-OPE-9 344 (11000) 344 (11400) 383 384 0.45 0.46 0.72 0.75 
7/2-OPE-10 378 (35000) 379 (34800) 404 404 0.87 0.89 1.54 1.60 
8/11 390 (49500) 390 (50000) 433 433 0.85 0.83 0.98 0.96 
12/3-OPE-14 377 (39500) 378 (39000) 437 437 0.82 0.80 0.76 0.74 
17/3-OPE-18 388 (38900) 389 (39300) 472 473 0.57 0.58 2.47 2.40 
24 381 (38000) 380 (38500) - - - - - - 
27/3-OPE-28 392 (40000) 391 (40500) 474 475 0.74 0.76 3.54 3.50 
29/31 400 (41900) 400 (41900) 470 471 0.90 0.90 2.10 2.00 
 
Table 1. Absorption and emission data at room temperaturein dichloromethane (DCM) and 
phosphate buffer (BPS) solution.a 
a) Dichloromethane have been used for the protected species (3, 7, 8, 12, 17, 24, 27, 29) whereas 
PBS for the deprotected ones (1-OPE-9, 2-OPE-10, 3-OPE-11, 3-OPE-14, 3-OPE-18, 3-OPE-
28, 31, 32). 
 
The absorption spectra of all the investigated species, in DCM solution (for the protected 3, 7, 8, 
12, 17, 24, 27, 29) as well as in aqueous solution (buffer phosphate for the deprotected 1-OPE-9, 
2-OPE-10, 3-OPE-11, 3-OPE-14, 3-OPE-18, 3-OPE-28, 31, 32), are characterized by an 
intense absorption in the UV region of =340-400 nm  in the 104-105 M-1 cm-1 range), due to 
spin-allowed transitions of the aromatic moieties. A batochromic effect is observed by 
increasing the number of ethynylene aromatic moieties, as a consequence of the increased 
conjugation. Most oligo(phenylene-ethynylene)sform aggregates and excimers when added to  
solvent/nonsolvent (solvent is able to dissolve the species whereas a non solvent is not) mixtures, 
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which are usually detected by absorption and fluorescence spectroscopies. In our case the 
concentration used was low enough to avoid these feature: concentration dependence was 
observed only when higher than 10-4 M and in mixed solvents.17 
With respect to the emission spectra, it is possible to observe that by increasing of the chain 
length, moving from 3 to 8 (passing from 1 to 3 phenylenethynylen unities) the emission energy 
decreases whereas the emission quantum yield doubles. This is reminiscent of the bathochromic 
shift in the corresponding absorption spectra.  
 
Figure 4.Absorption (top panel) and emission spectra(bottom panel) of 3, 7, 8 and 17. Please 
note that the absorption spectra are not reported in epsilon to better distinguish the absorption 
profile each other (for the epsilon value please refer to Table 1). 
 
The augmented conjugation between the peripheral subunits in 8 and 12 causes a further 
decrease of both luminescence excited state energy and quantum yield. By increasing the chain 
lengtht red shift of the absorption maximum is registered (see Table 1, Figure 4): this behaviour 
                                                          
17Babudri, F.;Colangiuli, D.; Di Bari, L.; Farinola, G. M.; Hassan Omar, O.,Naso, F.; Pescitelli, G. 
Macromolecules2006, 39, 5206-5212. 
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is consistent with a greater π-conjugation passing from 3 to 8/12. The molar extinction 
coefficients (ε) of the lowest-energy transition also increase with the same trend as it is possible 
to observe in Table 1. 
 
The insertion of one electron-donating group (NMe2) on the central subunit of the oligomer 17 
shifts the luminescence to the red, while the quantum yield decreases, still remaining at the high 
value of 0.57. The unstructured large emission profile suggests that in this case the excited state 
has a partial charge transfer character that could be tentatively attributed to nπ* transitions(see 
Table 1, Figure 4). The absence of luminescence in 24 can be adscribed to the presence of the 
NO2 electron-withdrawing group that acts as a quencher for these systems.
18It is important to 
stress that no changes in the photophysical properties havebeen observed between the acetylated 
compounds and the corresponding deacetylated ones, in DCM and aqueous solution. 
 
 
Figure 5. Normalized absorption and emission spectra of 17 (red line) and 29 (blue line in DCM 
solution. 
 
A direct comparison between the absorption and emission spectra of compound 17 and its 
corresponding quaternary ammonium salt 29 is shown in Figure 5. 
                                                          
18Yamaguchi, Y.; Tanaka, T.; Kobayashi, S.; Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i. J. Am. Chem. 
Soc. 2005, 127, 9332-9333 
80 
 
The absence of the lone pair on nitrogen in 29, due to the quaternization of dimethylamino 
group, provoked a further shift to red in the absorption, probably due to the fact that the electron-
donating ability of amines is inverted upon protonation or quaternization. An interesting 
observation correspond to the significant increase  of the quantum yield of emission of 29 
compared to 17 as a consequence of the loss of the lone pair. In fact the lone pair can act as 
electron donor to the excited state in 17, activating a further non radiative deactivation pathways 
via partial population of a charge separated state. The absence of this deactivation channel in 29 
brings to an higher quantum yield and longer emission lifetime. 
 
 
Figure 6. Absorption and emission (dashed lines) spectra of hydroxyl derivatives 3-OPE-11, 3-
OPE-18 and 3-OPE-28 
 
Figure 6 shows a comparison of absorption and emission spectra of three selected deacetylated 
trimers: 3-OPE-18, 3-OPE-28 and 3-OPE-11. The absorption spectra of the OPEs 3-OPE-18 
and 3-OPE-28, in aqueous solution (buffer phosphate) are characterized by intense broad low-
energy absorption bands centered at =388 nm and at 392 nm, respectively with  values in the 
range 104-105 M-1 cm-1. Theseabsorptions in the UV region are due to spin-allowed 
transitions centred on the aromatic skeleton of OPEs19. Excitation of  3-OPE-18 and 3-OPE-28 
                                                          
19Lanoë, P.-H.; Gallavardin, T.; Dupin, A.; Maury, O.; Baldeck, P. L.; Lindgren, M.; Monnereau, C.; 
Andraud, C. Org. Biomol. Chem.2012, 10, 6275-6278. 
3-OPE-18 
3-OPE-28 
3-OPE-11 
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in the range 280–420 nm allowed the appearance of emissive state bands in the blue region of 
spectrum. Interestingly, a closer look at the results presented in Table 1, summarized below 
(Figure 6) revealed clear differences between the photophysical properties of 3-OPE-18 and.In 
particular, moving from 3-OPE-18 to 3-OPE-28, the emission quantum yield increased [from 
= 0.57 (3-OPE-18) to =0. 74 (3-OPE-28)] as well as the excited state lifetime, measured by 
“Time correlated single photon counting” technicals [from /ns = 2.47 (3-OPE-18) to /ns 3.54 
(3-OPE-28)].  
Luminescence quantum yields () were determined by measuring luminescence spectra of an air-
equilibrated ethanol solution of anthracene (Φ= 0.2)20 and luminescence spectra of OPEs in air 
equilibrated solution using identical acquisition parameters. In equation 1, I is the integrated 
luminescence intensity, A is the absorbance at the excitation wavelength, and n is the refractive 
index of the solvent. The subscript “r” refers to a reference substance with known luminescence 
quantum yield (r) 
 
Equation 1 
 
Interestingly, both quantum yields were reduced with respect to compound 3-OPE-11 (=0.85) 
bearing two methoxy groups as substituents at each aromatic ring, and in which the 
dimethylamino group is not present. This behaviour could suggest that the excited singlet state 
decays faster in 3-OPE-18 because, in this case, the rate of intersystem crossing to the triplet 
excited state (responsible for sensing singlet oxygen) is enhanced with respect to 3-OPE-28. 
                                                          
20a) Demas, J. N.; Crosby, G. A.J. Phys. Chem.197,75, 991−1024. (b) Dempster, D. N.; Morrow, T.; 
Quinn, M. F.J. Photochem.1974,2, 329−341 
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Considering that 17 and 3-OPE-28 have the longer lifetimes, probably due to a partial 
intersystem crossing character of the radiative deactivation, we thought to examine in depth their 
photo physical properties, in particular to determine the production of singlet oxygen (1O2), 
which is the key species for further biological evaluation.  
 
 
Figure 7: Degradation of uric acid (= 292 nm) versus Time using as sensitizer 3-OPE-18 (blue 
squares), 3-OPE-28 (red squares) and the model compound 3-OPE-11 (green squares). The 
OPEs solution concentrations are 5x10-5M. 
 
On the basis of this assumption, we performed an indirect evaluation of singlet oxygen 
production by excitation of the oligomers 3-OPE-18, 3-OPE-28 and 3-OPE-11. The singlet-
oxygen generation was evaluated by a chemical method using uric acid (UA) as detector.21Under 
irradiation at neutral pH, uric acid is stable and shows one absorption band centered at 292 nm. 
When singlet oxygen (or ROS) is photo-produced, uric acid is irreversibly oxidized as 
highlighted by the reduced intensity of its absorption band. We used the methylene blue species 
                                                          
21a)Passarella Gerola, A.; Semensato, J.; Silva Pellosi, D.; Roberto Batistela, V.; Ribeiro Rabello, B.; 
Hioka, N.; Caetano, W., J. Photochem. Photobiol. A 2012, 232, 14-21. (b) Ribeiro Rabello, B.; Passarella 
Gerola, A.; Silva Pellosi, D. ;Tessaro, A. L. ; Aparício, J. L.; Caetano, W.; Hioka, N., J. Photochem. 
Photobiol. A. 2012, 238, 53-62. 
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as a reference photosensitizer. The decay curves of the UA absorption band at 292 nm as a 
function of the irradiation time in the presence of 3-OPE-18 (blue squares), 3-OPE-28 (red 
squares) and 3-OPE-11 (green squares) are reported in Figure 7 (concentrations 5x10-5M). The 
singlet oxygen quantum yields obtained for 3-OPE-18 (Φ1O2 0.15) and 3-OPE-28 (Φ1O2 0.09), 
listed in Table 1, are in line with the photophysical results above discussed, confirming that the 
reduced luminescence quantum yield for 3-OPE-11 could be ascribed to a more efficient 
sensitization of the triplet excited state of these species. 
 
2.3 Biological studies  
 
2.4.1. Cell internalization 
  
Once studied the photo physical properties, we thought to investigate the ability of these new 
oligomers to cell internalization. This first part of the biological study was undertaken in 
collaboration with Prof. Maria Teresa Sciortino, from Messina University.  
As a first step we performed uptake experiments for  compounds 1-OPE-9, 2-OPE-10, 3-OPE-
11, 3-OPE-18 and 3-OPE-28 on HEp-2 cells (cells from epidermoid carcinoma larynx tissue). 
Compounds were dissolved in DMSO in order to have a final concentration of 10mM. HEp-2 
cells were grown on culture slides and treated with the products to a final concentration of μM 
(in RPMI medium) for 24h. The internalization in the cells was observed with fluorescence 
electronic microscopy using blue filter (DAPI) or green filter (FITCH). 
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Figure 8  
 
The shortest glucoside 1-OPE-9 incubated for 24 h slightly internalized in HEp-2 cell lines 
(figure 8), the internalization is facilitated by the presence of the glucosidic substituents 
deacetylated.  
Glucoside 2-OPE-10 was unable to internalize probably as a consequence  of the elongation of 
the aromatic chain which renders the structure more lipophilic, but it was blocked on the cellular 
membrane as ordered and fluorescent sticks. In figure 1-OPE-9 it is possible to observe the 
fluorescence with blue filter (DAPI) and with green filter (FITCH).  
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Figure 9  
As expected, compound 3-OPE-11 was completely unable to be uptaken in Hep-2 cells due to its 
elongated ethynyl-aromatic chain.  
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Figure 10 
On the other hand, only changing the aromatic core substitution, and then passing from 3-OPE-
11 to 3-OPE-18, with a dimethyl amino substituted aromatic core,  massive internalization 
happens. Figure 10 refers to the cell internalization and efficient enlightening of glucoside 3-
OPE-18, showing the main localization in vesicles within the cytoplasmic compartment. 
Particularly, it is represented the fluorescence microscopy images of HEp-2 cells incubated with 
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3-OPE-18 (100 μM) and analyzed using a FITC filter (green emission) or a DAPI (blue 
emission). The more lipophilic OPE glucoside 17, acetylated analogue of 3-OPE-18, lightly 
internalized Hep-2 cells.  
After these observations and experimental results it is possible to conclude that the massive 
internalization of 3-OPE-18 is due to the synergic effect of several contributions: i) elongation 
of the hydrophobic chain, going from glucosides 1-OPE-9 to 3-OPE-11; ii) substitution of the 
aromatic central core with a dimethylamino group in 3-OPE-18 instead of a bis-methoxy moiety 
present in glucoside 3-OPE-11; iii) deacetylation of the sugar moieties, improving the 
hydrophilicity of 3-OPE-18 with respect to glucoside 17.  
 
 
 
 
Figure 11 
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The great luminescence quantum yield and the high degree of endocytosis of 3-OPE-18 permits 
to detect fluorescence emission even when cells are incubated at low concentrations up to 1µM 
(Figure 11).  
As last, the cell internalization of OPE compound 31, having a quaternary ammonium salt. in 
HEp-2 cells was evaluated by fluorescence microscopy with DAPI filter (Figure 12).  
The high fluorescence of compound 31 provoked a blurry image but it is plausible to affirm that 
31 internalized and that it was situated on the nuclear cellular membrane.  
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Figure 12 
 
2.4.2. OPEs photosensitizers in PDT. 
 
Having in our hands the first results in cell internalization of 3-OPE-18 and photophysical study 
of 3-OPE-18 and 3-OPE-28, including excited state lifetimes and singlet oxygen productions 
(2.2), we thought to study the possible application of 3-OPE-18 and 3-OPE-28 as 
photosensitizers (PSs) in photodynamic therapy (PDT). This part of the work was carried out in 
collaboration with Prof. Ángeles Juarranz Torres from the Universidad Autónoma de Madrid. 
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Phototherapy is a minimally invasive therapeutic procedure already approved for the treatment 
of various oncological and non-oncological pathologies of skin. Variants of phototherapy include 
targeted ultraviolet B (UVB) phototherapy, topical psoralen plus ultraviolet A (PUVA), and 
photodynamic therapy (PDT). All of them are localized forms of phototherapy to treat skin 
lesions, either as first-line treatment or as complementary treatment for those that do not respond 
to other topical treatments.22 
PDT are based on the specific accumulation of a photosensitizer (PS) in the target tissue, 
followed by irradiation with light at a wavelength matching the absorption spectrum of the 
photosensitizer. Upon light absorption, the PS transits from its ground state to an unstable 
excited singlet state, from which it can decay, either to the ground-state or to the excited triplet 
state. In this long-lived excited triplet state, the PS is able to produce singlet oxygen (1O2) which 
in turn gives rise to other reactive oxygen species (ROS), such as peroxides, superoxide anions 
or hydroxyl radicals. These species are able to react directly with a biological substrate. ROS can 
oxidize vital cellular components inducing an acute cell stress response culminating in cellular 
death, mainly by apoptosis and/or necrosis. The cell death pathway depended, among other 
factors, on the nature and intracellular localization of the PS and on tumor properties. 
The ideal PS should possess high photo-activity and selective photocytotoxicity for sick skin 
cells but low dark toxicity, activation at discrete wavelenghts, efficient and fast distribution and 
elimination from tissues and chemical and physical stability. The amphiphilic nature of PSs, 
having lipophilic and hydrophilic moieties, is also an important feature for their application in 
biological tests.  Although a significant number of photosensitizers are synthesized each year, 
                                                          
22 (a) Almutawa, F.; Thalib, L.; Hekman, D.; Sun, Q.; Hamzavi, I.; Lim, H.W., Photodermatol. 
Photoimmunol. Photomed. 2015, 31, 5-14. (b) Situm, M.; Bulat, V.; Majcen, K.; Dzapo, A.; Jezovita, J. 
Coll. Antropol. 2014, 38, 1249-53. 
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only a few of them fulfill the requirements to be used in phototherapy. Thus, the development of 
new photosensitizers continues to be a current objective of research in the field of PDT.23 
 
Subcellular localization of PSs: The efficiency of a photosensitizer for PDT is related to its 
subcellular localization.24 Therefore, we first evaluated the cell internalization and subcellular 
localization of OPEs 3-OPE-18 and 3-OPE-28 in HaCaT (human keratinocyte cells) HeLa 
(human cervical cancer cells) and HEp-2 (human larynx cancer cells) cells was analyzed by 
fluorescence microscopy under UV excitation light (360-370 nm) (Figure 13A). Similar results 
were observed under blue light excitation (460-490 nm). The intracellular luminescent signals of 
3-OPE-18 and 3-OPE-28 were observed after 6 h of incubation with 1·10-6 M of both 
compounds.  
Corresponding controls (without PSs incubation) of each cell type were also performed. In the 
three cell lines, after the incubation with PSs, an intense signal was visualized around the nucleus 
in a reticular pattern, as well as in a yuxtanuclear position. By contrast, control cells showed a 
very low signal, corresponding to mitochondrial autofluorescence. This indicated that signal 
emitted by treated HaCaT, HeLa and HEp-2 cells was due to the intracellular accumulation of 
the PSs, confirming the cellular uptakes of both compounds. In order to determine the places 
where PSs were located, cells were incubated with known markers for endoplasmic reticulum 
(ER-Tracker®) and Golgi apparatus (NBD®) (Figure 13B). ER showed a blue fluorescent signal 
                                                          
23  Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X. H.; Childs, C.J. H.; Sibata, C. H. Photodiagn. 
Photodyn. Ther. 2004, 1, 27−42.  (b) Garland, M.J.; Cassidy, C.M.; Woolfson, D.; Donnelly, R.F. 
Designing, Future Med. Chem. 2009, 1, 667-691. 
24 (a) Soares, A.R.M.; Neves M.G.P.M.S.; Tome, A.C.; Iglesias-de la Cruz M.C.; Zamarrón, A.; Carrasco, 
E.; González, S.; Cavaleiro, J.A.S.; Torres, T.; Guldi, D.M.; Juarranz, A., Chem. Res. Toxicol. 2012, 25, 
940-951. (b) Rello-Varona, S.;Gámez, A.;Moreno, V.;Stockert, J.C.; Cristóbal, J.;Pacheco, M.; Cañete, 
M.; Juarranz, A.; Villanueva, A. , Int. J. Biochem. Cell. Biol. 2006, 38, 23-OPE-183–2195. 
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under UV excitation light (λ = 360-370 nm) and Golgi apparatus emitted a green fluorescence 
under blue excitation light (λ = 460-490 nm).  
Comparison of the images obtained after incubation with 3-OPE-18 and 3-OPE-28 with those 
obtained with the known probes for specific organelles, confirmed that compounds 3-OPE-18 
and 3-OPE-28 are localized mainly in Golgi apparatus and endoplasmic reticulum. It is 
important to indicate that no differences were found in the intracellular localization of OPE-3-
OPE-18 or 3-OPE-28 in the three cell types. 
 
Figure 13  
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Effects induced by 3-OPE-18 and 3-OPE-28 – PDT on cell survival: The action of a PS on 
cells is related to the production of 1O2 and/or other ROS generated after light irradiation.
25  
Therefore, we next evaluated the toxicity of compounds 3-OPE-18 and 3-OPE-28 first in the 
absence of light and then after UV irradiation. The toxicity experiments were performed by 
incubation of HaCaT, HeLa or HEp-2 cells with 3-OPE-18 or 3-OPE-28 (ranging from 3·10-6to 
2.5·10-5 M) in the dark. In the absence of light the toxicity for both OPEs 3-OPE-18 and 3-OPE-
28, was dependent on the PS concentration (Table 2).  
Thus, concentrations of 3·10-6 and 5·10-6 M of both PSs did not induce any relevant toxic effect 
(survival rates above 90% in all cell lines), and higher PS concentrations (1·10-5 and 2.5·10-5M) 
caused a variable cell damage depending on the cell type (survival percentages between 60-
85%).  
The dark toxicity levels obtained for both OPEs 3-OPE-18 and 3-OPE-28 are similar to other 
reported PSs tested in vitro, including porphyrin derivatives and phtalocyanines.26 
 
 
[PS] 
HaCaT HeLa HEp-2 
3-OPE-18 3-OPE-28 3-OPE-18 3-OPE-28 3-OPE-18 3-OPE-28 
3·10-6 M 92.36 ± 1.6 91.45 ± 1.3 96.38 ± 1.6 96.61 ± 2.9 97.22 ± 1.4 97.73 ± 1.0 
5·10-6 M 91.41 ± 2.4 90.93 ± 2.0 95.43 ± 1.7 93.52 ± 2.2 96.28 ± 2.0 95.72 ± 2.4 
1·10-5 M 71.55 ± 3.2 70.23 ± 2.7 82.21 ± 2.5 76.89 ± 3.0 85.63 ± 2.9 80.07 ± 2.8 
2.5·10-5 M 61.18 ± 1.8 59.72 ± 2.8 77.76 ± 2.7 66.65 ± 3.1 81.49 ± 1.9 70.19 ± 1.2 
 
Table 2  
 
                                                          
25 a) Barata, J.F.; Zamarrón, A.; Neves, M.G.; Faustino, M.A.; Tomé, A.C.; Cavaleiro, J.A.; Röder, B.; 
Juarranz, A.; Sanz-Rodríguez, F. Eur. J. Med. Chem. 2015, 92, 135-144. (b) Zhi, Y.-G.; Lai, S.-W.; Chan, 
Q. K.-W.; Law, Y.-C.; Tong, G. S.-M.; Che, C.-M. Eur. J. Org. Chem. 2006, 3125–3139. 
26 (a) Henderson, T.J., Anal. Chem. 2002, 74, 191–198. (b) Demas, N. Crosby, G. A., J. Phys. Chem. 
1971, 75, 991-1024. 
92 
 
We next evaluated the effect of UVA irradiation on the cell cultures, first without the presence of 
the OPEs. As can been seen in Table 3, none of the tested doses (ranging from 0.25 to 2 J/cm2) 
induced substantial cytotoxic effects, the survival rates of HaCaT, HeLa and HEp-2 after UVA 
light irradiation (2 J/cm2) were 97.2%, 94.0% and 95.1%, respectively.  
 
 
UVA dose HaCaT HeLa HEp-2 
0.25 J/cm2 98.76 ± 1.0 99.01 ± 0.9 98.11 ± 1.8 
0.5 J/cm2 98.33 ± 1.1 97.50 ± 2.0 98.42 ± 1.3 
1 J/cm2 97.92 ± 2.1 96.79 ± 1.7 97.33 ± 1.5 
2 J/cm2 97.2 ± 1.2 94.0 ± 2.3 95.2 ± 1.6 
 
Table 3  
According to the above illustrated results we selected concentrations of 3·10-6 and 5·10-6 M of 
both compounds and 0.25, 0.5 and 1 J/cm2 of UVA light to evaluate the the synergic effect of the 
PSs compounds 18 and 3-OPE-28 plus UVA irradiation on the three cell lines. The photodynamic 
treatments, carried out by incubation with OPE-3-OPE-18 or OPE-3-OPE-28 for 6 h followed by 
UVA exposure, induced cytotoxic effects in HaCaT, HeLa and HEp-2, depending on the PS 
concentration and the UVA dose. Cell survival rates after PDT (Figure 14A), measured by MTT 
assay, were significantly decreased (P<0.01) in all the cell lines with respect to untreated controls. 
Viability after PDT was similar for both PSs, since no significant differences between 3-OPE-18 
and 3-OPE-28 were found. However, HeLa cell extended to be slightly more sensitive to PDT 
than HaCaT and HEp-2. The LD50  dose, which corresponds to the treatment conditions that 
induced approximately a 50% of cell death, was reached with concentrations of 3·10-6 of 3-OPE-
18 or 3-OPE-28 and followed by 0.25 J/cm2 of UVA radiation. The other tested conditions caused 
a lethality rate greater than 50%. In the case of 3-OPE-18, values lower than 10% of cell survival 
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(LD90) were obtained after cell treatment with 2.5·10-5 M and 2 J/cm2 of UVA light (data not 
shown). Similar results were found for 3-OPE-28. All these findings indicated that compounds 3-
OPE-18 and 3-OPE-28 were not toxic for the cells in the absence of light at concentrations lower 
than 5·10-6 M, confirming that the cytotoxic effect when UVA light was applied was due to the 
production of reactive oxygen species (ROS). These cytotoxic values are comparable with other  
 
Figure 14  
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PSs used in PDT under UVA light irradiation, such as curcumin27, hypericin or psoralen.28 Both 
PSs reached a good photodynamic effect when combined with UVA light, but we did not observed 
selectivity for tumour HeLa and HEp-2 cells compared to non-tumour HaCaT cell line. The cell 
morphology was also analyzed 24 h after phototreatments, using phase contrast microscopy 
(Figure 14B). 
 
 This analysis revealed that 3-OPE-18 and 3-OPE-28-based PDT induced notable changes in the 
morphology of HaCaT, HeLa and HEp-2 cells. These alterations were dependent on the treatment 
conditions (PS concentration and UVA light dose) and did not differ when 3-OPE-18 or 3-OPE-
28 were used. Under a LD50 conditions, HaCaT cells showed cytoplasmic retraction and cell 
elongation, as well as the appearance of apoptotic (with membrane blebbing) and necrotic (with 
loss of membrane integrity) figures.  
 
The tumoural cell lines (HeLa and HEp-2) also suffered retraction of their cytoplasm, cellular 
stretching and a strongly cytoplasmic vacuolization, which is indicative of cell degeneration 
processes. In addition, we noticed the apparition of a large amount of rounded cells, indicating a 
possible mitotic blockage, as well as a large number of cells detached from the substrate, floating 
on culture medium. All the changes observed confirmed the results obtained from cell viability 
assays. 
 
Nuclear morphology was also evaluated 24 h after PDT by Höechst-33258 staining and 
fluorescence microscopy (Figure 15A-B). Nuclear retraction was observed in the three cell lines 
when subjected to LD50 dose of both phototreatments, in comparison to untreated cells, as well 
                                                          
27 Dempster, D. N.; Morrow, T.; Quinn, M. F., J. Photochem. 1974, 2, 329-341. 
28 Rello, S.; Stockert, J.C.; Moreno, V.; Gámez, A.; Pacheco, M.; Juarranz, A.; Cañete, M.; Villanueva, 
A., Apoptosis. 2005, 10, 201-208. 
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as the appearance of apoptotic and necrotic morphologies. Furthermore, a great amount of 
mitotic nuclei was observed in HeLa and HEp-2 cell lines, most of them abnormal metaphases. 
 
 
 
Figure 15  
Nuclei morphology was observed 24 h after PDT using Höechst-33258 staining and fluorescence 
microscopy (in figure 15A). The controls (untreated cells) of the three cell lines displayed well 
defined interphasic and mitotic (*) nuclei. Nevertheless, when treated with OPE-3-OPE-18 or 
OPE-3-OPE-28, PDT (LD50 dose), cultures showed an increment of apoptotic and necrotic 
nuclei. Also, in HeLa and HEp-2 cultures an increase of mitotic cells was observed (figure 15 B). 
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Details of normal (a) and altered (b) mitotic figures as well as apoptotic (c) and necrotic (d) cells 
are also shown. 
 
Acridine Orange / ethidium bromide staining: The cytotoxicity of LD50 of 3-OPE-18 and 3-
OPE-28 in PDT was also evaluated using acridine orange/ethidium bromide staining (AO/EtBr) 
(Figure 15). This method allowed us to distinguish between viable, rounded, apoptotic and 
necrotic cells. As shows Figure 16A, the PDT induced evident alterations in the morphology of 
HaCaT, HeLa and HEp-2 cells, in comparison with their control counterparts. These 
morphological changes were similar for both PSs. After PDT, HaCaT cultures showed an 
increase of apoptotic and necrotic cells. In HeLa and HEp-2 cultures, besides apoptotic and 
necrotic figures, a large number of rounded cells densely stained as green, were observed. In 
order to determine the exact percentage of each cellular condition, a cell counting was 
performed.  
 
The percentage of cells in each established condition was similar for 3-OPE-18 (Figure 16B) 
and 3-OPE-28 (Figure 16C) phototreatments. HaCaT cells showed a significantly higher 
proportion of apoptotic and necrotic figures in comparison with tumor cell lines. By contrast, in 
the case of HeLa and HEp-2, cell counting revealed a significant increase (P<0.01) of rounded 
cells as compared to HaCaT and to its control counterparts. All of these results suggest that 
photodynamic treatment could be triggering a mitotic blockage in tumor cell lines, while in 
HaCaT mainly induce apoptotic processes. 
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Figure 16  
 
Cytoskeleton of microtubules as a target for 3-OPE-18  or 3-OPE-28-PDT: To get insight 
into the mechanisms by which PDT using 3-OPE-18 or 3-OPE-28 as PSs reach their effects on 
HaCaT, HeLa and HEp-2 cells, we also evaluated the changes induced by PDT in the 
cytoskeleton of microtubules (MTs) (Figure 16). MTs are cytoskeletal polymers essential for cell 
structure, cell division and intracellular transport and their role in tumor progression makes them 
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a key target for anti-cancer therapies, including PDT.29 As shown Figure 17A, the interphasic 
HaCaT, HeLa and HEp-2 cells showed a well-developed MT network and no alterations were 
observed in the mitotic spindle of dividing cells. However, cells showed a clear increase in 
microtubular changes 24 h after phototreatments with LD50 doses.  
Most HaCaT cells retracted their cytoplasm and thus showed an altered and disorganized MT 
network. Moreover, apoptotic morphologies were also observed. With respect to HeLa and HEp-
2 cells, in addition to the described alterations, there was also an increase in the number of 
dividing cells and many of them showed modifications of the spindle apparatus, such as the 
presence of extrapoles (three and four-poles spindles) and the consequent abnormalities in the 
distribution of chromosomes in the metaphase plate. 
In order to determine also the percentage of cells in possible mitotic blockage, mitotic index was 
quantified 24 h after 3-OPE-18 and 3-OPE-28 phototreatments (Figure 17B). As shown in 
Figure 17A, after 3-OPE-18 and 3-OPE-28-PDT in LD50 conditions, mitotic index of HeLa and 
HEp-2 was significantly higher as compared to untreated (control) cells. By contrast, mitotic 
index of HaCaT cells did not change after PDT. The percentage of mitotic cells with abnormal 
metaphase plates was also calculated (Figure 17B). In the same way, PDT of HeLa and HEp-2 
cells subjected to LD50 of 3-OPE-18 or 3-OPE-28 presented a significantly higher percentage 
of altered metaphases in comparison with untreated cells, while phototreatments did not induce 
aberrant metaphases in HaCaT cells. These findings suggest that MTs could be a target of 
phototreatments with compounds 3-OPE-18 and 3-OPE-28 plus UVA light, which cause the 
disorganization and collapse of MTs network and, in the case of tumoral cell lines, also the 
incorrect functioning of mitotic apparatus and thus the appearance of aberrant metaphases. 
                                                          
29 (a)Wakamiya, T.; Matsubara, Y.; Yoshida, Z.-i., J. Am. Chem. Soc. 2005, 127, 9332-9333 (b) Liu, K.; 
Liu, P.C.; Liu, R.;Wu, X. Med., Sci. Monit. Basic. Res. 2015, 21, 15-20. 
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Figure 17  
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In conclusion, compounds 3-OPE-18 and 3-OPE-28 are susceptible to be excited by UVA light 
and produced a high photodynamic effect causing tumour cell death even with low singlet 
oxygen production. This photodynamic effect seems to induce damage in the MTs network of 
tumour cells, triggering a blockage in the metaphase of cell cycle, which can lead to cell death. 
The glucose-ended OPEs tested have been able to produce singlet oxygen with moderated 
efficiencies. The study presented here provides the first use of OPEs as photosensitizers and 
could be a starting point to extend the application of these luminescent oligomers in 
photodynamic therapy. 
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Synthetic modifications of OPEs 
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Chapter 3 
 
In order to modulate and enhance the biological and photo-physical properties of our OPE 
glicosides (Cap. 2) and to study their supramolecular behavior, we thought to act some structural 
modification to their structure, following four different strategies: 
1. Changing sugar to modulate biological properties; 
2. Modifying the linear structure to study the aggregation; 
3. Inserting a bodipy core to modulate photo-physical properties; 
4. Building a C-2 symmetric structure containing an enantiomerical pure functions. 
The preliminar synthetic results of these modifications are reported in this chapter.  
 
3.1 Synthesis of galacto-OPEs 
The biological results obtained with our gluco-OPEs on different cell lines were illustrated in 
Chapter 2; taking into account that a different carbohydrate linked to our fluorescent probes could 
be determining in cell selectivity, we thought to insert a different sugar at the end of our OPE chain, 
with the final aim to observe how it could influence the biological behavior. 
The chosen monosaccharide was β-galactose: in fact it is known that the galacto-derivatives easily 
link to lectines, proteins presents on the cellular membrane, helping the cell internalization1.  
 
Having in mind that, as shown in Chapter 2, from a biological point of view the more interesting 
synthesized molecule was 182, we planned to synthesize the galacto-analogous using the same 
convergent strategy. 
                                                          
1(a) Collins,B. E.; Paulson; J.C.; Curr. Opin. Chem. Biol., 2004, 8, 617-625. (b) Lundquist, J. J.; Toone, E.J.; 
Chem. Rev., 2002, 102, 555-578. 
2 Barattucci, A.; Deni, E.; Bonaccorsi, P.; Ceraolo, M. G.;  Papalia, T.; Santoro,A.; Sciortino, M. T.;  
Puntoriero, F., J. Org. Chem. 2014, 79, 5113−5120. 
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The first step was the synthesis of 33,the properly galactose building block. It was obtained by 
reaction from commercial 1,2,3,4,6-penta-O-acetil-β-D-galactopyranose in dry CH2Cl2and 
propargylalchol, in presence of trimethylsilyltriflate (TMSOTf) 3(Scheme 1). 
O
OAc
AcO
OAc
O
OAc
O
OAc
AcO
OAc
OAc
OAc
HO
TMSOTf
dry CH2Cl2
0°C, 1h 33  
Scheme 1 
 
The addition of TMSOTf must be carried out slowly and at controlled temperature (0°C) to avoid 
the formation of side products. Compound 33 was obtained by chromatographic purification as a 
white crystal in very good yields (78%). 
Once obtained 33, it was possible build the appropriate galacto-monoderived, corresponding to 
gluco-one 4 (Chapter 2, scheme 4), that could be used in the cross coupling reaction with the 
dimethylamino core 16 (chapter 2, scheme 10). Compounds 33 and 2(chapter 2, scheme 2) were 
reacted (scheme 2) in the same molecular ratio (2 :33= 2.1:1) and reaction conditions seen for the 
preparation of 4. After 3 hours the reaction was complete and compound 34 was obtained by 
chromatographic separation as a white solid.  
 
Scheme 2 
                                                          
3Giovenzana, G. B.; Lay, L.; Monti, D.; Palmisano, G.; Panza, L. Tetrahedron1999, 55, 14123-14136. 
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As for 17, the synthesis of compound 35 was reached in five hours thanks to the Ag2O-modified 
Sonogashira reaction (scheme 3).4 
 
 
 
Scheme 3 
Deacetylation5 of 35 occurred using an excess of aqueous ammonia in THF/MeOH at room 
temperature and led to quantitative formation of 36. The acetamide formed was removed by 
evaporation in vacuo and by washings with MeOH; 36 was obtained as a brilliant yellow solid. 
Studies are underway to determine how the presence of galacto- substituent could modulate the 
biological activity in photodinamic treatments against tumor cells. 
                                                          
4 Mori, A.; Kondo, T.; Kato, T.; Nishihara Y. Chem. Lett. 2001, 286-287. 
5Hasegawa, T.; Numata, M.; Okumura, S.; Kimura, T.; Sakurai, K.; Shinkai, S. Org. Biomol. Chem.2007, 5, 
2404-2412. 
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3.2 Synthesis of trifunctionalized OPEs 
It is widely known that oligophenyleneethynylenes have the ability to self-assemble into different 
supramolecular structures6 in different solvent mixtures. Furthermore it’s known in literature that 
the introduction of enantiopure moieties (often derived from biomolecules, e.g., monosaccharides, 
aminoacids or nucleosides) as substituents on the conjugated skeleton of OPEs or PPEs 
(poliphenyleneethynylenes, cap.1) significantly affects their solid state organization and opens 
intriguingpossibilities in enantioselective sensing applications7. These results opened the possibility 
to use OPEs in nanomaterial field. 
With these prerequisites, we thought that our OPEs, containing both hydrophobic (linear OPE 
chain) and hydrophilic (sugar terminations) moieties could be very appealing in aggregation studies. 
Having in our hands linear and di-sugar ended wires, we thought to insert a third hydrophilic arm on 
our systems, with the double intention to help the water solubility and reinforce the intermolecular 
interactions (e.g. hydrogen bonding between the sugar moieties and pi-staking between the aromatic 
counterparts) for possible applications in studies of supramolecolar aggregation.  
 
The synthetic strategy was very intuitive and easy to realize: as a central trifunctionalized core 
commercial 1,3,5-triethynyl benzene was used: cross-coupling with mono derivative 4 in dry DMF 
(scheme 4), gave 37 after 4 hours  and in good yields (60%).Chromatographic separation is 
indispensable to purify 37from other undesidered products, coming from dimerization of mono- and 
disubstituted compounds, anyway formed in little percentages. 
                                                          
6a) F. Garcia, L. Sanchez, J. Am. Chem. Soc.2012, 134, 734 –742 (b) F. Garcia, F. Aparicio, G. Fernandez, L. 
Sanchez, Org. Lett.2009, 11, 2748 –2751 (c) K. Yoosaf, A. Belbakra, N. Armaroli, A. Llanes, Pallas, D. 
Bonifazi, Chem. Commun.2009, 2830 –2832 
7(a) Kushon, S. A.; Ley, K. D.; Bradford, K.; Jones, R. M.; McBranch, D.; Whitten, D. Langmuir2002, 18, 
7245−7249 (b) Torsi, L.; Farinola, G. M.; Marinelli, F.; Tanese, M. C.; Hassan Omar, O.; Valli, L.; Babudri, 
F.; Palmisano, F.; Zambonin, P. G.; Naso,F. Nat. Mater.2008, 7, 412−417. 
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Scheme 4 
 
Treatment of compound 37 with NH3aq.in a mixture of MeOH/THF at rt, after 16 hours afforded 38 
quantitatively (Scheme 5), interesting for the presence of three sugar substituents. 
Aggregation studies in organic solvents and in water will be performed on compound 37 and on its 
respective deacetyled 38, as for the linear analogous. 
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Scheme 5 
 
3.3 Synthesis of BODIPY-OPEs 
 
Thanks to their photophysical behavior, including the production of oxygen singlet by irradiation 
with UV-Vis light, our synthesized OPEs demonstrated to act with very good results in 
photodynamic treatments in HEp-2 and Hela tumor cells (chapter 2). It is also known that,in 
biological field, both for bio-imaging (emission interceptable with fluorescence detectors) and for 
photo-dynamic treatment against not epidermal cancers, more penetrating radiations, like the 
infrared ones,have to be used.8 
Herein, our modification is aimed to the synthesis of a new OPE which can absorb and emit 
radiations with higher wavelength, near  to biological ‘red-window’: for this reason, we thought to 
                                                          
8 (a) Thivierge, C.; Han, J.; Jenkins, R. M.; Burgess, K.; J. Org. Chem., 2011, 76, 5219; (b) Xiao, Y.; Zhang, 
D.; Qian, X.; Costela, A.; Garcia-Moreno, I.; Martin, V.; Perez-Ojeda, M. E.; Banuelos, J.; Gartzia, L.; 
Arbeloa, I. L.; Chem. Commun., 2011, 47, 11513. 
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introduce in the OPE’s skeleton a bodipy (BoronDiPyrromethene) core which, thanks to 
extraordinary photo physical properties,9 could considerably shift the wavelength of adsorption and 
emission of our molecules. The choice of bodipy wasn’t casual; in fact, the group in which I 
developed my thesis, is being involved for several years also in the synthesis of glycoconjugated 
bodipy10 and in their application in bio-imaging11 
The first step was the synthesis of a proper bodipy core, containing two reactive arms available to 
react with the monoderived 4. Scheme 6shows the complete synthetic route that leads to the 
formation of bodipy 42.  
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Scheme 6 
 
The first reaction is the one-pot formation of bodipy 39:12 Condensation of acetyl chloride and 2,4-
dimethyl-pirrole at 50°C followed by the addition of triethylamine and BF3OEt2, afforded 
cyclization to bodipy 39, obtained as a red wine colored solid and with a48% yield. NIS iodation of 
                                                          
9Ulrich, G.; Ziessel, R.; Harriman, A.; Ang. Chem. Int. Ed. 2008, 47, 1184-1201   
10 Papalia, T.; Barattucci, A.; Aversa, M. C.; Campagna, S.; Puntoriero, F.; Bonaccorsi, P.; Chem. Commun. 
2012, 48, 10550–10552 
11 Papalia, T.; Siracusano, G.; Colao, I.; Barattucci, A.; Aversa, M. C.; Serroni, S.; Zappala, G.; Campagna, 
S.; Sciortino M. T.; Puntoriero, F.; Bonaccorsi, P.; Dyes Pigments 2014, 110, 67. 
12Florian, A.; Mayoral, M. J.; Stepanenko, V.; Fernandez, G. Chem. Eur. J. 2012, 18, 14957-14961 
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39 at the free 2 and 6 positions13 gave quantitatively 40 as a red solid. Compound 40 was 
functionalized by cross coupling reaction in presence of a large excess of commercial 
ethynyltrimethylsilane: this implicates the double insertion of two ethynyl groups at the 
borondipirromethenic core. This already known reaction14 was performed using classical 
Sonogashira conditions: Pd(II)/CuI in dry THF and Et3N, with the obtainment of 41 in71% yield. 
Finally, by treatment of 41 at -78° and under Argon with TBAF (tetrabutylammonium fluoride), the 
typical reactive for the cleavage of a C-Si bond, –TMS groups were removed to give 42 in very 
good yields (73%).  
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Scheme 7 
 
Copper-free Sonogashira coupling was used for the assembly of 42 and 4, in dry DMF and Et3N 
and Pd(PPh3)4 as catalyst: the formation of bodipy-OPE 43 happened in 12 hours reaction, a longer 
reaction time compared to the other Sonogashira couplings (2.1, 3.1, 3.2): this is probably due to the 
lower reactivity of the core on respect to the electron-rich aromatics used until now. 
                                                          
13Bonnier, C.; Machin, D. D.; Abdi, O.; Koivisto, B. D. Org Biomol Chem. 2013, 11, 3756-3760 
14Lin, H.-Y.; Huang, W.-C.; Chen, Y.-C.; Chou, H.-H.; Hsu, C.-Y.; Lin, J. T.; Lin, H.-W. Chem. Commun. 
2012, 48, 8913–8915 
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For an acceptable success of this reaction, it was important to work in strictly anhydrous conditions, 
particularly keeping attention to the dryness of solvents. The formation of 43 was confirmed only 
by 1H-NMRspectrum (Figure 1) of the little quantitative of isolated compound, butit was not 
completely characterized  because of the very low yields of reaction. For this reason, studies 
arebeing performed to optimize the final synthetic step. 
 
 
 
Figure 1 
 
3.4 Synthesis of Sulfoxides-OPEs 
 
The group in which I developed my PhD thesis has got a great experience on sulfoxides in 
asymmetric synthesis:for this reason it was envisaged the possibility of using phenylene-ethylene 
units in the construction of C2-symmetric molecular compounds containing enantiomerically pure 
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sulfinylfunctions. In particular, the isoborneolsulfinyl moiety appeared a significant chiral controller 
and an interesting residue.15 
For this purpose, it was decided to combine the classical synthetic procedure of OPE preparation, 
which involves the Sonogashira cross-coupling, with the well-known sulfenic acid/alkyne syn-
addition to obtain sulfinyl derivatives in a stereo controlled manner.16  
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Scheme8 
 
Treatment of thiol 44 with Triton B (benzyl(trimethyl)ammonium hydroxide) gave are active 
thiolate that immediately reacted, at -78° and in anhydrous THF, with methyl acrylate to afford 
quantitavely sulfide 45, which was stereoselectively oxidized by m-CPBA (m-chloroperoxybenzoic 
acid) to a mixture of sulfoxide epimers 46, new precursors of transient sulfenic acid47 (Scheme 8). 
                                                          
15 (a) Aversa, M. C.; Barattucci, A.; Bonaccorsi, P.; Faggi, C.; Gacs-Baitz, E.; Marrocchi, A.; Minuti, L.; 
Taticchi, A.; Tetrahedron 2005, 61, 7719; (b) Aversa, M. C.; Barattucci, A.; Bonaccorsi, P.; Caruso, F.; 
Giannetto, P.; Arkivoc 2004, 79; (c) Adams, H.; Jones, D. N.; Aversa, M. C.; Bonaccorsi, P.; Giannetto, P.; 
TetrahedronLett. 1993, 34, 6481 
16 Barattucci, A.; Aversa, M. C.; Deni, E.; Papalia, T.; Bonaccorsi, P.; Helvetica Chimica Acta 2014, 97 1237 
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To test the best thermolysis conditions, 46 was heated in different solvents (toluene, 1,4-
dioxane,1,2-dichloroethane (DCE), THF) at their respective reflux temperature, in thepresence of an 
excess (1 :6) of two different dialkynes, 1,3- or 1,4-diethynylbenzene. 
While only decomposition products were obtained in toluene and dioxane, 47 was efficiently 
generated in situ in dichloroethane (DCE) at reflux and trapped by 1,3-or 1,4-diethynylbenzene to 
give 48 and 49 in excellent yields (>70%).  
The high diastereo selectivity of both additions (Scheme 8) is ascribable to the preferred 
conformation adopted by 47, due to a strong intramolecular H-bond between the sulfenic and the -
OH functions. 
The two couples of epimers 48R/48S and 49R/49S were easily separated by column 
chromatography and the four compounds were obtained in enantiomerically pure form.  
 
 
Scheme9 
 
The results of cross-coupling reactions of48R or 49R with 1,4-diiodo-2,5-dimethoxybenzene 2in 
DMF solution, and in the presence of a large excess of Et3N and a catalytic amount of Pd(PPh3)4 are 
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outlined in Scheme 9. Despite the large excess of base, no racemization at the S-atom occured, and 
enantiomerically pure C2-symmetric bis-sulfoxides 50 and 51were obtained as sole products in high 
yields. 
An inspection of the 1H-NMR spectra of 48R, 48S, and 50, as for 49R, 49S, and 51, was useful to 
confirm the configurations at the S-atom. Altogether the simplicity of the 1H-NMR spectra of 50 
and 51 confirms their C2 symmetry (figure 2). 
 
 
 
 
 
Figure 2 
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Synthesis of Azobenzene containing 
Oligo(Phenylene)Ethynylenes 
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Chapter 4 
 
Azobenzenes are compounds with the capacity to adsorb energy and use it for a molecular 
movement: the cis-trans isomerization. This process is a reversible transformation between two 
geometrical isomers with different absorption spectra. This transformation occurs as a 
consequence of an external input, like light or heat. The trans (E) isomer is more stable (~14 Kcal 
mol-1 (0.6 eV)) than the cis (Z) one. The energy barrier necessary to transform the trans to cis isomer is 
around is ~23 Kcal mol-1 (1.0 eV). In fact, in the dark and at room temperature, the predominant isomer 
is the trans one. 
When a solution containing the azobenzene is irradiated at a fixed wavelength, the process of 
photoisomerization trans→cis starts (figure 1). This process leads to a notable change in the 
dipolar moment and in the photophysical properties of the azobenzene. The photoisomerization 
can be followed by Uv/Vis because the absorption spectra of trans and cis are different.1 Other 
techniques, mainly NMR, could also be applied to follow the photoisomerization process .  
 
 
 
Figure 1 
                                                          
1 a) Rau, H.; Photochromism, Molecules and Systems; 1990, 165. b) Suginome, H.; CRC Handbook of 
Organic Photochemistry and Photobiology; 1995, 824.   
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The UV/Vis spectroscopy is the technique more frequently used to study the photoisomerization. In 
general, in the adsorption spectrum, both isomers present two characteristic bands corresponding to the 
electronic transitions π→π* and n→π*. The π→π* transition is in the near UV (300-400nm), the n→π* is 
in the visible field and it’s responsible of the typical color of the azo-systems. 
The absorption spectra of the isomers E (trans) and Z (cis) have these typical features2: 
 
 The trans (E) isomer: the band π→π* is more intense, with a molar extinction  coefficient  (ε) ~ 
2-3 x 104 M-1 cm-1. The second band (n→π*) is less intense (ε ~ 400 M-1 cm-1) because it 
corresponds to a forbidden transition (Figura 2, blue line).  
 The cis (Z) isomer: the band π→π* is slightly shifted toward lower wavelengths (hypsochromic 
effect) and the intensity is lower (ε ~ 7-10 x 103 M-1 cm-1). On the other hand, the transition 
n→π* (380-520 nm) absorption shows a higher  intensity (ε ~ 1500 M-1 cm-1) compared to trans 
isomer (Figura 2, pink line). 
 
 
Figure 2 
 
For the synthesis of azobenzenes, the most frequently used method is the azoic coupling, that 
involves diazonium salts.3 Other procedures, like the Mills reactions, the reductive coupling of 
                                                          
2 N. Tamai, H. Miyasaka, Chem. Rev. 2000, 100, 1875-1890.   
3I. Szelle, H. Zollinger, Top. Curr. Chem. 1983, 112, 1-66.    
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nitro compounds and the oxidation of anilines also allow the synthesis  of aromatic azo- 
compounds.4(Figure 3). 
 
 
Figure 3 
 
4.1 Synthesis of OPEs with an azobenzene core 
 
The group of prof. M. C. Carreno, in which I spent a great  part of my PhD, is specialized in the 
synthesis of enantiopure sulfinyl azobenzenes and in the studies of their photophysical 
properties.5 
 
                                                          
4 a) S. Wada, M. Urano, H. Suzuki, J. Org. Chem. 2002, 67, 8254-8257. b) E. Leyva, M. S. Plats, G. 
Persy, J. Wirz, J. Am. Chem. Soc., 1986, 108, 3783-3790.   
5 (a) M. C. Carreño, G. Fernández Mudarra, E. Merino, M. Ribagorda, J. Org. Chem. 2004,69, 3413-3416 
(b) M. C. Carreño, I. García, M. Ribagorda, E. Merino, S. Pieraccini, G. P. Spada, Org. Lett. 2005, 7, 
2869-2872.   
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With the aim to cross the lines of research of the groups working at the Università di Messina 
and at the  Universidad Autónoma de Madrid, the synthesis of an  OPE system with an 
azobenzene core was envisaged, in order to study the photo-physical properties of the resulting 
products, as well as to study the photo-isomerization cis-trans of these new products.With this 
idea in mind, we tried to insert an azobenzene core in a OPE system. The synthesis was planed 
on the retrosynthesis shown in Figure 4. 
O
AcO
AcO
OAc
O
OAc
N
N X
X
N
NO
O
OAcAcO
AcO
AcO
O
O
AcO OAc
OAc
OAc
52
1
53
R
R
R
R
X=Br, I  
 
Figure 4 
 
Thus, starting from an azobenzene having two aromatic halogenated moieties, the introduction of 
two phenylenenethynylene acetylenic moieties through a Sonogashira coupling could lead, 
directly to the target structure 53. coupling.  
 
As seen before (figure 3), the most frequently used method for the synthesis of the azo-
compound is the azoic coupling between an aryldiazonium salt and an activated aromatic 
compounds. This reaction is based on an initial reaction of a primary aromatic amine with 
sodium nitrite under acidic conditions at low temperature giving an intermediate diazonium salt, 
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which is  then reacted with an aromatic nucleophilic compound. Generally, the coupling is very 
fast and leads to the formation of azobenzene with overall good yields. 
 
Figure 4 
 
The first attempt to obtain an aza-core was performed using the azoic coupling on the previously 
synthesized compound 15 (Chapter 2), already containing two aromatic arms able to react in the 
Sonogashira reaction.  
The in situ formation of  diazobenzene was attempted in controlled conditions, followed by the 
slow addition of  a solution of compound 15 and KOH (Scheme 1).  
 
 
Scheme 1 
 
The formation of the desired azobenzene wasn’t observed by TLC, and this negative result was 
confirmed by 1H-NMR analysis: in fact, only the signals of starting product 15 were present in 
the final spectrum.  
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A second attempt was performed utilizing the same method shown in scheme 1 but changing the 
starting products: also in this case, the reaction between commercial 2,5-dibromoaniline and 
dimethylaniline was totally uncessfull. 
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Scheme 2 
 
An alternative synthetic method was found after a careful research in the literature: a copper-
catalyzed approach (Figure 5) to the synthesis of symmetric and asymmetric aromatic azo-
compounds.6  
 
Figure 5 
 
This method was applied to the synthesis of a new core: azobenzene 52, containing two –I 
groups at the aromatic rings, fundamental to further react in Sonogashira conditions and to form 
the two new C=C bonds.  
NH2I
I
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60º, 20h
N
N I
52  
Scheme 3  
                                                          
6 Zhang, C.; Jiao, N.; Angew. Chem. Int. Ed. 2010, 49, 6174 –6177 
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Compound 52 was synthesized starting from commercial p-iodoaniline, in presence of CuBr and 
pyridine mixed in toluene under O2 (1 atm). The reaction mixture was stirred vigorously at 60°C 
for 20 h to afford compound 52 in quantitative yield.(Scheme 3) 
O
AcO
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OAc
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OAc
Pd(PPh3)4,
DMF/TEA,
60º, 2h
N
N I
I
N
NO
O
OAcAcO
AcO
AcO
O
O
AcO OAc
OAc
OAc
52
1
53  
Scheme 4  
 
To test the reactivity of  52 in our copper-free Sonogashira conditions it was reacted at 60°C with 
peracetylated propargyl glucoside 1 (in 1:2 molecular ratio) in dry DMF and Et3N, in the 
presence of Pd(PPh3)4. After 2 hours the reaction was complete and led to the formation of 50 as 
a red powder after chromatographic separation. The reaction occurred in good yield. Compound 
53 was identified by NMR as the most stable trans (E) stereoisomer.. 
Having shown that azocompound 52 could react in cross-coupling conditions, we attempted the 
synthesis of 54. Recation of an equimolecular amount of azobenzene 52 and glucoside derivate 5 
(Chapter 2), in a mixture 2:1 DMF/THF, in presence of Ag2O and a catalytic amount of 
Pd(PPh3)4 (Scheme 5) was carried carried out to give the azo-OPE 54, that  could be obtained as 
a brilliant orange powder by chromatography with a 67% isolated yield. 
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Scheme 5 
 
4.2 Photoisomerization Studies 
 
The absorption spectra of 53 and 54 in MeOH are reported in Figure 6. In the case of 53 the  
absorption profile is dominated by an intense band appearing at max = 360 nm, which 
corresponds to  the azobenzene * absorption. A less intense band is observed at max = 450 
nm, which is assigned  to a n* transition. In compound 54, the former contribution can be 
recognized superimposed on the much stronger OPE band at 416 nm, while the latter is 
completely covered by a tail on the visible region.  
 
 
 
Figure 6. Normalized absorption spectra of Azobenzene, 53, 54 in MeOH. 
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Preliminary experiments have been performed to investigate the photoisomerization ability of 
these new species. 
Irradiation at 360 nm of a methanol solution of 53 and 54 at 298 K leads to strong spectral 
changes, as expected for the trans - cis photoisomerization of the azobenzene moieties, shown in 
Figures 7 and 8. 
 
  
Figure 7. TransCis photo-isomerization of 53 in methanol at room temperature exc=360 nm 
 
 
 
Figure 8. TransCis photo-isomerization of 54 in methanol at room temperature exc=410 nm. 
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In both cases, on continued irradiation, a photostationary state is reached. The initial trans-
species can be completely recovered by keeping the solution in the dark. The thermal cis - trans 
reaction at 298 K is quite slow (t1/2 = 32 h), so that the cis-species could be deeply studied. 
The trans - cis photoisomerization quantum yields (upon irradiation at the absorbtion maxima) 
are very similar for the two investigated species in MeOH (= 0.08 @360 nm for 53 and = 0.09 
@360 nm for 54)  but smaller to those of the model azobenzene compound (= 0.13 in MeOH 
exc=365 nm). The wavelength dependence of this behaviour is still under investigation in more 
details but the lowering of isomerization quantum yields is typical of sterically hindered 
azobenzenes.  
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Chapter 5 
 
The synthetic design and optimization of the carbohydrate-functionalized 
oligo(phenyleneethynylene)s developed during this PhD thesis, allowed to withdraw the following 
conclusions:  
 
1. A strategy based on the exploitation of Pd(0) catalyzed cross-coupling reactions between 
alkynes and halogen substituted aryl derivatives has allowed the synthesis of a new family 
of OPEs in a convergent manner.  
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A peracetylated carbohydrate moiety (glucose or galactose) is incorporated as a propargyl 
glycoside which is used in one of these couplings. The great applicability of the 
methodology was demonstrated through the synthesis of phenyleneethynylene glycosides of 
different  lengths  and having different substituents at the central core such as p-dimethoxy 
phenyl, benzene, N,N-dimethyl anilines and their ammonium salts, BODIPY and 
azobenzenes. 
In Figure 1 some of the compounds synthesized with different substituents: OMe, NMe2, 
+NMe3 (11, 18 and 31) on aromatic central ring and the hybrid OPEs with BODIPY and 
azobenzene central unities (43 and 51) are shown. 
 
2. The photophysical properties as wavelength of absorption and emission and quantum 
yieldswere studied. The synthesized OPEs adsorb and emit at blue-green wavelengths (350-
480nm).Quantum yield (, for the OPEs with three phenylenethynylene units, are higher 
than 0.57.Generation of singlet oxygen was demonstrated to be efficient for compounds 18 
and 28.  
 
Their biocompatibility in vitro was demonstrated by  their high luminescence at low 
concentrations (1µm) and internalization in the 
cells.  
Figure 2 
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The amino derived compounds 18 and 28 were shown to be active as photosensitizers in 
Photo Dinamic Therapy when irradiated with UVA light , due to the generation of singlet 
oxygen which provokes cell death.  
 
3. An initial study of photochromic properties of OPE azobenzene 
derivatives 50 and 51 has been carried out to evaluate their photoisomerization ability. 
Using  UV/vis spectroscopy, the photoisomerization was shown to occur. Other techniques 
(mainly NMR and CD) should be applied to investigate if these carbohydrate substituted 
Azobenzene OPEs fill the criteria to be used as enantiopure, water soluble molecular 
switches.  
 
5.1 Publications: 
Part of the work developed in this Ph. D. work has been published: 
 
Barattucci, A.; Deni, E.; Bonaccorsi, P.; Ceraolo, M. G.; Papalia, T.; Santoro, A.; Sciortino, M. 
T.; Puntoriero, F., J. Org. Chem. 2014, 79, 5113. 
 
Barattucci, A. Aversa, M. C.; Deni, E.;Papalia, T.; Bonaccorsi, P.; Helvetica Chimica Acta 
2014, 97, 1237. 
 
Deni, E.; Zamarrón, A.; Bonaccorsi, P.; Carreño, M.C.; Juarranz, A.; Puntoriero, F.; Sciortino, 
M.T.; Ribagorda, M.; Barattucci,A., Eur. J. Med. Chem., 2016, (submitted). 
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Chapter 6 
 
6.1 General Synthetic Methods.  
Solvents were purified according to standard procedures. All of the reactions were monitored by 
TLC on commercially available precoated plates (silica gel 60 F254), and the products were 
visualized with vanillin [1 g dissolved in MeOH (60 mL) and conc. H2SO4 (0.6 mL)] and UV 
lamp. Silica gel 60 was used for column chromatography. Proton (1H) and carbon (13C)  NMR 
spectra were recorded on a Varian 500 spectrometer (at 500 MHz for 1H; and 125 MHz for 13C) 
or a AV-300 Bruker (at 300 MHz for 1H; and 75 MHz for 13C) using CDCl3 as solvent, unless 
differently stated. Chemical shifts are given in parts per million (ppm) (δ relative to residual 
solvent peak for 1H and 13C: δ 7.26 and 77.0 ppm respectively), coupling constants (J) are given 
in hertz; the attributions are supported by heteronuclear single-quantum coherence (HSQC), 
Heteronuclear Multiple Bond Correlation (HMBC) and correlation spectroscopy (COSY) 
experiments, and given in accordance with the numeration indicated in the designed structures. 
Mass spectra (m/z) and HRMS were recorded under the conditions of electron impact (EI) and 
electrospray (ES) in a Waters VG Autospect spectrometer. Melting points were obtained in open 
capillary tubes and are uncorrected.  
qNMR analysis protocol: 530 μL aliquots of a dmso-d6 solution of a known concentration  of  
18 or 28 were transferred into a 5 mm WILMAD NMR tube into which a stem coaxial tube 
(WILMAD, WGS-5BL, 50 mm L × 2 mm stem o.d.), loaded with 60 μL of a 29.11 mM dmso-d6 
solution of maleic acid TraceCERT® (Sigma-Aldrich) was subsequently inserted. Accurate 
integration of the CH resonance of maleic acid (δ = 6.28 ppm) vs significant aliphatic peaks of 1 
(5.14, 4.67 and 4.33 ppm) and 2 (5.14, 4.64 and 4.31ppm) provided the effective compound 
concentration, then compared with the calculated one.  90° pulse excitation, 15 s recycle delay, 
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and 64 transients. 
 
A general procedure for deacetilation of compounds 3, 7, 8, 12, 17, 27, 29, 30, 35, 37 is given: 
General Procedure A. The starting product (0.2mmol)  was dissolved in of THF-MeOH (1:1, 
40mL).  To this mixture a large excess of aqueous ammonia (12mL) was added and the reaction 
was then maintained under continuous stirring at RT overnight, until the disappearance of the 
starting product by TLC. Solvents were removed under reduced pressure and the undesired 
acetamide was eliminated by a series of MeOH washings of the obtained solid. 
2-Propyn-1-yl-β-D-glucopyranoside 2,3,4,6-tetraacetate 11  
To a solution of 1,2,3,4,6-penta-O-acetil-β-D-glucopyranose (5.0g, 12.55 mmol) in 36 mL of dry 
CH2Cl2, at 0°C and under Argon, 1.48 mL of propargyl alchol (25.10 mmol, d = 0.958 g/mL), 
4.59 mL di trimethylsilyltriflate (25.10 mmol, d=1.228 g/mL) and molecular sieves 4Ǻ were 
added. The mixture was heated to RT and maintained under continuous stirring until the 
disappearance of 1 by TLC (1 hour). The reaction was quenched by adding NaHCO3 (40 mL) 
and the organic phase washed with water (2 x 30 mL). The organic phases were dried over 
anhydrous Na2SO4, the solvent evaporated under reduced pressure. Column chromatography was 
performed with hexane/EtOAc 70:30 as eluant, and compound 1 was obtained as a white solid 
(3.4 g, 70%). TLC: Rf = 0.50 (hexane/EtOAc 70:30). 
 
1,4-Diiodo-2,5-dimethoxybenzene 2.2 
                                                 
1 Giovenzana, G. B.; Lay, L.; Monti, D.; Palmisano, G.; Panza, L. Tetrahedron 1999, 55, 14123-14136. 
 
2 Yi, C.; Blum, C.; Lehamann, M.; Keller, S.; Liu, S. X.; Frei, G.; Neels, A.; Hauser, J.; Schürch, S.; 
Decurtins, S. J. Org. Chem. 2010, 75, 3350-3357.  
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To a solution of H5IO6 (0.73 g, 3.44 mmol) in 5 mL of CH3OH, I2 (1.60 g, 15.10 mmol) was 
added; after ten minutes under vigorous stirring at RT commercial 1,4-dimethoxybenzene (0.675 
g, 2.78 mmol) was added. The mixture was to reflux and maintained under continuous stirring 
for 4h. The reaction was quenched by adding a solution of Na2S2O5 10%wt (5 mL) and extracted 
with dichloromethane (3 x 10 mL). The organic phases were washed with brine and then dried 
over anhydrous Na2SO4. The solvent evaporated under reduced pressure to give 2 as a pale 
yellow solid (1.80 g, 4.63mmol, 95%). 
OMe
OMe
I
I
2  
Compound 3. 2-propyn-1-yl-β-D-glucopyranoside 2,3,4,6-tetraacetate 1 (1.00 g, 2.59 mmol), 
1,4-diiodo-2,5-dimethoxybenzene 2 (0.48 g, 1.23 mmol), Pd(PPh3)4 (0.17 g, 0.15 mmol) were 
dissolved in dry DMF (10 mL). To this mixture Et3N (10 mL) was slowly added. The mixture, 
under Ar atmosphere, was heated at 65 °C and maintained under continuous stirring for 2 h until 
the disappearance of 2 by TLC.  Column chromatography was performed with hexane/EtOAc 
65:35 as eluant, and compound 3 was obtained as a white solid (0.80 g, 0.88 mmol, 72%).  
 
TLC: Rf 0.55 (hexane/EtOAc 40:60). Mp 178-180 °C. 
1H NMR: 6.92 (s, 2H, H-3,6), 5.27 (t, 
J2',3' = J3',4' = 9.3, 2H, 2 x H-3’), 5.12 (t, J3',4' = J4',5' = 9.3, 2H, 2 x H-4’), 5.05 (dd, J1',2' = 8.3, J2',3' = 
9.3, 2H, 2 x H-2’), 4.90 (d, J1',2' = 8.3, 2H, 2 x H-1’), 4.64 (s, 4H, 2 x CH2C≡), 4.28 and 4.17 
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(split AB system, J5',6'A = 5.6, J5',6'B = 2.4, J6'A,6'B = 12.2, 4H, 2 x H2-6’), 3.85 (s, 6H, 2 x OCH3), 
3.76 (ddd, J4',5' = 9.3, J5',6'A = 5.6, J5',6'B = 2.4, 2H, 2 x H-5’), 2.07, 2.04, 2.02, and 2.00 (four s, 
24H, 8 x CH3CO). 
13C NMR: 170.7, 170.3, 169.5, and 169.4 (8 x CO), 154.0 (C-2,5), 115.7 
(C-3,6), 112.8 (C-1,4), 98.3 (2 x C-1’), 89.2 and 83.2 (2 x C≡C), 72.8 (2 x C-3’), 71.9 (2 x C-
5’), (2 x C-2’), 68.3 (2 x C-4’), 61.8 (2 x C-6’), 57.0 (2 x CH2C≡), 56.4 (2 x OCH3), 20.7 
and 20.6 (8 x CH3CO). Anal. Calcd for C42H50O22 (906.83): C, 55.63; H, 5.56. Found: C, 55.49; 
H, 5.58. 
 
Compound 4. 2-propyn-1-yl β-D-glucopyranoside 2,3,4,6-tetraacetate 1 (1.42 g, 3.67 mmol), 
1,4-diiodo-2,5-dimethoxybenzene 2 (3.00 g, 7.69 mmol) and Pd(PPh3)4 (0.50 g, 0.43 mmol) 
were dissolved in dry DMF (30 mL). To the mixture Et3N (30 mL) was slowly added. The 
mixture was heated at 60 °C and maintained under continuous stirring  and under Ar atmosphere 
for 3h, until the disappearance of 1 by TLC. Column chromatography was performed with 
hexane/EtOAc 70:30 as eluant, and compound 4 was obtained as a white solid (1.90 g, 2.93 
mmol, 80%).  
 
TLC: Rf 0.64 (hexane/EtOAc 40:60). Mp 65-67 °C.
 1H NMR:7.29 (s, 1H, H-3), 6.84 (s, 1H, H-
6), 5.25 (t, J2',3' = J3',4' = 9.3, 1H, H-3’), 5.11 (t, J3',4' = J4',5' = 9.3, 1H, H-4’), 5.03 (dd, J1',2' = 7.7, 
J2',3' = 9.3, 1H, H-2’), 4.88 (d, J1',2' = 7.7, 1H, H-1’), 4.61 (s, 2H, CH2C≡), 4.27 and 4.15 (split AB 
system, J5',6'A = 4.4, J5',6'B = 2.5, J6'A,6'B = 12.2, 2H, H2-6’), 3.84 and 3.83 (two s, 6H, 2 x OCH3), 
3.75 (ddd, J4',5' = 9.3, J5',6'A = 4.4, J5',6'B = 2.5, 1H, H-5’), 2.07, 2.03, 2.02, and 2.00 (four s, 12H, 4 
x CH3CO). 
13C NMR: 170.7, 170.3, and 169.4 (4 x CO), 154.8 (C-2), 152.3 (C-5), 122.3 (C-3), 
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115.1 (C-6), 111.9 (C-1), 98.3 (C-1’), 88.4 (C-4), 87.3 and 85.4 (C≡C), 72.8 (C-3’), 71.9 (C-5’), 
71.1 (C-2’), 68.4 (C-4’), 61.8 (C-6’), 57.2, 57.0, and 56.5 (2 x OCH3 and CH2C≡), 20.7 and 20.6 
(4 x CH3CO). Anal. Calcd for C25H29IO12 (648.40): C, 46.31; H, 4.51. Found: C, 46.44; H, 4.50. 
 
Compound 5. To a solution of compound 4 (1.00 g, 1.54 mmol) and Pd(PPh3)4 (0.18 g, 0.16 
mmol) in dry DMF (7 mL), commercial Ethynyltrimethylsilane (0.65 mL, 4.62 mmol) and dry 
Et3N (7 mL) were slowly added. The mixture, under Ar atmosphere, was heated at 65 °C and 
maintained under continuous stirring for 2h, until the disappearance of 4 by TLC.  Column 
chromatography was performed with hexane/EtOAc 80:20 as eluant, and compound 5 was 
obtained as a white solid (0.81 g, 1.31 mmol, 85%).  
 
TLC: Rf 0.78 (hexane/EtOAc 40:60). Mp 59-61 °C. 
1H NMR: 6.95 and 6.89 (two s, 2H, H-3,6), 
5.25 (t, J2',3' = J3',4' = 9.4, 1H, H-3’), 5.10 (t, J3',4' = J4',5' = 9.4, 1H, H-4’), 5.03 (dd, J1',2' = 7.7, J2',3' = 
9.4, 1H, H-2’), 4.88 (d, J1',2' = 7.7, 1H, H-1’), 4.62 (s, 2H, CH2C≡), 4.28 and 4.15 (split AB 
system, J5',6'A = 4.7, J5',6'B = 2.4, J6'A,6'B = 12.2, 2H, H2-6’), 3.85 and 3.84 (two s, 6H, 2 x OCH3), 
3.74 (ddd, J4',5' = 10.0, J5',6'A = 4.7, J5',6'B = 2.5, 1H, H-5’), 2.07, 2.04, 2.03, and 2.01 (four s, 12H, 
4 x CH3CO), 0.27 [s, 9H, Si(CH3)3]. 
13C NMR: 170.7, 170.3, 169.4, and 169.3 (4 x CO), 154.2 
and 153.9 (C-2,5), 116.1 and 115.8 (C-3,6), 113.7 and 112.4 (C-1,4), 100.7 and 100.6 (C≡CSi), 
98.2 (C-1’), 89.0 and 83.4 (CH2C≡C), 72.8 (C-3’), 71.9 (C-5’), 71.1 (C-2’), 68.3 (C-4’), 61.8 (C-
6’), 57.0 (CH2C≡), 56.5 and 56.3 (2 x OCH3), 20.7, 20.6, and 20.5 (4 x CH3CO), - 0.05 
[Si(CH3)3]. Anal. Calcd for C30H38O12Si (618.70): C, 58.24; H, 6.19. Found: C, 58.30; H, 6.20 
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Compounds 6 and 7. Compounds 4 (0.50 g, 0.77 mmol) and 5 (0.48 g, 0.78 mmol), Pd(PPh3)4 
(0.13 g, 0.11 mmol), and Ag2O (0.18 g, 0.78 mmol) were suspended in a mixture (1:2) of dry 
DMF (10 mL) and THF (5 mL). The mixture was heated at 70 °C and left under Ar atmosphere 
and continuous stirring until completation of the reaction (5 hours). After filtration over Celite, 
the solvents were removed under reduced pressure, and the obtained reaction crude was 
subjected  to silica gel column chromatography using hexane/EtOAc 50:50 as eluant, to obtain 
first compound 6 as a yellow low-melting solid (42 mg, 0.04 mmol, 5%) and then compound 7 
as a yellow solid (0.44 g, 0.41 mmol, 53%).  
Compound 6.  
 
TLC: Rf 0.40 (hexane/EtOAc 30:70). 
1H NMR: 6.98 and 6.92 (two s, 4H, 2 x H-3,6), 5.26 (t, 
J2',3' = J3',4' = 9.3, 2H, 2 x H-3’), 5.12 (t, J3',4' = J4',5' = 9.3, 2H, 2 x H-4’), 5.04 (t, J1',2' = J2',3' = 9.3, 
2H, 2 x H-2’), 4.90 (d, J1',2' = 9.3, 2H, 2 x H-1’), 4.64 (s, 4H, 2 x CH2C≡), 4.28 and 4.17 (split 
AB system, J5',6'A = 4.4, J5',6'B = 1.9, J6'A,6'B = 12.2, 4H, 2 x H2-6’), 3.86 and 3.84 (two s, 12H, 4 x 
OCH3), 3.76 (ddd, J4',5' = 9.3, J5',6'A= 4.4, J5',6'B = 1.9, 2H, 2 x H-5’), 2.08, 2.04, 2.03, and 2.01 
(four s, 24H, 8 x CH3CO). 
13C NMR: 170.9, 170.6, 169.7, and 169.6 (8 x CO), 155.6 and 154.2 
(2 x C-2,5), 116.3 and 115.9 (2 x C-3,6), 113.6 and 112.6 (2 x C-1,4), 98.5 (2 x C-1’), 90.0, 83.5, 
79.7, and 79.6 (4 x C≡C), 73.1 (2 x C-3’), 72.2 (2 x C-5’), 71.4 (2 x C-2’), 68.6 (2 x C-4’), 62.1 
(2 x C-6’), 57.3 (2 x CH2C≡), 56.7 and 56.6 (4 x OCH3), 20.9 and 20.8 (8 x CH3CO). Anal. 
Calcd for C54H58O24 (1091.02): C, 59.45; H, 5.36. Found: C, 59.38; H, 5.34. 
Compound 7.  
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TLC: Rf 0.35 (hexane/EtOAc 30:70). Mp 80-81 °C. 
1H NMR: 7.04 and 6.94 (two s, 4H, 2 x H-
3,6), 5.27 (t, J2',3' = J3',4' = 9.3, 2H, 2 x H-3’), 5.12 (t, J3',4' = J4',5' = 9.3, 2H, 2 x H-4’), 5.05 (dd, 
J1',2' = 8.3, J2',3' = 9.3, 2H, 2 x H-2’), 4.92 (d, J1',2' = 8.3, 2H, 2 x H-1'), 4.65 (s, 4H, 2 x CH2C≡), 
4.28 and 4.17 (split AB system, J5',6'A = 4.4, J5',6'B = 2.4, J6'A,6'B = 12.3, 4H, 2 x H2-6’), 3.90 and 
3.88 (two s, 12H, 4 x OCH3), 3.77 (ddd, J4',5' = 9.3, J5',6'A = 4.4, J5',6'B = 2.4, 2H, 2 x H-5’), 2.08, 
2.05, 2.03, and 2.01 (four s, 24H, 8 x CH3CO). 
13C NMR:170.7, 170.3, 169.4, and 169.3 (8 x 
CO), 154.1 and 153.9 (2 x C-2,5), 115.7 and 115.5 (2 x C-3,6), 113.8 and 112.4 (2 x C-1,4), 98.3 
(2 x C-1’), 91.2, 89.1, and 83.4 (3 x C≡C), 72.8 (2 x C-3’), 71.9 (2 x C-5’), 71.1 (2 x C-2’), 68.4 
(2 x C-4’), 61.8 (2 x C-6’), 57.0 (2 x CH2C≡), 56.5 and 56.3 (4 x OCH3), 20.7 and 20.6 (8 x 
CH3CO). Anal. Calcd for C52H58O24 (1067.00): C, 58.53; H, 5.48. Found: C, 58.65; H, 5.47.  
 
Compound 8. Compounds 2 (0.50 g, 1.28 mmol), 5 (1.58 g, 2.56 mmol), Pd(PPh3)4 (0.22 g, 0.19 
mmol) and Ag2O (0.59 g, 2.55 mmol) were suspended in a mixture (1:2) of dry DMF (10 mL) 
and dry THF (5 mL). The mixture was heated at 70 °C for 6h and maintained under Ar 
atmosphere and continuous stirring until the disappearance of the starting products 2 and 5 by 
TLC (hexane/EtOAc 3:7). After filtration over Celite, the solvents were removed under reduced 
pressure, and on the reaction crude column chromatography was performed with hexane/EtOAc 
50:50 as eluant, and compound 8 was obtained as a yellow solid (1.04 g, 0.85 mmol, 66%).  
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TLC: Rf 0.47 (hexane/EtOAc 40:60). Mp 169-171 °C. 
1H NMR: 7.06, 7.05, and 6.94 (three s, 
6H, 3 x H-3,6), 5.27 (t, J2',3' = J3',4' = 9.3, 2H, 2 x H-3’), 5.12 (t, J3',4' = J4',5' = 9.3, 2H, 2 x H-4’), 
5.05 (dd, J1',2' = 7.8, J2',3' = 9.3, 2H, 2 x H-2’), 4.91 (d, J1',2' = 7.8, 2H, 2 x H-1’), 4.65 (s, 4H, 2 x 
CH2C≡), 4.28 and 4.17 (split AB system, J5',6'A = 4.9, J5',6'B = 2.4, J6'A,6'B = 12.3, 4H, 2 x H2-6’), 
3.92, 3.90, and 3.88 (three s, 18H, 6 x OCH3), 3.77 (ddd, J4',5' = 9.3, J5',6'A = 4.9, J5',6'B = 2.4, 2H, 2 
x H-5’), 2.08, 2.05, 2.03, and 2.01 (four s, 24H, 8 x CH3CO). 13C NMR: 170.7, 170.3, 169.5, 
and 169.4 (8 x CO), 154.1, 153.9, and 153.8 (3 x C-2,5), 115.7 and 115.5 (3 x C-3,6), 113.8, 
113.4, and 112.3 (3 x C-1,4), 98.3 (2 x C-1'), 91.5, 91.2, 89.1, and 83.5 (4 x C≡C), 72.8 (2 x C-
3’), 71.9 (2 x C-5’), 71.1 (2 x C-2’), 68.3 (2 x C-4’), 61.8 (2 x C-6’), 57.1 (2 x CH2C≡),  56.6, 
56.5 and 56.3(6 x OCH3), 20.7 and 20.6 (8 x CH3CO). Anal. Calcd for C62H66O26 (1227.17): C, 
60.68; H, 5.42. Found: C, 60.80; H, 5.43. 
 
Compound 9. It was obtained following procedure A starting from 3 (0.18 g), as a white solid 
(0.13 g, 0.19 mmol, 96%).  
 
TLC: Rf 0.15 (CHCl3/MeOH 80:20). Mp 230-233 °C. 
1H NMR (dmso-d6): 7.04 (s, 2H, H-3,6), 
5.12 (d, Jvic = 4.9, 2H, 2 x OH), 4.96 (d, Jvic = 4.9, 2H, 2  x OH),  4.91 (d, Jvic = 5.4, 2H, 2  x OH) 
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, 4.65 and 4.52 (AB system, Jgem = 15.7, 4H, 2 x CH2C≡), 4.53 (t, JOH,6= 4.9, 2H, 2 x 6’-OH), 
4.32 (d, J1’,2’ = 7.9, 2H, 2 x H-1’), 3.77 (s, 6H, 2 x OCH3), 3.65 and 3.43 (split AB m, 4H, 2 x 
H2-6’), 3.16 - 2.93 (m, 8H, 2 x H-2’-5’). 13C NMR (dmso-d6):153.6 (C-2,5), 115.8 (C-3,6), 
112.2 (C-1,4), 101.1 (2 x C-1’), 91.1 and 81.9 (2 x C≡C), 77.0 and 76.7 (2 x C-3’,5’), 73.3 (2 x 
C-2’), 70.0 (2 x C-4’), 61.2 (2 x C-6’), 56.1 (2 x OCH3), 55.8 (2 x CH2C≡). Anal. Calcd for 
C26H34O14 (570.54): C, 54.73; H, 6.01. Found: C, 54.79; H, 6.00.  
 
Compound 10. It was obtained following procedure A starting from 7 (0.23g), as a white solid 
(0.14 g, 0.19 mmol, 96%).  
 
TLC: Rf 0.10 (CHCl3/MeOH 80:20). Mp 206-207 °C. 
1H NMR (dmso-d6): .10 and 7.08 (two 
s, 4H, 2 x H-3,6), 5.14 (d, Jvic = 4.9, 2H, 2 x OH), 4.97 (d, Jvic = 4.9, 2H, 2 x OH), 4.91 (d, Jvic = 
5.4, 2H, 2 x OH), 4.67 and 4.55 (AB system, Jgem = 15.6, 4H, 2 x CH2C≡), 4.54  (t, JOH,6= 4.9, 
2H, 2 x 6’-OH), 4.34 (d, J1’,2’ = 7.8, 2H, 2 x H-1’), 3.81 and 3.80 (two s, 12H, 4 x OCH3), 3.67 
and 3.46 (split AB m, 4H, 2 x H2-6’), 3.19 - 2.98 (m, 8H, 2 x H-2’-5’). 13C NMR (dmso-d6): 
153.7 and 153.2 (2 x C-2,5), 115.9 and 115.3 (2 x C-3,6), 112.8 and 112.2 (2 x C-1,4), 101.0 (2 
x C-1’), 91.3,  91.1 and 81.9 (3 x C≡C), 77.0 and 76.7 (2 x C-3’,5’), 73.3 (2 x C-2’), 70.1 (2 x C-
4’), 61.2 (2 x C-6’), 56.3 and 56.1 (4 x OCH3), 55.8 (2 x CH2C≡). Anal. Calcd for C36H42O16  
(730.71): C, 59.17; H, 5.79. Found: C, 59.14; H, 5.80.  
 
Compound 11. It was obtained following procedure A starting from 8 (0.25g), as a yellow solid 
(0.17 g, 0.19 mmol, 96%).  
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TLC: Rf 0.05 (CHCl3/MeOH 80:20). Mp 248-250 °C. 
1H NMR (dmso-d6): 7.13, 7.12, and 7.09 
(three s, 6H, 3 x H-3,6), 5.15 (d, Jvic = 5.4, 2H, 2 x OH), 4.98 (d, Jvic = 4.9, 2H, 2 x OH), 4.93 (d, 
Jvic = 5.4, 2H, 2 x OH), 4.68 and 4.55 (AB system, Jgem = 15.6, 4H, 2 x CH2C≡), 4.55  (t, JOH,6 = 
5.5, 2H, 2 x 6’-OH), 4.34 (d, J1’,2’ = 7.9, 2H, 2 x H-1’), 3.84, 3.82, and 3.80 (three s, 18H, 6 x 
OCH3), 3.69 and 3.45 (split AB m, 4H, 2 x H2-6’), 3.19 - 2.98 (m, 8H, 2 x H-2’-5’). 13C NMR 
(dmso-d6): 153.7, 152.4, and 153.3 (3 x C-2,5), 115.9,115.5, and 115.4 (3 x C-3,6), 112.8, 
112.7 and 112.3 (3 x C-1,4), 101.1 (2 x C-1’), 91.3,  91.2 and 82.0 (4 x C≡C), 77.0 and 76.7 (2 x 
C-3’,5’), 73.3 (2 x C-2’), 70.0 (2 x C-4’), 61.2 (2 x C-6’), 56.3, 56.2, and 56.1 (6 x OCH3), 55.8 
(2 x CH2C≡). Anal. Calcd for C46H50O18 (890.88): C, 62.02; H, 5.66. Found: C, 62.05; H, 5.67.  
 
Compounds 12 and 13. To a solution in dry DMF (12 mL) of 4 (1.98 g, 3.05 mmol, 2.1 equiv), 
commercial 1,4-diethynylbenzene (0.18 g, 1.43 mmol, 1 equiv) and Pd(PPh3)4 (0.20 g, 0.17 
mmol, 0.12 equiv) dry Et3N (12 mL) was slowly added. The obtained mixture was heated at 
70°C and maintained under Ar atmosphere and continuous stirring until the disappearance of 
1,4-diethynylbenzene by TLC (3 hours). Column chromatography was performed with 
hexane/EtOAc 60:40 as eluant, and a mixture of 12 and 13 was obtained. A second column 
chromatography (eluant toluene/acetonitrile 90:10) was necessary to obtain first 13 as a yellow 
solid (0.30 g, 0.23 mmol, 16%) and then 12 as a yellow solid (0.83 g, 0.71 mmol, 50%). 
Compound 12. 
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 TLC: Rf 0.59 (hexane/EtOAc 40:60). Mp 182-184 °C. 
 1H NMR: 7.54 (s, 4H, H-2,3,5,6), 7.01 
and 6.94 (two s, 4H, 2 x H-3’,6’), 5.27 (t, J2",3" = J3",4" = 9.3, 2H, 2 x H-3"), 5.12 (t, J3",4" = J4",5" = 
9.3, 2H, 2 x H-4"), 5.05 (dd, J1",2" = 8.3, J2",3" =9.3, 2H, 2 x H-2"), 4.91 (d, J1",2" = 8.3, 2H, 2 x H-
1"), 4.65 (s, 4H, 2 x CH2C≡), 4.28 and 4.17 (split AB system, J5",6"A = 4.9, J5",6"B = 2.4, J6"A,6"B = 
12.2, 4H, 2 x H2-6"), 3.92 and 3.89 (two s, 12H, 4 x OCH3), 3.76 (ddd, J4",5" = 9.3, J5",6"A = 4.9, 
J5",6"B = 2.4, 2H, 2 x H-5"), 2.08, 2.05, 2.03, and 2.01 (four s, 24H, 8 x CH3CO). 
13C NMR: 
170.6, 170.3, 169.4, and 169.3 (8 x CO), 154.1 and 153.9 (2 x C-2’,5’), 131.6 (C-2,3,5,6), 
123.1 (C-1,4), 115.8 and 115.5 (2 x C-3’,6’), 113.7 and 112.4 (2 x C-1’,4’), 98.2 (2 x C-1"), 
94.9, 89.1, 87.4, and 83.4 (4 x C≡C), 72.8 (2 x C-3"), 71.9 (2 x C-5"), 71.1 (2 x C-2"), 68.3 (2 x 
C-4"), 61.8 (2 x C-6"), 57.0 (2 x CH2C≡), 56.5 and 56.3 (4 x OCH3), 20.7 and 20.6 (8 x CH3CO). 
Anal. Calcd for C60H62O24 (1167.12): C, 61.75; H, 5.35. Found: C, 61.62; H, 5.36. 
Compound 13.  
 
TLC: Rf 0.63 (hexane/EtOAc 40:60). Mp 109-111 °C. 
1H NMR: 7.52 (m, 8H, 2 x H-2,3,5,6), 
7.01 and 6.95 (two s, 4H, 2 x H-3',6'), 5.27 (t, J2",3" = J3",4" = 9.3, 2H, 2 x H-3"), 5.12 (t, J3",4" = 
J4",5" = 9.3, 2H, 2 x H-4"), 5.05 (dd, J1",2" = 7.8, J2",3" =9.3, 2H, 2 x H-2"), 4.91 (d, J1",2" = 7.8, 2H, 
2 x H-1"), 4.65 (s, 4H, 2 x CH2C≡), 4.28 and 4.17 (split AB system, J5",6"A = 4.9, J5",6"B = 2.4, 
J6"A,6"B = 12.2, 4H, 2 x H2-6"), 3.89 and 3.88 (two s, 12H, 4 x OCH3), 3.76 (ddd, J4",5" = 9.3, 
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J5",6"A = 4.9, J5",6"B = 2.4, 2H, 2 x H-5"), 2.08, 2.05, and 2.04 (three s, 24H, 8 x CH3CO). 
13C 
NMR: 170.7, 170.3, 169.5, and 169.4 (8 x CO), 154.1 and 153.9 (2 x C-2',5'), 132.4 and 131.6 
(2 x C-2,3,5,6), 124.1 and 121.6 (2 x C-1,4), 115.7 and 115.5 (2 x C-3',6'), 113.5 and 112.6 (2 x 
C-1',4'), 98.2 (2 x C-1"), 94.6, 89.2, 88.2, 83.4, 82.1, and 77.2 (6 x C≡C), 72.8 (2 x C-3"), 71.9 (2 
x C-5"), 71.1 (2 x C-2"), 68.3 (2 x C-4"), 61.8 (2 x C-6"), 57.0 (2 x CH2C≡), 56.5 and 56.3 (4 x 
OCH3), 20.7 and 20.6 (8 x CH3CO). Anal. Calcd for C70H66O24 (1291.26): C, 65.11; H, 5.15. 
Found: C, 65.26; H, 5.13. 
 
Compound 14. It was obtained following procedure A starting from 12 (0.23g), as a pale 
yellow solid (0.15g, 0.19 mmol, 94%).  
 
TLC: Rf 0.05 (CHCl3/MeOH 80:20). Mp ≥280 °C. 1H NMR (dmso-d6): 7.58 (s, 4H, H-
2,3,5,6), 7.18 and 7.09 (two s, 4H, 2 x H-3’,6’), 5.15 (d, Jvic = 4.9, 2H, 2 x OH), 4.98 (d, Jvic = 
4.9, 2H, 2 x OH), 4.94 (d, Jvic = 5.3, 2H, 2 x OH), 4.68 and 4.55 (AB system, Jgem = 15.6, 4H, 2 x 
CH2C≡), 4.54  (t, JOH,6= 5.7, 2H, 2 x 6’-OH), 4.34 (d, J1”,2” = 7.9, 2H, 2 x H-1"), 3.82 and 3.81 
(two s, 12H, 4 x OCH3), 3.70 and 3.45 (split AB m, 4H, 2 x H2-6"), 3.19 - 2.97 (m, 8H, 2 x H-2"-
5"). 13C NMR (dmso-d6): 153.7 and 153.5 (2 x C-2’,5’), 131.6 (s, C-2,3,5,6), 122.5 (C-1,4), 
115.8 and 115.6 (2 x C-3’,6’), 112.5 and 112.2 (2 x C-1’,4’), 101.1 (2 x C-1"), 94.1,  91.4, 88.1.2 
and 82.0 (4 x C≡C), 77.0 and 76.7 (2 x C-3",5"), 73.3 (2 x C-2"), 70.1 (2 x C-4"), 61.2 (2 x C-
6"), 56.3 and 56.1 (4 x OCH3), 55.8 (2 x CH2C≡). Anal. Calcd for C44H46O16 (830.83): C, 63.61; 
H, 5.58. Found: C, 63.63; H, 5.59.  
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Compound 15. A DMF solution (12 mL) of 2,5-dibromoaniline (1.00 g, 3.98 mmol, 1 equiv) 
was added at RT under Ar atmosphere to anhydrous K2CO3 (5.00 g, 36.18 mmol). To the 
obtained suspension 1.2 mL of iodomethane (20 mmol, 5 equiv) were added, the mixture was 
heated at 100 °C, and maintained in these conditions under continuous stirring until completion 
by TLC (hexane/EtOAc 9.5:0.5). After 48 h, the reaction was quenched by adding water (7 mL) 
and extracted with dichloromethane (3 x 10 mL). The organic phases were dried over anhydrous 
Na2SO4, the solvent evaporated under reduced pressure to give pure 15 as a transparent oil (1.08 
g, 3.87 mmol, 97%).  
 
TLC: Rf 0.85 (hexane/EtOAc 95:5). 
1H NMR: 7.35 (d, 1H, J3,4 = 8.8, H-3), 7.14 (d, 1H, J4,6 = 
2.4, H-6), 6.96 (dd, 1H, J3,4 = 8.8, J4,6 = 2.4, H-4), 2.76 [s, 6H, N(CH3)2]. 
13C NMR:  152.8 (C-
1), 134.7 (C-3), 126.2 (C-4), 123.5 (C-6), 119.9 and 117.2 (C-4,5), 43.7 [N(CH3)2]. Anal. Calcd 
for C8H9Br2N (278.97): C, 34.44; H, 3.25; N, 5.02. Found: C, 34.50; H, 3.26; N, 5.03. 
 
Compound 16. To a solution in dry DMF (15 mL) of 15 (1.00 g, 3.58 mmol, 1 equiv), 
commercial ethynyltrimethylsilane (3.05 mL, 21.60 mmol, 6 equiv) and Pd(PPh3)4 (0.41 g, 0.35 
mmol, 0.1 equiv) Et3N (15 mL) was slowly added. The mixture was heated at 70 °C and 
maintained under Ar atmosphere and continuous stirring until the disappearance of starting 
products (after 2 hours) by TLC (hexane/EtOAc 9:1).  Column chromatography was performed 
with hexane as eluant, and compound 16 was obtained as a transparent oil (0.62 g, 1.98 mmol, 
55%).  
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TLC: Rf 0.67 (hexane/EtOAc 90:10). 
1H NMR7.33 (d, 1H, J3,4 = 7.9, H-3), 6.94 (m, 2H, H-
4,6), 2.93 [s, 6H, N(CH3)2], 0.25 [s, 18H, 2 x Si(CH3)3]. 
13C NMR 154.7 (C-1), 134.6 (C-3), 
123.8 and 120.1 (C-4,6), 115.0 and 105.1 (C-2,5), 104.3, 104.2, 101.4, and 95.3 (2 x C≡C), 43.1 
[N(CH3)2], - 0.02 and - 0.17 [2 x Si(CH3)3]. Anal. Calcd for C18H27NSi2 (313.58): C, 68.94; H, 
8.68; N, 4.47. Found: C, 68.88; H, 8.70; N, 4.48. 
 
Compound 17. Compounds 16 (0.18 g, 0.57 mmol, 1 equiv) and 4 (0.75 g, 1.16 mmol, 2 equiv), 
Ag2O (0.27 g, 1.16 mmol, 2 equiv) and Pd(PPh3)4 (0.10 g, 0.09 mmol, 0.16 equiv) were 
suspended in dry DMF (4 mL) and THF (2 mL). The obtained mixture was heated at 70 °C and 
maintained under Ar atmosphere and continuous stirring for 7h, until the disappearance of 
starting products by TLC (hexane/EtOAc 3:7) After filtration over Celite, the solvents were 
removed under reduced pressure, and the obtained reaction crude was subjected  to silica gel 
column chromatography Column chromatography was performed with hexane/EtOAc 50:50 as 
eluant, and compound 17 was obtained as a brilliant yellow solid (0.42 g, 0.35 mmol, 61%).  
 
TLC: Rf 0.56 (hexane/EtOAc 40:60). Mp 91-93 °C.
1H NMR: 7.46 (d, J5,6 = 8.4, 1H, H-6), 7.08 
(m, 2H, H-3,5), 7.00, 6.99, 6.93 and 6.91 (four s, 4H, 2 x H-3’,6’), 5.25 (t, J2",3" = J3",4" = 9.5, 2H, 
2 x H-3"), 5.10 (t, J3",4" = J4",5" = 9.5, 2H, 2 x H-4"), 5.03 (dd, J1",2" = 8.0, J2",3" = 9.5, 2H, 2 x H-
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2"), 4.90 (d, J1",2" = 8.0, 2H, 2 x H-1"), 4.64 (s, 4H, 2 x CH2C≡), 4.27 and 4.16 (split AB system, 
J5",6"A = 4.9, J5",6"B = 2.4, J6"A,6"B = 12.7, 4H, 2 x H2-6"), 3.87, 3.86, and 3.85 (three s, 12H, 4 x 
OCH3), 3.76 (ddd, J4",5" = 9.5, J5",6"A = 4.9, J5",6"B = 2.4, 2H, 2 x H-5"), 3.02 [br s, 6H, N(CH3)2], 
2.06, 2.03, 2.02, and 2.01 (four s, 24H, 8 x CH3CO). 
13C NMR: 170.7, 170.3, 169.5, and 169.4 
(8 x CO), 154.5, 154.1, 153.9, and 153.8 (C-2, 2 x C-2’,5’), 134.3 (C-6), 128.2 (C-4), 123.7 and 
120.0 (C-3,5), 115.7, 115.6, 115.5, and 115.1 (2 x C-3’,6’), 115.0, 114.4, 113.8, 112.3, and 111.9 
(C-1, 2 x C-1’,4’), 98.3 (2 x C-1"), 95.5, 94.6, 92.6, 89.1, 88.9, 86.6, 83.5, and 83.4 (4 x C≡C), 
72.8 (2 x C-3"), 71.9 (2 x C-5"), 71.1 (2 x C-2"), 68.3 (2 x C-4"), 61.8 (2 x C-6"), 57.1 (2 x 
CH2C≡), 56.5, 56.4 and 56.3 (4 x OCH3), 43.5 [N(CH3)2], 20.7 and 20.6 (8 x CH3CO). Anal. 
Calcd for C62H67NO24 (1210.19): C, 61.53; H, 5.58; N, 1.16. Found: C, 61.66; H, 5.57; N, 1.16. 
 
Compound 18. It was obtained following procedure A starting from 17 (0.24g), as a pale 
yellow solid (0.17g, 0.19 mmol, 95%).  
 
TLC: Rf 0.05 (CHCl3/MeOH 80:20). Mp 202-203 °C. 
1H NMR (dmso-d6):7.44 (d, J5,6 = 8.3, 
1H, H-6), 7.16, 7.10, 7.07 and 7.06 (four s, 4H, 2 x H-3’,6’), 7.01 (m, 2H, H-3,5), 5.14 (d, Jvic = 
4.9, 2H, 2 x OH), 4.97 (d, Jvic = 4.8, 2H, 2 x OH), 4.92 (d, Jvic = 5.4, 2H, 2 x OH), 4.67 and 4.54 
(AB system, Jgem = 16.1, 4H, 2 x CH2C≡), 4.56  (t, JOH,6 = 5.9, 2H, 2 x 6’-OH), 4.33 (d, J1”,2” = 
7.8, 2H, 2 x H-1"), 3.81 and 3.80 (two s, 12H, 4 x OCH3), 3.66 and 3.44 (split AB m, 4H, 2 x H2-
6"), 3.18 - 2.97 (m, 8H, 2 x H-2"-5"), 2.97 [s, 6H, N(CH3)2]. 
13C NMR (dmso-d6): 154.1, 
153.8, 153.7, and 153.5 (C-2, 2 x C-2’,5’), 134.5 (C-6), 123.3 (C-4), 122.7 and 119.2 (C-3,5), 
115.8, 115.6, and 115.0 (2 x C-3’,6’), 113.7, 113.2, 112.5, 112.4, and 112.0 (C-1, 2 x C-1’,4’), 
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101.1 (2 x C-1"), 94.8, 94.3, 92.8, 91.3, 91.2, 87.3, 82.1, and 82.0 (4 x C≡C), 77.1 and 76.7 (2 x 
C-3",5"), 73.3 (2 x C-2"), 70.1 (2 x C-4"), 61.2 (2 x C-6"), 56.3 and 56.2 (4 x OCH3), 55.9 (2 x 
CH2C≡), 42.7 [N(CH3)2]. Anal. Calcd for C46H51NO16 (873.89): C, 63.22; H, 5.88; N, 1.60. 
Found: C, 63.25; H, 5.87; N, 1.60.  
 
Compound 22.3  A DMF solution (5 mL) of 21 (0.40 g, 1.35 mmol, 1 equiv) was added at RT 
under Ar atmosphere to anhydrous K2CO3 (2.38 g, 17.22 mmol). To the obtained suspension 
0.41 mL of iodomethane (6.75 mmol, 5 equiv) were added, the mixture was heated at 100 °C, 
and maintained in these conditions under continuous stirring until completion by TLC 
(hexane/EtOAc 9:1). After 70 h, the reaction was quenched by adding water (5 mL) and 
extracted with dichloromethane (3 x 10 mL). The organic phases were dried over anhydrous 
Na2SO4, the solvent evaporated under reduced pressure. The reaction crude was subjected to 
silica gel column chromatography (eluant hexane/EtOAc 90:10) and 22 has been isolated as a 
yellow solid (0.26 g, 0.80 mmol, 59%). TLC: Rf 0.80 (hexane/EtOAc 80:20).  
 
Mp 81-83 °C, Rf=0.85.  
 
Compound 23. In a flask containing 22 (0.25 g, 0.77 mmol, 1 equiv) were added commercial 
ethynyltrimethylsilane (0.65 mL, 4.62 mmol, 6 equiv), Pd(PPh3)4 (0.09 g, 0.08 mmol, 0.1 equiv). 
The compounds were dissolved in dry DMF (6 mL) and to the solution was slowly added dry 
Et3N (6 mL). The mixture was heated at 70 °C and maintained under Ar atmosphere and 
                                                 
3 Moroni et al.; Macromolecules, 1997, 30, 1964-1972. 
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continuous stirring 1h until the disappearance of starting products. Column chromatography was 
performed with hexane as eluant, and compound 23 was obtained as a yellow oil (0.19 g, 0.53 
mmol, 69%).  
 
 
TLC: Rf 0.48 (hexane/EtOAc 80:20).
1H NMR8.19 (s, 1H, H-3), 6.85 (s, 1H, H-6), 3.16 [s, 
6H, N(CH3)2], 0.28 and 0.24 [two s, 18H, 2 x Si(CH3)3]. 
13C NMR: 156.1 (C-1), 139.6 (C-4), 
133.1 (C-3), 120.7 (C-6), 119.7 and 110.7 (C-2,5), 103.7, 102.6, 102.5, and 100.8 (2 x C≡C), 
42.5 [N(CH3)2], - 0.27 and - 0.42 [2 x Si(CH3)3]. Anal. Calcd for C18H26N2O2Si2 (358.58): C, 
60.29; H, 7.31; N, 7.81. Found: C, 60.40; H, 7.29; N, 7.78. 
 
Compound 24.  23 (0.22 g, 0.61 mmol, 1 equiv), 4 (0.75 g, 1.16 mmol, 2 equiv.), Pd(PPh3)4 
(0.10 g, 0.09 mmol, 0.15 equiv), and Ag2O (0.27 g, 1.16 mmol, 2 equiv) were suspended in dry 
DMF (4 mL) and THF (2 mL). The obtained mixture was heated at 70 °C for 30h and maintained 
under Ar atmosphere and continuous stirring until the disappearance of starting products. After 
filtration over Celite, solvents were removed under reduced pressure, and the reaction crude was 
subjected  to silica gel column chromatography, performed with hexane/EtOAc 50:50 as eluant: 
compound 24 was obtained as a pale green oil (0.31 g, 0.25 mmol, 41%). TLC: Rf 0.36 
(hexane/EtOAc 40:60).  
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1H NMR:  8.s, 1H, H-6), 7.10 (s, 1H, H-3), 6.98, 6.96, and 6.93 (three s, 4H, 2 x H-3’,6’), 
5.27 (t, J2",3" = J3",4" = 9.4, 2H, 2 x H-3"), 5.12 (t, J3",4" = J4",5" = 9.4, 2H, 2 x H-4"), 5.05 (dd, J1",2" 
= 8.2, J2",3" = 9.4, 2H, 2 x H-2"), 4.90 (d, J1",2" = 8.2, 2H, 2 x H-1"), 4.65 (s, 4H, 2 x CH2C≡), 
4.27 and 4.16 (split AB system, J5",6"A = 4.1, J5",6"B = 2.3, J6"A,6"B = 12.3, 4H, 2 x H2-6"), 3.91, 
3.89, and 3.86 (three s, 12H, 4 x OCH3), 3.78 (ddd, J4",5" = 9.4, J5",6"A = 4.1, J5",6"B = 2.3, 2H, 2 x 
H-5"), 3.28 [s, 6H, N(CH3)2], 2.08, 2.05, 2.03, and 2.01 (four s, 24H, 8 x CH3CO). 
13C NMR: 
170.2, 169.4, and 169.3 (8 x CO), 155.6, 154.3, 154.1, and 154.0 (C-2 and 2 x C-2’,5’), 139.0 
(C-5), 133.0 (C-6), 120.1, 119.9, 115.8, 115.4, and 114.9 (C-3 and 2 x C-3’,6’), 113.4, 113.2, 
112.5, and 110.5 (C-1 and 2 x C-1’,4’), 98.2 (2 x C-1"), 93.3, 93.1, 93.0, 92.1, 89.5, 89.3, and 
83.3 (4 x C≡C), 72.8 (2 x C-3"), 71.9 (2 x C-5"), 71.1 (2 x C-2"), 68.3 (2 x C-4"), 61.8 (2 x C-
6"), 57.0 (2 x CH2C≡), 56.5, 56.4, and 56.2 (4 x OCH3), 42.8 [N(CH3)2], 20.7 and 20.6 (8 x 
CH3CO). Anal. Calcd for C62H66N2O26 (1255.19): C, 59.33; H, 5.30; N, 2.23. Found: C, 59.26; 
H, 5.29; N, 2.23. 
 
Compound 25. To a flask were added Pd(PPh3)4 (0.45g, 0.39mmol, 0.15 equiv), 1 (1.00g, 
2.59mmol, 1equiv) and 16 (1.45g, 5.18mmol, 2 equiv); the flask was capped with a rubber 
septum and evacuated. After backfilling with N2, this process was repeated three times. To the 
flask were added dry DMF (20mL) and Et3N (20mL) at room temperature. The reaction mixture 
was heated at 65°C, and maintained under continuous stirring for 4 h, until the disappearance of 
compound 1 by TLC (hexane/EtOAc 7:3) (Hexane/EtOAc 70:30). Solvents were removed under 
reduced pressure and the solid residue was dissolved in CH2Cl2 ad filtered on celite. The 
volatiles were removed in vacuo and the reaction crude was purified by flash chromatography on 
silica gel, using Hexane/EtOAc (90:10) as eluant, giving compound 25 as a pale yellow oil 
(0.91g, 1.55mmol, 60%).  
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TLC: Rf0.60. 1H NMR:  (d, J5,6 = 8.1, 1H, H-5), 7.11 (d, J2,6 = 1.0, 1H, H-2), 6.93 (dd, J5,6 
= 8.1, J2,6 = 1.0, 1H, H-6), 5.25 (t, J2’,3’ = J3’,4’ = 9.3, 1H, H-3’), 5.10 (t, J3’,4’ = J4’,5’ = 9.3, 1H, H-
4’), 5.02 (bdd, J1’,2’= 8.3  J2’,3’ = 9.3, 1H, H-2’),4.80 (d, J1’,2’ = 8.3, 1H, H-1’), 4.56 (s, 2H, 
CH2C≡), 4.27 and 4.14 (split AB system, J5’,6A’= 4.2, J5’,6B’ = 1.8, J6A’,6B’ = 12.6, 2H, H2-6’), 3.79 
(m, 1H, H-5’), 2.78 (s, 6H, [N(CH3)2]), 2.06, 2.03, 2.01 and 1.99 (four s, 12H, 4 x CH3CO). 13C 
NMR: 170.2 and 169.4 (4 x CO), 151.9 (C-3), 134.0 (C-5), 126.8 and 123.6 (C-2 and C-
6), 121.9 and 119.9 (C-1 and C-4), 98.4 (C-1’), 86.3 and 83.9 (C≡C), 72.7 (C-3’), 71.8 (C-5’), 
71.1 (C-2’), 68.2 (C-4’), 61.8 (C-6’), 56.8 (CH2C≡), 44.0 ([N(CH3)2]), 20.6 and 20.5 (4 x 
CH3CO). Calc. for C25H30BrNO10 583.11; found positive ESI-MS: [M-H+ ] = 584.1114. 
Compound 26. To a flask were added Pd(PPh3)4 (0.27g, 0.23mmol, 0.15equiv), 25 (0.91g, 
1.55mmol, 1equiv) and ethynyltrimethylsilane (1.31mL, 9.3mmol, 6 equiv); the flask was 
capped with a rubber septum and evacuated. After backfilling with N2, this process was repeated 
three times. To the flask were added dry DMF (11 mL) and Et3N (11 mL) at room temperature. 
The mixture was heated at 65°C, and maintained under continuous stirring for 24h, until the 
disappearance of compound 25 by TLC (Hexane/EtOAc 7:3). Solvents were removed in vacuo 
and the solid residue was dissolved in CH2Cl2 ad filtered on celite. The volatiles were removed 
under reduced pression and the crude purified by flash chromatography on silica gel using 
Hexane/EtOAc (90:10) as eluant to give compound 26 as a yellow oil (0.77g, 1.27mmol, 82%).  
 
TLC: Rf0.55. 1H NMR:  (d, J5,6 = 7.8, 1H, H-5), 6.86 (d, J2,6 = 1.2, 1H, H-2), 6.87 (dd, J5,6 
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= 7.8, J2,6 = 1.2, 1H, H-6), 5.24 (t, J2’,3’ = J3’,4’ =  9.3, 1H, H-3’), 5.09 (t, J3’,4’ = J4’,5’ = 9.3, 1H, H-
4’), 5.01 (bdd, J1’,2’= 8.1  J2’,3’ = 9.3, 1H, H-2’),4.82 (d, J1’,2’ = 8.1, 1H, H-1’), 4.57 (s, 2H, 
CH2C≡), 4.27 and 4.15 (split AB system, J5’,6A’ = 4.5, J5’,6B’ = 2.1, J6A’,6B’ = 12.3, 2H, H2-6’), 3.74 
(m, 1H, H-5’), 2.94 (s, 6H, [N(CH3)2]), 2.06, 2.03, 2.01 and 1.99 (four s, 12H, 4 x CH3CO), 0.24 
(s, 9H, [Si(CH3)3]). 
13C NMR: 170.2, 169.4 and 169.3 (4 x CO), 154.8 (C-3), 134.8 (C-
5), 123.2 and 119.8 (C-2 and C-6), 122.8 and 116.2 (C-1 and C-4), 104.0, 101.7, 87.2 and 84.4 
(C≡C), 98.4 (C-1’), 72.8 (C-3’), 71.9 (C-5’), 71.1 (C-2’),68.3 (C-4’), 61.8 (C-6’), 56.9 (CH2C≡), 
43.1 [N(CH3)2], 21.0, 20.7 and 20.5 (4 x CH3CO), 0.2 ([Si(CH3)3]). Calc. for C30H39NO10Si 
601.23; found positive ESI-MS: [M-H+]  = 602.2422. 
 
Compound 27. To a flask were added Pd(PPh3)4 (0.11g, 0.09mmol, 0.15 equiv), Ag2O (0.30 g, 
1.28 mmol, 2equiv), 26 (0.77g, 1.28mmol, 2equiv) and 1,4-iodo-2,5-dimethoxybenzene 2 (0.25g, 
0.64mmol, 1 equiv); the flask was capped with a rubber septum and evacuated. After backfilling 
with N2, this process was repeated three times. To the flask were added dry DMF (10mL) and 
dry THF (5mL). The reaction mixture was heated at 70°C for 7 h, until the disappearance of 
compound 25 by TLC (Hexane/EtOAc 1:1). Solvents were removed in vacuo and the solid 
residue was dissolved in CH2Cl2 ad filtered on celite. The volatiles were removed under reduced 
pression and the crude purified by column chromatography on silica gel using Hexane/EtOAc 
(60:40) as eluant to give compound 27 as a brilliant yellow oil (0.43g, 0.36mmol, 57%). 
 
TLC: Rf0.35. 1H NMR:  (d, J5’,6’ = 7.8, 2H, 2 x H-5’), 6.99 (s, 2H, H-3 and H-6), 6.97 (d, 
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J2’,6’ = 1.2, 2H, 2xH-2’), 6.96 (dd, J5’,6’ = 7.8, J2’,6’ = 1.2, 2H, 2xH-6’), 5.28 (t, J2’’,3’’ = J3’’,4’’ = 9.3, 
2H, 2xH-3’’), 5.12 (t, J3’’,4’’ = J4’’,5’’ = 9.3, 2H, 2xH-4’’), 5.04 (bdd, J1’’,2’’= 8.2  J2’’,3’’ = 9.3, 2H, 
2xH-2’’),4.85 (d, J1’’,2’’ = 8.2, 2H, 2xH-1’’), 4.60 (s, 4H, 2xCH2C≡), 4.29 and 4.17 (split AB 
system, J5’’,6A’’ = 4.4, J5’’,6B’’ = 2.5, J6A’’,6B’’ = 12.2, 4H, 2xH2-6’’), 3.89 (s, 6H, 2xOCH3), 3.77 (m, 
2H, 2xH-5’’), 3.03 (s, 12H, 2x[N(CH3)2]), 2.08, 2.05, 2.03 and 2.02 (four s, 24H, 8 x CH3CO). 
13C NMR: 170.2, 169.4 and 169.3 (8 x CO), 154.3 and 153.9 (C-2, C-5, C-3’), 134.3 (C-
5’), 123.5 (C-6’), 122.6 (C-4’), 119.9 (C-2’), 115.5, 114.9 and 114.8 (C-1, C-3, C-4 and C-6), 
113.6 (C-1’), 98.4 (C-1’’), 98.1, 93.0, 87.2 and 84.4 (C≡C), 72.7 (C-3’’), 71.8 (C-5’’), 71.1 (C-
2’’),68.3 (C-4’’), 61.7 (C-6’’), 56.9 (CH2C≡), 56.3 (OCH3), 43.3 [N(CH3)2], 20.7 and 20.5 (8 x 
CH3CO). Calc. for C62H68N2O22 1192.43: found positive MALDI [M+] = 1192.4; Purity by 
qNMR: 96.3%.%.  
 
Compound 28. It was obtained following procedure A starting from 27 (0.43g, 0.36mmol) with 
the final obtaining of compound 28 as a brilliant yellow solid (0.30g, 0.35mmol, 97%).  
 
TLC: Rf0.05 (CHCl3/MeOH 80:20). Mp 123-125°C. 
1H NMR (dmso-d6):  7.40 (d, J5’,6’ = 8.7, 
2H, 2xH-5’), 7.12 (s, 2H, H-3 and H-6), 6.95 (m, 4H, 2xH-2’ and 2xH-6’),  5.14 (d, J2’’,OH = 4.4, 
2H, 2xOH-2’’), 4.97 and 4.92 (two d, J3’’, OH = J4’’,OH =4.4, 4H, 2xOH-3’’ and 2xOH-4’’), 4.64 
and 4.51 (AB system and m, Jgem=15.7, 6H, 2 x CH2C≡ and 2 x OH-6’’), 4.31 (d, 2H, J1’’,2’’ = 7.8, 
2xH-1’’), 3.83 (s, 6H, 2xOCH3), 3.70 and 3.46 (split AB m, 4H, 2 x H2-6’’), 3.16-2.98 (m, 8H, 
2xH-2’’, 2xH-3’’, 2xH- 4’’, 2xH-5’’), 2.96 (s, 12H, 2x[N(CH3)2]). 13C NMR (dmso-d6):  153.9 
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and 153.5 (C-2, C-5 and C-3’), 134.4 (C-5’), 131.5 (C-1’), 122.8, 122.6, 119.5 and 119.4 (C-
2’and C-6’), 114.9 and 114.8 (C-3 and C-6), 113.7 and 112.9 (C-1, C-4 and C-4’), 101.2 (C-1’’), 
94.2,  92.8,  87.1 and 85.6 (C≡C), 77.0 and 76.5 (C-3’’ and C-5’’), 73.3 (C-2’’), 70.0 (C-4’’), 61.3 
(C-6’’), 56.2 (CH2C≡), 55.7 (OCH3), 42.6 [N(CH3)2]. Calc. for C46H52N2O14 856.34; found 
positive ESI-MS: [M-H+] = 857.3515; Purity by qNMR: 96.3%.  
 
Compound 29. Compound 17 (0.50g, 0.41mmol, 1eq) was dissolved in dry dichloromethane. To 
this solution a equimolar amount of MeOTf (0.07g, 0.41mmol, 1eq) was added under Ar 
atmosphere. The mixture was heated at reflux temperature (40°) and maintained under 
continuous stirring until the disappearance of the starting product 17 by TLC (hexane/EtOAc 
3:7) (2h). Solvents were removed under reduced pressure to give 29 as an orange solid (0.49g, 
0.40mmol, 97%).  
 
TLC: Rf: (0.10).  Mp 162-164 °C. 1H NMR:  (d, J3,5 = 1.0, 1H, H-3), 7.78 (d, J5,6 = 7.8, 1H, 
H-6), 7.70 (dd, J3,5 = 1.0,  J5,6 = 7.8, 1H, H-5), and 6.96 (three s, 4H, 2 x H-3’,6’), 
5.27 (t, J2",3" = J3",4" = 9.3, 2H, 2 x H-3"), 5.12 (t, J3",4" = J4",5" = 9.3, 2H, 2 x H-4"), 5.04 (broad 
dd, J1",2" = 7.9, J2",3" = 9.3, 2H, 2 x H-2"),4.90 (d, J1",2" = 7.8, 2H, 2 x H-1"), 4.66 and 4.65 (two s, 
4H, 2 x CH2C≡), 4.28 and 4.17 (split AB m, 4H, 2 x H2-6"), 4.09 [(s, 9H, N(CH3)3], 3.95, 3.90, 
3.89, and 3.88 (four s, 12H, 4 x OCH3), 3.77 (m, 2H, 2 x H-5"), 2.08, 2.05, 2.03, and 2.01 (four 
s, 24H, 8 x CH3CO). 
13C NMR: 170.3, 169.5, and 169.4 (8 x CO), 155.2 and 154.1 (2 x 
C-2’,5’), 145.1 (C-2), 137.1 (C-6), 133.1 (C-5), 125.9 (C-4), 122.9 (C-3), 115.7, 115.5, 114.8, 
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114.5, 113.6, 112.2,  and 110.8 (C-1, 2 x C-1’,3’,4’,6’), 100.2, 92.2, 91.3, 90.5, 89.8, 88.7, 83.2, 
and 82.9 (4 x C≡C), 98.3 (2 x C-1"), 72.8 (2 x C-3"), 71.9 (2 x C-5"), 71.1 (2 x C-2"), 68.3 (2 x 
C-4"), 61.8 (2 x C-6"), 57.1 and 57.0 (2 x CH2C≡),  and(4 x OCH3), 56.0 
[N(CH3)3], 20.7 and 20.6 (8 x CH3CO). Anal. Calcd for C64H70F3NO27S (1374.29): C, 55.93; H, 
5.13; N, 1.02. Found: C, 56.03; H, 5.12; N, 1.02.  
 
Compound 30. To compound 27 (0.40g, 0.33 mmol, 1eq) dissolved in dry CH2Cl2 (2mL).was 
added, under Ar atmosphere, methyl trifluoromethanesulfonate (0.11g, 0.66mmol, 2eq). The 
mixture was heated at reflux temperature (40°) and maintained under continuous stirring until the 
disappearance of the starting product by TLC (hexane/EtOAc 3:7) (6h). Solvents were removed 
under reduced pressure to give 30 a yellow-orange solid (0.38g, 0.31mmol, 94%). 
 
 Mp 210°-213° TLC Rf (0.10)1H NMR: 7.90 (s, 2H, 2xH-2’), 7.70 (dd, J5’,6’ = 7.8, J2’,6’ = 1.2, 
2H, 2xH-6’),  (m, 2H, 2 x H-5’), 7.07 (s, 2H, H-3 and H-6), 5.26 (t, J2’’,3’’ = J3’’,4’’ = 9.3, 2H, 
2xH-3’’), 5.12 (t, J3’’,4’’ = J4’’,5’’ = 9.3, 2H, 2xH-4’’), 5.00 (bdd, J1’’,2’’= 8.2  J2’’,3’’ = 9.3, 2H, 2xH-
2’’),4.84 (d, J1’’,2’’ = 8.2, 2H, 2xH-1’’), 4.62 (s, 4H, 2xCH2C≡), 4.27 and 4.17 (split AB system, 
J5’’,6A’’ = 4.4, J5’’,6B’’ = 2.5, J6A’’,6B’’ = 12.2, 4H, 2xH2-6’’), 4.06 (s, 18H, 2x[N(CH3)3]), 3.97 (s, 
6H, 2xOCH3), 3.83 (m, 2H, 2xH-5’’), 2.06, 2.04, 2.01 and 2.00 (four s, 24H, 8 x CH3CO). 13C 
NMR: 170.2, 169.4 (8 x CO), 155.1 and 145.1 (C-2, C-5, C-3’), 137.3 (C-5’), 133.3 (C-
6’), 133.1 (C-4’), 128.4 (C-2’), 119.4, 116.1, 114.4 and 112.7 (C-1, C-3, C-4 and C-6), 113.6 (C-
1’), 99.7 (C-1’’), 98.8, 90.9, 89.4 and 84.3 (C≡C), 72.7 (C-3’’), 71.8 (C-5’’), 71.3 (C-2’’),68.2 
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(C-4’’), 61.8 (C-6’’), 56.7 (CH2C≡), 56.4 (OCH3), 56.0 [N(CH3)3], 20.7 and 20.5 (8 x CH3CO). 
Calc. for C64H74N2O22
2+ 
 
Compound 31 Following procedure A, starting from 29 (0.49g, 0.40mmol) was obtained 
compound 31 as a brilliant yellow solid (0.34g, 0.39mmol, 97%).  
 
TLC (hexane/EtOAc 3:7), Rf (0.10). Mp 162-164 °C.  1H NMR (dmso-d6):  8.04 (broad s, 1H, 
H-3), 7.92 (broad  d, J5,6 = 7.9, 1H, H-6), 7.82 (broad  d,  J5,6 = 7.9, 1H, H-5), 7.31, 7.19, 7.15, 
and 7.15 (four s, 4H, 2 x H-3’,6’), 5.14 (m, 2H, 2 x OH), 4.98 (broad d, 2H, 2 x OH), 4.95 
(broad d, 2H, 2 x OH), 4.61-4.53 (m, 6H, 2 x CH2C≡ and 2 x 6’-OH), 3.92 [(s, 9H, N(CH3)3], 
3.90, 3.84, and 3.82 (three s, 12H, 4 x OCH3), 3.70 and 3.46 (split AB m, 4H, 2 x H2-6"), 3.18 - 
2.98 (m, 8H, 2 x H-2"-5"). 13C NMR: 154.5, 153.8, 153.7 and 153.6 (2 x C-2’,5’), 145.1 (C-2), 
136.9 (C-6), 132.9 (C-5), 124.6 (C-3), 124.1 (C-4), 116.0, 115.8, 115.6, and 115.4 (2 x C-3’,6’), 
115.0, 113.9, 113.3, 111.4,  and 110.8 (C-1, 2 x C-1’,3’,4’,6’), 101.1 and 101.0  (2 x C-1"), 98.8, 
92.8, 92.2, 91.8, 90.3, and 81.9 (4 x C≡C), 77.1 and 76.7 (2 x C-3",-5"), 73.3 (2 x C-2"), 70.1 (2 
x C-4"), 61.2 (2 x C-6"),  and(4 x OCH3), 55.8 (2 x CH2C≡), 55.3 [N(CH3)3]. 
Anal. Calcd for C48H54F3NO19S (1038.00): C, 55.54; H, 5.24; N, 1.35. Found: C, 55.55; H, 5.23; 
N, 1.35.  
 
Compound 32 To a flask was added 30 (0.33g, 0.26mmol, 1eq.) and following the procedure A 
compound 32 afforded as a brilliant pale orange solid (0.22g, 0.24mmol, 92%).  
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TLC(hexane/EtOAc 3:7), Rf (0.10) Mp 165-169 °C. 1H NMR (dmso-d6):  8.01 (broad s, 1H, H-
2’), 7.90 (broad  d, J5,6 = 7.9, 1H, H-6’), 7.82 (broad  d,  J5,6 = 7.9, 1H, H-5’), 7.4 (s, 4H, 2 x H-
3’,6’), 5.14 (m, 2H, 2 x OH), 5.01 (broad d, 2H, 2 x OH), 4.96 (broad d, 2H, 2 x OH), 4.72-4.55 
(m, 6H, 2 x CH2C≡ and 2 x 6’-OH), 4.33 (d, 2H, 2 x H-1") 3.93 [(s, 18H, N(CH3)3], 3.90 (s, 6H, 
2 x OCH3), 3.70 and 3.46 (split AB m, 4H, 2 x H2-6"), 3.18 - 2.98 (m, 8H, 2 x H-2"-5"). 
13C 
NMR: 155.7 and 154.8 (2 x C-2’,5’), 145.2 (C-2), 137.0 (C-6), 133.2 (C-5), 125.2 (C-3), 124.0 
(C-4), 116.3, 115.6, 115.3, and 115.1 (2 x C-3’,6’), 114.0, 112.5,  and 110.8 (C-1, 2 x C-
1’,3’,4’,6’), 101.6 and 101.5  (2 x C-1"), 98.9, 98.6, 91.0, 90.7 (4 x C≡C), 77.3, 77.0 and 76.9 (2 
x C-3",-5"), 73.9 and 74.4 (2 x C-2"), 70.2 (2 x C-4"), 68.9 (2 x C-6"), (4 x OCH3), 58.6 (2 
x CH2C≡), 55.6 [N(CH3)3]. Anal. Calcd for C48H58N2O142+(886.98) 
 
33. To a solution of 1,2,3,4,6-penta-O-acetil-β-D-galactopyranose (5.0g, 12.55 mmol, 1eq.) in 36 
mL of dry CH2Cl2, at 0°C and under Argon, were added 1.48 mL of propargylic alcool (25.10 
mmol, d = 0.958 g/mL, 2eq.), 4.59 mL di trimethylsilyltriflate (25.10 mmol, d=1.228 g/mL, 2 
eq.) and molecular sieves 4Ǻ. The mixture was heated to RT and maintained under continuous 
stirring for 1h. The reaction was quenched by adding NaHCO3 (40 mL) and the organic phase 
washed with water (2 x 30 mL). The organic phases were dried over anhydrous Na2SO4, the 
solvent evaporated under reduced pressure. Column chromatography was performed with 
hexane/EtOAc 70:30 as eluant, and compound 33 was obtained as a white solid (3.4 g, 70%). 
TLC(hexane/EtOAc 8:2): Rf = 0.50. 
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Compound 34. 2-propyn-1-yl β-D-galactopyranoside 2,3,4,6-tetraacetate 33 (1.42 g, 3.67 mmol, 
1 equiv) and 1,4-diiodo-2,5-dimethoxybenzene 2 (3.00 g, 7.69 mmol, 2.1 equiv), were dissolved 
in dry DMF (30 mL). To th solution, at rt, was added Pd(PPh3)4 (0.50 g, 0.43 mmol, 0.12 equiv). 
Then to the mixture was slowly added Et3N (30 mL). The mixture under Ar atmosphere was 
heated at 60 °C and maintained under continuous stirring for 3h until the disappearance of 33 by 
(hexane/EtOAc 7:3). Column chromatography was performed with hexane/EtOAc 70:30 as 
eluant, and compound 34 was obtained as a white solid (1.90 g, 2.93 mmol, 80%).  
 
TLC: Rf 0.64. Mp 67-69 °C.
 1H NMR7.29 (s, 1H, H-3), 6.85 (s, 1H, H-6), 5.40 (d, J3',4' = 2.0, 
1H, H-4’), 5.24 (dd, J2',3' = J1',2' = 8.0, J2',4' = 2.0, 1H, H-2’), 5.07 (dd, J3',4' = J3',2' = 7.0, J1',3' = 3.0, 
1H, H-3’), 4.84 (d, J1',2' = 8.0, 1H, H-1’), 4.63 (s, 2H, CH2C≡), 4.19 and 4.12 (m, 2H, H2-6’), 
3.84 and 3.83 (two s, 6H, 2 x OCH3), 3.75 (m, 1H, H-5’), 2.15, 2.05, 2.04, and 1.99 (four s, 12H, 
4 x CH3CO). 
13C NMR: 170.3, 170.2, 170.1 and 169.5 (4 x CO), 154.7 (C-2), 152.2 (C-5), 
122.3 (C-3), 115.1 (C-6), 111.9 (C-1), 98.8 (C-1’), 88.5 (C-4), 87.3 and 82.9 (C≡C), 70.9 (C-3’), 
70.8 (C-5’), 70.7 (C-2’), 68.6 (C-4’), 68.5 (C-6’), 61.36 (CH2C≡), 57.1, 57.0, and 56.5 (2 x 
OCH3 ), 20.7 and 20.6 (4 x CH3CO). Anal. Calcd for C25H29IO12 (648.40): C, 46.31; H, 4.51. 
Found: C, 46.44; H, 4.50. 
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Compound 35.  16 (0.22 g, 0.61 mmol, 1 equiv), 34 (0.75 g, 1.16 mmol, 2 equiv), Pd(PPh3)4 
(0.10 g, 0.09 mmol, 0.15 equiv), Ag2O (0.27 g, 1.16 mmol, 2 equiv) were suspended in dry DMF 
(4 mL) and THF (2 mL). The mixture was heated at 70 °C for 30h and maintained under Ar 
atmosphere and continuous stirring until the disappearance of starting products. After filtration 
over Celite, the solvents were removed under reduced pressure, and the obtained reaction crude 
was subjected  to silica gel column chromatography with hexane/EtOAc 50:50 as eluant, and 
compound 35 was obtained as a yellow solid (0.31 g, 0.25 mmol, 41%).  
 
TLC: Rf 0.36 (hexane/EtOAc 40:60). Mp 181°-183°.
1H NMR: 7.48 (d, J5,6 = 8.4, 1H, H-6), 
7.09 (m, 2H, H-3,5), 7.00, 6.99, 6.93 and 6.91 (four s, 4H, 2 x H-3’,6’), 5.42 (d, 2H, J3’',4’' = 2.0, 
1H, H-4’’), 5.26 (dd, 2H, J2’',3’' = J1’',2’' = 8.0, J2’',4'’ = 2.0, 1H, H-2’’), 5.09 (dd, 2H, J3'’,4’' = J3’',2’' = 
7.0, J1’',3’' = 3.0, 1H, H-3’’), 4.86 (d, 2H, J1’',2’' = 8.0, 1H, H-1’’), 4.67 (s, 4H, 2x CH2C≡), 4.27 
and 4.18 (m, 4H, H2-6’’), 3.89 and 3.87 (three s, 12H, 4 x OCH3), 3.75 (m, 2H, H-5’’), 3.04 
[broad s, 6H, N(CH3)2], 2.16, 2.07, 2.04, and 2.00 (four s, 24H, 8 x CH3CO). 
13C NMR: 170.4, 
170.2, 170.1, and 169.6 (8 x CO), 154.1and 153.8 (C-2, 2 x C-2’,5’), 134.4 (C-6), 128.8 (C-4), 
123.8 and 120.0 (C-3,5), 115.7, 115.6 and 115.1 (2 x C-3’,6’), 113.8, 112.3 and 111.9 (C-1, 2 x 
C-1’,4’), 98.9 (2 x C-1"), 90.7, 89.2, 86.3, 83.5 (4 x C≡C), 70.9 (2 x C-3"), 70.8 (2 x C-5"), 68.7 
(2 x C-2"), 67.0 (2 x C-4"), 61.2 (2 x C-6"), 57.1 (2 x CH2C≡), 56.4 and 56.3 (4 x OCH3), 43.5 
[N(CH3)2], 20.8, 20.7 and 20.6 (8 x CH3CO).  
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Compound 37. To commercial 1,3,5 ethynyl benzene (0.20 g, 1.3 mmol, 1 equiv), 4 (2.59 g, 4 
mmol, 3 equiv) and Pd(PPh3)4 (0.45 g, 0.39 mmol, 0.30 equiv) in dry DMF (20 mL) was slowly 
added Et3N (20 mL). The solution under inert atmosphere was heated at 60 °C and maintained 
under continuous stirring for 4h until the disappearance of 4 by (hexane/EtOAc 4:6). Column 
chromatography was performed with Hexane/AcOEt 50:50 (gradient to Hexane/AcOEt 10/90) as 
eluant, and compound 37 was obtained as a white solid (0.90 g, 0.52 mmol, 40%).  
 
TLC: Rf 0.64 (hexane/EtOAc 70:30). Mp 65-67 °C.
 1H NMR:7.71 (s, 3H, H-2, H-4, H-6), 7.00 
and 6.84 (2s, 6H, 3xH-3’, 3xH-6’), 5.26 (t, J2",3" = J3",4" = 9.3, 3H, 3 x H-3"), 5.12 (t, J3",4" = J4",5" 
= 9.3, 3H, 3x H-4"), 5.04 (dd, J1",2" = 8.3, J2",3" =9.3, 3H, 3x H-2"), 4.91 (d, J1",2" = 8.3, 3H, 3x H-
1"), 4.65 (s, 6H, 3x CH2C≡), 4.30 and 4.15 (split AB system, J5",6"A = 4.9, J5",6"B = 2.4, J6"A,6"B = 
12.2, 6H, 3 x H2-6"), 3.89 and 3.88 (two s, 24H, 8 x OCH3), 3.76 (ddd, J4",5" = 9.3, J5",6"A = 4.9, 
J5",6"B = 2.4, 3H, 3 x H-5"), 2.07, 2.04, 2.02, and 2.01 (four s, 36H, 12 x CH3CO). 
13C NMR: 
170.4, 170.0, 169.2, and 169.2 (12 x CO), 153.9 and 153.8 (3 x C-2’,5’), 134.1 (C-2,3,5,6), 
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123.7 (C-1,4), 115.6 and 115.4 (3 x C-3’,6’), 113.2 and 112.4 (3 x C-1’,4’), 98.2 (3 x C-1"), 
98.1, 93.2, 89.1, and 83.2 (6 x C≡C), 72.6 (3 x C-3"), 71.7 (3 x C-5"), 71.0 (3 x C-2"), 68.2 (3 x 
C-4"), 61.6 (3 x C-6"), 56.9 (3 x CH2C≡), 56.3, 56.2, 56.1 and 56.0 (6 x OCH3), 20.5 and 20.4 
(12 x CH3CO).  
 
Compound 38. It was obtained following procedure A starting from 37 (0.20g, 0.12mmol) with 
the final obtaining of compound 36 as a brilliant yellow solid (0.13g, 0.11mmol, 94%). 
 
 
TLC: Rf0.05 (CHCl3/MeOH 80:20). Mp 123-125°C. 
1H NMR: 7.68 (s, 3H, H-2, H-4, H-6), 7.23 
and 7.10 (2s, 6H, 3xH-3’, 3xH-6’), 5.14 (d, Jvic = 4.9, 3H, 3 x OH), 4.97 (d, Jvic = 4.9, 3H, 3  x 
OH),  4.93 (d, Jvic = 5.4, 3H, 3  x OH) , 4.69 and 4.52 (AB system, Jgem = 15.7, 4H, 3 x CH2C≡), 
4.53 (t, JOH,6= 4.9, 3H, 3 x 6’-OH), 4.33 (d, J1’,2’ = 7.9, 3H, 3 x H-1’), 3.84 and 3.81 (s, 9H, 3 x 
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OCH3), 3.69 and 3.67 (split AB m, 6H, 3 x H2-6’), 3.16 - 3.00 (m, 12H, 3 x H-2’-5’). 13C NMR 
(dmso-d6):153.7 and 153.6 (C-2,5), 115.9 (C-3,6), 112.8 and 111.9 (C-1,4), 101.1 (3 x C-1’), 
91.5, 87.7 and 82.0 (3 x C≡C), 77.0 and 76.7 (3 x C-3’,5’), 73.3 (3 x C-2’), 70.1 (3 x C-4’), 61.2 
(3 x C-6’), 56.3, 56.2 (3 x OCH3), 55.9 (3 x CH2C≡).  
 
Compound 394: First step: To a solution of 2,4-dimethylpirrole (2.42g, 25.5 mmol, 1eq.) in dry 
CH2Cl2 (80 mL), at RT and under Ar atmosphere, was slowly added AcCl (0.91mL, 12.75 mmol, 
0.5eq.). the mixture was heated at 50° for 3 hours under stirring. The solvent was removed under 
pressure to give a red solid. 
Second step: The red solid was suspended in a mixture 2:1 Toluene/CH2Cl2 (160/8mL), after 
adding of triethylamine (8.51 mL, 61,15mmol, ) the suspension was maintained at RT and under 
stirring until the complete solubilization (30 minutes). To the solution were added BF3OEt2 
(10.85 mL, 87.91 mmol, ) and the mixture was heated  at 60° for 1,5 h. The volatiles were 
removed under reduced pression and the crude purified by column chromatography on silica gel 
using Hexane/EtOAc (90:10) as eluant to give compound 39 as a brilliant red solid (2.68g, 42%). 
TLC: Rf0.35.  Mp.= 158-160°C. Rf = 0.75 (hexane/EtOAc 8.2).  
 
39
N
B
N
F F
 
 
Compound 405: 2.75 g of N-iodosuccinimide (12.21 mmol) were dissolved in dry CH2Cl2 (35 
mL) and were slowly added to a solution of 39 (1,60 g, 6.10 mmol) in CH2Cl2 (20 mL). The 
mixture was maintained at RT overnight. The solvent was evaporated in vacuo and the crude 
                                                 
4 Florian, A.; Mayoral, M. J.; Stepanenko, V.; Fernandez, G. Chem. Eur. J. 2012, 18, 14957-14961 
 
5 Bonnier, C.; Machin, D. D.; Abdi, O.; Koivisto, B. D. Org Biomol Chem. 2013, 11, 3756-3760 
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purified by column chromatography on silica gel using Hexane/EtOAc (from 90:10 to 70/30) as 
eluant to give compound 40 as a brilliant red solid (2.5g, 80%). Mp. 117-119°C. Rf = 0.65 TLC 
(hexane/AcOEt 8:2).  
N
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N
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Compound 41. 40 (1.10g, 2.14 mmol), Pd(PPh3)Cl2 (57 mg, 0.08 mmol) and CuI (16 mg, 0.08 
mmol) were dissolved in dry THF (35 mL). Then dry Et3N (35 mL) and ethyniltrimthylsilane 
(1.82 mL, 12.84 mmol) were added and the mixture was heated at 70°C for 20h. The volatiles 
were removed under reduced pression and the crude purified by column chromatography on 
silica gel using Hexane/CH2Cl2 (1:2) as eluant to give compound 41 as a orange solid (0.700 g, 
71%). Mp 129-131°C. Rf = 0.50 (TLC hexane/CH2Cl2 1:1).  
N
B
N
F F
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Compound 42.6 41 (0.60 g, 1.93 mmol) was dissolved in dry THF (20 mL). To the mixture,  
cooled at -78°C and under vigorous stirring and under Ar atmosphere, TBAF in THF (5.7mL, 
1M, ) was added dropwise. The solution was maintained at RT for 5h. By adding water it is 
formed a precipitate that was collected by filtration. 42 was obtained as a dark red solid (0.300g, 
73%). Mp 114-116°C.  Rf = 0.40 (Hexane/EtOAc 8:2).  
                                                 
6 Lin, H.-Y.; Huang, W.-C.; Chen, Y.-C.; Chou, H.-H.; Hsu, C.-Y.; Lin, J. T.; Lin, H.-W. Chem. 
Commun. 2012, 48, 8913–8915 
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Compound 43. Compound 4 (0.83 g, 1.29 mmol, 2.0 equiv) and 42 (0.20 g, 0.65 mmol, 1 equiv) 
were dissolved in dry DMF (10 mL). To this mixture was added Pd(PPh3)4 (0.09 g, 0.08 mmol, 
0.12 equiv) and then (10 mL) Et3N. The mixture, under Ar atmosphere, was heated at 65 °C and 
maintained under continuous stirring for 12 h until the disappearance of 4 by (hexane/EtOAc 
2:8). Column chromatography was performed with hexane/EtOAc 50:50 (gradient to 
hexane/AcOEt 30:70) as eluant, and compound 43 was obtained as a violet oil (0.30 g, 0.22 
mmol, 34%). TLC: Rf 0.35 (EtOAc/hexane 70: 30).
1H-NMR of impure product is reported in 
figure 1 (Chapter 3). 
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Compound 45. To a solution of thiol 44(1.90 g, 10.20 mmol) in anh. THF (43 ml), under Ar 
atmosphere at –78°, Triton B sol. (40 wt.% in MeOH, 0.51 ml, 1.33 mmol) was added. After 5 
min stirring at -78°, methyl acrylate (1.03 ml, 11.44 mmol) was added and the reaction was 
allowed to reach r.t. and left stirring until completion (overnight). The mixture was concentrated 
in vacuo and the crude residue was purified by flash cc (AcOEt / hexane 1:9) to provide sulfide 
45 (2.63 g, 9.65 mmol, 95%) as a transparent oil.  
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Rf 0.65 (AcOEt / hexane 3:7). 
1H-NMR (CDCl3): 3.85 (dd, J2',3' = 8.3, 1H, H-2’), 3.70 (s, 3H, 
OCH3), 2.63 and 2. 84 (m, 7H, H2-2, H2-3, H2-10’, OH), 1.00 and 1.76 (m, 7H, H2-3’, H-4’, H2-
5’, H2-6’), 0.82 and 1.05 (2 s, 6H, H3-8’, H3-9’). 13C-NMR (CDCl3): 172.5 (C-1) , 76.7 (C-2’), 
52.1 (C-1’) , 51.9 (OCH3), 47.6 (C-7’) , 45.1 (C-4’) , 39.1 (C-3’),  34.2 (C-2) , 31.9 (C-10’) , 
28.4 (C-3), 27.1 and 31.0 (C-5’and  C-6’)19.9 and 20.6 (C-8’and C-9’). Anal. calc. for 
C14H24O3S (272.40): C 61.73, H 8.88; found: C 61.71, H 8.89. 
 
Compound 46 (epimeric mixture of sulfoxides). A sol. of 45 (2.61 g, 9.58 mmol) in CH2Cl2 (40 
ml) was stirred at –78° and a sol. of m-CPBA (77%, 2.15 g, 9.58 mmol) in CH2Cl2 (40 ml) was 
slowly added. The reaction was monitored by (hexane/EtOAc 8:2)  and appeared complete by 
the end of the oxidant addition. The reaction was quenched by adding aq. Na2S2O3 (10 wt.%) and 
the combined organics were washed twice with a satd. NaHCO3 sol. and twice with brine, dried 
(Na2SO4), filtered, concentrated in vacuo to provide sulfoxide 46 (2.62 g, 9.08 mmol, 95%) as a 
transparent oil. Major epimer Rf 0.10 (hexane/EtOAc 7:3).
 
 
1H-NMR (CDCl3): 4.02 (dd, J2',3' = 8.3, 3.9, H-2’), 3.71 (s, 3H, OCH3), 0.63 and 1.00 (2s, 6H, 
H3-8’, H3-9’), 2.79-3.11 (m, 5H, H2-2, H2-3, OH) 2.38 and 3.25 (AB system, 2H, J10'A,10'B = 13.2, 
H2-10’),1.05-1.85 (m, 7H, H2-3’, H-4’, H2-5’, H2-6’). 13C-NMR (CDCl3): 171.6 (C-1), 76.8 (C-
2’), 53.1 (C-10’), 52.2 (OCH3), 49.2 (C-1’), 48.1 (C-7’), 48.0 (C-3), 44.9 (C-4’), 38.4 (C-3’), 
30.8 (C-5’),  27.0 (C-6’),  26.7 (C-2), 19.8 (C-8’), 20.4, (C-9’).  Anal. calc. for C14H24O4S 
(288.40): C 58.30, H 8.39; found: C 58.28, H 8.40. 
 
General procedure of thermolysis of sulfoxides 46 in the presence of diethynylbenzenes:  
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A sol. of sulfoxides 46 (0.70 g, 2.43 mmol) and commercial diethynyl acceptor (1.84 g, 14.59 
mmol) in DCE (10 ml) was heated at reflux (83 °C) and maintained under stirring until the 
disappearance of starting sulfoxides by (hexane/EtOAc 8:2)  (overnight). The solvent was 
removed under reduced pressure and the crude material was purified by cc on silica gel (hexane/ 
AcOEt, gradient from 9:1 to 7:3) to give the unreacted alkyne and 48 (70% total yield of 
epimeric mixture) or 49 (75% total yield of epimeric mixture). Epimers are reported in order of 
retention time.  
OH
SO
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10'
1'
1
4
2'
 
Compound 48R. (major, more mobile, epimer). White crystals, yield 60%, M.p. 164-166°C, Rf 
0.75 (hexane /AcOEt 7: 3).1H-NMR (CDCl3): 7.35 and 7.53 (AA’BB’ system, J = 8.3, 4H, H-2, 
H-3, H-5, H-6), 6.07 and 6.14 (2 s, 2H, =CH2), 4.16 (dd, J2',3' = 7.9 , 4.4, 1H, H-2’), 2.35 and 2.95 
(AB system, J10'A,10'B = 13.7, 2H, H2-10’), 3.17 (s, 1H, H-C≡), 1.05 and 1.85 (m, 7H, H2-3’, H-4’, 
H2-5’, H2-6’), 0.63 and 1.00 (2 s, 6H, H3-8’, H3-9’). 13C-NMR (CDCl3): 152.3 (C=), 134.0 (C-1), 
126.2 and 132.9  (C-2, C-3, C-5, C-6), 123.4 (C-4), 117.5 (=CH2), , 79.1 (≡CH), 82.7 (C≡), 76.9 
(C-2’), 55.2 (C-10’), 51.5 (C-1’), 48.1 (C-7’), 45.1 (C-4’), 38.4 (C-3’), 27.1 and 30.8 (C-5’, C-
6’), 19.8 and 20.3 (C-8’, C-9’). Anal. calc. for C20H24O2S (328.47): C 73.13, H 7.36; found: C 
73.16, H 7.37. 
 
Compound 48S. (minor, less mobile, epimer). Pale yellow oil, yield 10%, Rf 0.45 (hexane / 
AcOEt 7: 3). 1H-NMR (CDCl3): 7.39 and 7.50 (AA’BB’ system, Jortho = 8.3, 4H, H-2, H-3, H-5, 
H-6) 6.09 and 6.16 (2 s, 2H, =CH2), 4.10 (dd, J2',3' = 7.8, 3.9, 2H, H-2’), 3.38 (broad s, 1H, OH), 
3.16 (s, 1H, ≡CH), 2.37 and 3.21 (AB system, J10'A,10'B = 14.1, 2H, H2-10), 1.05-1.80 (m, 7H, H2-
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3’, H-4’, H2-5’, H2-6’), 0.65 and 0.99 (2 s, H3-8’, H3-9’). 13C-NMR (CDCl3): 151.9 (C=), 134.1 
(C-1), 126.3 and 132.7 (C-2, C-3, C-5, C-6), 123.2 (C-4), 118.2 (=CH2), 82.7 (C≡),79.0 (≡CH), 
76.2 (C-2’), 52.3 and 52.4 (C-1’and C-10’), 48.9 (C-7’), 44.5 (C-4’), 40.0 (C-3’), 29.6 and 31.3 
(C-5’, C-6’), 20.1 and 20.3 (C-8’, C-9’).  Anal. calc. for C20H24O2S (328.47): C 73.13, H 7.36; 
found: C 73.11, H 7.35. 
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Compound 49R (major, more mobile, epimer). Yellow crystals, yield 64%, Mp 108-110°C, Rf 
0.78 (hexane /AcOEt 7: 3). 1H-NMR (CDCl3): 7.36 and 7.54 (m, 4H, H-2, H-4, H-5, H-6), 4.17 
(dd, J2',3' = 8.3, 3.9, 2H, H-2’), 6.07 and 6.14 (2 s, 2H, =CH2), 3.94 (broad  s, 1H, OH), 3.15 (s, 
1H,  ≡CH), 2.36 and 2.96 (AB system, J10'A,10'B = 13.2, 2H, H2-10’), 1.10 and 1.93 (m, 7H, H2-3’, 
H-4’, H2-5’, H2-6’), 0.64 and 1.02 (2 s, 6H, H3-8’, H3-9’). 13C-NMR (CDCl3): 152.0 (C=) 133.7 
(C-1), 126.4, 129.1, 129.7 and 132.8 (C-2, C-4, C-5, C-6), 123.2 (C-3), 117.4 (=CH2), 82.3 
(C≡),78.5 (≡CH), 76.7 (C-2’), 54.9 (C-10’), 51.3 (C-1’), 47.9 (C-7’), 44.9 (C-4’), 38.2 (C-3’), 
26.9 and 30.6 (C-5’, C-6’), 19.8 and 20.2 (C-8’, C-9’).  Anal. calc. for C20H24O2S (328.47): C 
73.13, H 7.36; found: C 73.15, H 7.36. 
 
Compound 49S (minor, less mobile, epimer). Pale yellow oil, yield 11%, Rf 0.50 (hexane 
/AcOEt 3:7). 1H-NMR (CDCl3): 7.32-7.53 (m, 4H, H-2, H-4, H-5, H-6), 6.05 and 6.12 (2 s, 2H, 
=CH2), 4.07 (dd, J2',3' = 7.5, 3.5, 2H, H-2’), 3.12 (s, 1H, ≡CH), 3.11 (broad s, 1H, OH), 2.33 and 
3.17 (AB system, J10'A,10'B = 14.2, 2H, H2-10’), 1.00 and 1.83 (m, 7H, H2-3’, H-4’, H2-5’, H2-6’),  
0.62 and 0.96 (2 s, 6H, H3-8’, H3-9’). 13C-NMR (CDCl3): 151.5 (C=), 134.1 (C-1), 126.7, 129.0, 
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129.8 and 132.7  (C-2, C-4, C-5, C-6), 123.0 (C-3), 118.0 (=CH2), 82.6 (C≡),78.4 (≡CH), 76.1 
(C-2’), 52.2 and 52.5 (C-1’, C-10’), 48.7 (C-7’), 44.5 (C-4’), 40.1 (C-3’), 27.3 and 31.2 (C-5’), 
C-6’), 20.0 and 20.2 (C-8’, C-9’). Anal. calc. for C20H24O2S (328.47): C 73.13, H 7.36, found: C 
73.14, H 7.35. 
 
Compound 50 and 51. Pd(PPh3)4 (0.07 g, 0.06 mmol), 1,4-diiodo-2,5-dimethoxybenzene (0.20 
g, 0.51 mmol) and the alkyne 48R or 49R (0.39 g, 1.19 mmol) were dissolved in dry DMF (8 
ml). To this mixture Et3N (8 ml) was added. The mixture was heated at 60 °C and maintained 
under continuous stirring under Ar until the disappearance of the alkyne was verified by 
(hexane/EtOAc 1:1)  Solvents were removed under reduced pressure. The reaction crude was 
subjected to silica gel cc (eluant hexane / AcOEt 3:7). 
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Compound 50. 3 Hours reaction time, Yellow crystals, yield 85%, M.p. 200-202°C, Rf 0.55 
(hexane /AcOEt 6:4). 1H-NMR (CDCl3): 7.40 and 7.62 (AA’BB’ system, Jortho = 8.3, 4H, H-2",H-
3", H-5", H-6"), 7.04 (s, 2H, H-3, H-6), 6.10 and 6.15 (2 s, 2H, =CH2), 4.17 (dd, J2',3' = 8.3, 4.4, 
1H, H-2'), 3.94 (broad s, 1H, OH), 3.92 (s, 3H, OCH3), 2.38 and 2.97 (AB system, J10'A,10'B = 
13.4, 2H, H2-10'), 1.88 and 1.11 (m, H2-3’, H-4’, H2-5’, H2-6’), 0.64 and 1.02 (2 s, H3-8’, H3-9’). 
13C-NMR (CDCl3): 153.9 (C-2), 152.3 (C=), 132.0 (C-1", C-5), 126.2, 132.4 (C-2", C-3", C-5", 
C-6"),124.4 (C-4"),117.2 (=CH2), 115.5 (C-3, C-6),  113.2 (C-1, C-4), 92.2 and 87.4 (C≡C), 76.9 
(C-2'), 56.4 (OCH3), 55.2 (C-10'), 51.4 (C-1'), 48.0 (C-7'), 45.0 (C-4'), 38.4 (C-3'), 30.8 and 27.0 
164 
 
(C-5', C-6'), 20.3 and 19.7 (C-8', C-9'). Anal. calc. for C48H54O6S2 (791.07): C 72.88, H 6.88; 
found: C 72.90, H 6.90. 
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Compound 51. 20 Hours reaction time, Yellow crystals, yield 80%, Mp 102-104°C; Rf 0.47 
(hexane /AcOEt 6: 4). 1H-NMR (CDCl3): 7.61 and 7.34 (m, 3H, H-2", H-4", H-6"), 7.06 (s, 2H, 
H-3, H-6), 6.09 and 6.16 (2 s, 2H, =CH2), 4.17 (ddd, J2',3' = 7.8, 3.9, J2',OH = 2.9, 1H, H-2'), 3.95 
(d, 1H, OH), 3.93 (s, 3H, OCH3), 2.39 and 2.98 (AB system, J10'A,10'B = 13.2, H2-10'), 1.12-1.83 
(m, 7H, H2-3’, H-4’, H2-5’, H2-6’), 0.62 and 1.02 (2 s, H3-8’, H3-9’). 13C-NMR (CDCl3): 153.9 
(C-2, C-5), 152.3 (C=), 134.0 (C-1"), 126.1, 129.2, 129.6 and 132.5 (C-2", C-4", C-5", C-6"), 
124.4 (C-3"), 117.6 (=CH2), 115.5 (C-3, C-6), 113.2 (C-1, C-4), 86.7 and 94.0 (C≡C), 76.9 (C-
2'), 56.4 (OCH3), 55.1 (C-10'), 51.4 (C-1'), 48.1 (C-7'), 45.1 (C-4'), 38.4 (C-3'), 27.0 and 30.7 (C-
5', C-6'), 19.7 and 20.3 (C-8', C-9'). Anal. calc. for C48H54O6S2 (791.07): C 72.88, H 6.88; found: 
C 72.91, H 6.87. 
 
Compound 50. Azobenzene 49 (1.00 g, 2.30 mmol, 1 equiv), 1 (1.66 g, 4.60 mmol, 2 equiv), 
Pd(PPh3)4 (0.32 g, 0.28 mmol, 0.12 equiv) were dissolved in dry DMF (10 mL). To the mixture 
was added slowly Et3N (10 mL). The mixture under Ar atmosphere was heated at 60 °C and 
maintained under continuous stirring. The reaction was monitored by TLC (hexane/EtOAc 6:4)  
and appeared complete by the end of the compound 1. The volatiles were removed in vacuo. 
Column chromatography was performed with hexane/AcOEt 70:30 as eluant, and compound 50 
was obtained as a dark orange solid (2.50 g, 2.63mmol, 81%). TLC: Rf 0.40 (hexane/EtOAc 
60:40).  
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1H NMR: 7.90 (d, J2,3 = J5,6 = 8.7, 4H, H-3,5), 7.59 (d, J2,3 = J5,6 = 8.7, 4H, H-2,6), 5.28 (t, J2',3' 
= J3',4' = 9.3, 2H, 2 x H-3’), 5.14 (t, J3',4' = J4',5' = 9.3, 2H, 2 x H-4’), 5.06 (dd, J1',2' = 8.3, J2',3' = 9.3, 
2H, 2 x H-2’), 4.86 (d, J1',2' = 8.3, 2H, 2 x H-1’), 4.64 (s, 4H, 2 x CH2C≡), 4.32 and 4.15 (split 
AB system, J5',6'A = 5.6, J5',6'B = 2.4, J6'A,6'B = 12.2, 4H, 2 x H2-6’), 3.77 (ddd, J4',5' = 9.3, J5',6'A = 
5.6, J5',6'B = 2.4, 2H, 2 x H-5’), 2.09, 2.06, 2.03, and 2.02 (four s, 24H, 8 x CH3CO). 13C NMR: 
170.7, 170.3, 169.5, and 169.4 (8 x CO), 152.0 (2xC-1), 132.6 (2xC-2,6), 123.1 (2xC-3,5), 
98.5 (2 x C-1’), 89.7 and 86.1 (2 x C≡C), 72.8 (2 x C-3’), 71.9 (2 x C-5’), (2 x C-2’), 68.3 
(2 x C-4’), 61.8 (2 x C-6’), 57.0 (2 x CH2C≡), 20.7 and 20.6 (8 x CH3CO).  
 
Compound 51. Azobenzene 49 (1.00 g, 2.30 mmol, 1 equiv), 4 (2.95 g, 4.6 mmol, 2 equiv), 
Pd(PPh3)4 (0.32 g, 0.27 mmol, 0.12 equiv) and Ag2O (1.00g, 4.6mmol, 2equiv) were weighted in 
a flask. The solids were suspended in dry DMF/THF (2:1, 18mL). The obtained mixture under 
Ar atmosphere was heated at 60 °C and maintained under continuous stirring for 7h until the 
disappearance of 4 by TLC (hexane/EtOAc 6:4). The solution was filtered on Celite/Silica 1:1 
and the volatiles were removed in vacuo. Column chromatography was performed with 
hexane/AcOEt 50:50 as eluant, and compound 51 was obtained as a brilliant orange solid (1.60 
g, 1.26mmol, 54%). TLC: Rf 0.25. 
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1H NMR: 7.93 (d, J2,3 = J5,6 = 8.7, 4H, 2xH-3,5), 7.72 (d, J2,3 = J5,6 = 8.7, 4H, 2xH-2,6), 7.05 
and 6.96 (two s, 4H, 2xH-3’,5’) 5.28 (t, J2’',3’' = J3’',4’' = 9.3, 2H, 2 xH-3’’), 5.13 (t, J3’',4'’ = J4’',5’' = 
9.3, 2H, 2 x H-4’’), 5.06 (dd, J1’',2’' = 8.3, J2’',3’' = 9.3, 2H, 2 x H-2’’), 4.66 (d, J1’',2’' = 8.3, 2H, 2 x 
H-1’’), 4.64 (s, 4H, 2 x CH2C≡), 4.32 and 4.15 (split AB system, J5’',6’'A = 5.6, J5’',6’'B = 2.4, 
J6’'A,6’'B = 12.2, 4H, 2 x H2-6’’), 3.91 and 3.90 (two s, 12H, 4 x OCH3), 3.77 (ddd, J4’',5'’ = 9.3, 
J5’',6’'A = 5.6, J5’',6’'B = 2.4, 2H, 2 x H-5’’), 2.09, 2.07, 2.04, and 2.02 (four s, 24H, 8 x CH3CO). 
13C NMR: 170.7, 170.3 and 169.4 (8 x CO), 154.1 (2xC-2’,5’), 151.9 (2xC-1), 132.6 (2xC-
2,6), 123.0 (2xC-3,5), 116.1 and 115.7 (2x C-3’,6’), 113.6 and 112.8 (2xC-1’,4’), 98.3 (2 x C-
1’’), 94.9, 89.2, 88.2 and 83.4 (2 x C≡C), 72.8 (2 x C-3’’), 71.9 (2 x C-5’’), (2 x C-2’’), 
68.4 (2 x C-4’), 61.8 (2 x C-6’’), 57.0 (2 x CH2C≡), 56.5 and 56.4 (4 x OCH3), 20.7 and 20.6 (8 
x CH3CO).  
 
6.2 Equipment and methods for the absorption spectroscopy and photophysical 
experiments 
UV/Vis absorption spectra were taken on a Jasco V-560 spectrophotometer. For steady-state 
luminescence measurements, a Jobin Yvon-Spex Fluoromax 2 spectrofluorimeter was used, 
equipped with a Hamamatsu R3896 photomultiplier. The spectra were corrected for 
photomultiplier response using software purchased with the fluorimeter. For the luminescence 
lifetimes, an Edinburgh OB 900 time-correlated single-photon-counting spectrometer was used. 
As excitation sources, a Hamamatsu PLP 2 laser diode (59 ps pulse width at 408 nm) and/or the 
nitrogen discharge (pulse width 2 ns at 337 nm) were employed. Emission quantum yields for 
acetonitrile deaerated solutions were determined using the optically diluted method.3 As 
luminescence quantum yield standards we used an air equilibrated ethanol solution of anthracene 
(0.2).4 
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Experimental uncertainties on the absorption and photophysical data are as follows: absorption 
maxima, 2 nm; molar absorption, 15%; luminescence maxima, 4 nm; luminescence lifetimes, 
10%; luminescence quantum yields, 20%. 
 
Singlet oxygen evaluation. A direct comparison between the oligomers and Methylene blue 
species in solution by monitoring the UA photooxidation is not possible, because different 
excitation wavelengths were used for the photoproduction of 1O2. Therefore, the efficiency of 
singlet-oxygen deliver was calculated by normalizing for the photon flux of the lamp at the 
lambda used for excitation (400 nm for OPEs and 600 nm for the methylene blue).  
The absorption spectra were recorded in ultrapure spectroscopic solvents. UV/Vis absorption 
spectra were taken on a Jasco V-560 spectrophotometer. For steady-state luminescence 
measurements, a Jobin Yvon-Spex Fluoromax 2 spectrofluorimeter was used, equipped with a 
Hamamatsu R3896 photomultiplier. The spectra were corrected for photomultiplier response 
using software purchased with the fluorimeter. For the luminescence lifetimes, an Edinburgh OB 
900 time-correlated single-photon-counting spectrometer was used. As excitation sources, a 
Hamamatsu PLP 2 laser diode (59 ps pulse width at 408 nm) and/or the nitrogen discharge (pulse 
width 2 ns at 337 nm) were employed. Emission quantum yields for acetonitrile deaerated 
solutions were determined using the optically diluted method.37 As luminescence quantum yield 
standards we used an air equilibrated ethanol solution of anthracene (0.2).38 Experimental 
uncertainties on the absorption and photophysical data are as follows: absorption maxima, 2 nm; 
molar absorption, 15%; luminescence maxima, 4 nm; luminescence lifetimes, 10%; 
luminescence quantum yields, 20%. 
 
6.3 Biological study. Materials And Methods 
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Cell cultures. The human carcinoma cells used in this study were HEp-2 (derived from a larynx 
carcinoma) and HeLa (derived from a cervical carcinoma) cells.  
HEp-2 cells were grown on culture slides and treated with compounds 9, 10, 11, 18 and 31 to a 
final concentration of 100 μM (in RPMI medium) for 24h. The cells were subsequently analyzed 
using a DAPI filter (blue emission) or a FITC filter (green emission). In addition to evaluate the 
capability to emit also at lower concentrationHEp-2 cells were grown on 12 well plates and 
treated with a solution of compound-20 to a final concentration of 100 μM, 10 μM and 1 μM (in 
RPMI medium) for 24h. The cells were subsequently detached from the substrate using trypsin 
and layered on polylysinated slides. Samples were  analyzed using a DAPI filter (blue emission) 
(objectives 40 X) on a Biomed fluorescence microscope (Leitz, Wetzlar, Germany). To test the 
cells toxicity of compounds a standard trypan blue exclusion assay was employed. 
The spontaneously transformed HaCaT cell line, obtained from human keratinocytes, has been 
used as control of nontumorogenic cells. HeLa and HaCaT cells were cultured using Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 10% (v/v) fetal bovine serum (FBS), 50 
units/mL penicillin and 50 µg/mL streptomycin. HEp-2 cells were cultured in RPMI medium 
also supplemented with FBS, penicillin and streptomycin (all from GE Healthcare Life Sciences, 
HyClone Laboratories, Logan, Utah, USA). Cell cultures were performed under standard 
conditions at 37ºC, 95% of humidity and 5% of CO2 and the medium was changed each two 
days. 
 
Photosensitizers administration. Stock solutions of both 18 (3-OPE18) and 28 (3-OPE28) were 
prepared in DMSO (Panreac) at a concentration of 10-3 M. The work solutions were obtained by 
dissolving the compounds in DMEM/RPMI with 1% FBS. The final concentration of DMSO 
was always lower than 0.5% (v/v), and the lack of toxicity of this solvent for the cells was also 
tested and confirmed. All the treatments were performed when cultures reached around 60-70% 
of confluence.  
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Intracellular localization of 18 (3-OPE18) and 28 (3-OPE28) For the analysis of 18 (3-OPE18) 
and 28 (3-OPE28)  subcellular localization, the cells were plated on glass coverslips placed into 
wells and incubated with 1x10-6 M of 18 (3-OPE18) or 28 (3-OPE28) for 6 h at 37ºC. After 
incubation, cells were washed twice with PBS, mounted on slides with a drop of PBS and 
immediately observed under the fluorescence microscope coupled to a digital capture camera 
(Olympus BX61) using the appropriate filters of excitation light (UV, 365 nm, exciting filter 
UG-1). In addition, to better determine the intracellular localization of 1 (NMe2) or 2 (bis-NMe2), 
the distribution pattern of both compounds was compared with that of specific organelles. For 
this purpose, cells were incubated with known fluorescent probes for endoplasmic reticulum 
(ER-Tracker, Molecular Probes; Eugene, OR) and Golgi apparatus (NBD, Molecular Probes; 
Eugene, OR). The fluorescent probes were used at the concentrations indicated by the suppliers 
and were incubated for 30 min. After incubation, cells were washed twice in PBS and observed 
under fluorescence microscope. The fluorescence excitation and emission wavelengths of ER-
Tracker were 374 and 430 nm respectively. In the case of NBD were 466 and 536 nm 
respectively. 
Photodynamic treatments. Cells seeded on 24 well plates were incubated for 6 h with variable 
concentrations of 18 (3-OPE18) and 28 (3-OPE28) (from 3 x 10-6 M to 2.5 x 10-5 M). 
Afterwards, the media were removing, replaced by fresh media and cells were irradiated with 
different UVA light doses, ranging from 0.25 to 2 J/cm2 (UVA source: CAMAG, λ = 300-400 
nm, power: 15.9 W/m2 at 10 cm from the source). After irradiation, cells were washed three 
times with PBS, complete DMEM or RPMI was added, and were maintained in the incubator for 
24 h until evaluation. To assess the possible dark cytotoxic effect of both PSs, cells were 
incubated in the dark for 18 h with different PS concentrations. In the same way, to test the effect 
of UVA light alone, cells were subjected to different light doses (0.25 - 2 J/cm2). 
Morphological Studies. Changes in general cell morphology and nuclear morphology after PDT 
were analyzed by phase contrast microscopy and Höescht-33258 staining, respectively. In the 
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second case, cells were fixed in formaldehyde (3.7% in PBS) for 15 min, washed and stained 
with 2.5 μg/mL Hoescht- 33258 dye (H-33258) (Sigma) for 5 min. After washing with distilled 
water, preparations were mounted with ProLong® Gold Antifade Reagent (Invitrogen). Death 
type was determinate analyzing nuclei morphology according to morphological criteria 
previously published.39 
 
Viability assays. Cell viability was assessed 24 h after treatments using the MTT assay and the 
acridine orange (AO)/ethidium bromide (EtBr) method. Regarding the MTT assay, following 
treatments, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT Sigma, St Louis, 
USA) solution was added to each well at a final concentration of 50 µg/mL, and plates were 
incubated at 37˚C for 4 h. The formazan crystals were dissolved in DMSO and the absorbance at 
542 nm was measured using a spectrophotometer (Espectra Fluor 4, Tecan). The results were 
expressed as cell survival percentage of control (cell survival (%) = (mean OD value of PDT-
treated cells / mean OD value of control cells) x 100%).  
The AO/EB method was applied according as previously described by Liu and cols.40 This 
method allowed us to confirm the tendency of the cell death rate detected by MTT assay and, 
moreover, to determine approximately the type of cell death induced by PDT. AO is a vital dye 
able to stain nuclear DNA across an intact cell membrane, while EB can only stains cells that 
have lost their membrane integrity. A solution of PBS containing 50 µg/ml AO and 50 µg/ml EB 
was prepared. Then, 300 µL of this solution were added to each well and immediately analyzed 
under the fluorescent microscope. 200 cells of each condition were counted within 15 min after 
the addition of the fluorochromes. Cells were classified as (1) living cells (uniformly stained as 
green), (2) rounded cells (possible mitotic arrest and densely stained as green); (3) apoptotic cells 
(early apoptosis: densely stained as green but showing orange fragments; late apoptosis: densely 
stained as orange and condensed chromatin) and (4) necrotic cells (uniformly stained as orange-
red stained and no chromatin condensation) (Figure S16, ESI). 
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Immunofluorescence. For immunodetection of α-tubulin, cells were raised on coverslips and 
subjected to PDT and, 24 h after treatment, were fixed and permeabilized in methanol (-20ºC) 
for 7 min. Then, cells were washed twice in PBS and incubated with α -tubulin primary antibody 
(Sigma-Aldrich. St. Louis, MO) for 1 h at 37ºC.  After washing, cells were incubated with Alexa 
Fluor 488-conjugated goat anti-mouse IgG secondary antibody (1:250) (Invitrogen, California, 
USA) for 45 min at 37ºC, washed in PBS and mounted in Prolong Gold Antifade Reagent 
(Invitrogen, California, USA).  
 
Microscopical observations and statistical analysis. Microscopic observation was carried out 
using a fluorescence microscope (Olympus BX61) equipped with the following filter sets for 
fluorescence microscopy: ultraviolet (UV, 365 nm, exciting filter UG-1), blue (450−490 nm, 
exciting filter BP 490), and green (545 nm, exciting filter BP 545). Images were obtained with 
the digital camera Olympus CCD DP70 and processed using the Adobe PhotoShop CS5 
extended version 12.0 software (Adobe Systems Inc., USA).  
Data are expressed as the mean value ± standard deviations (SD). Statistical analysis was carried 
out with SPSS Statistics 20.0 (IBM®). The statistical significance was determined using the T 
test for independent samples (*: P<0.1; **: P<0.05; ***: P<0.01). 
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